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Abstract 
Articular cartilage is a thin hydrated tissue, which covers articulating surfaces. In the native 
articular cartilage tissue, the extracellular matrix (ECM) is a fibrillar mesh of interacting 
proteoglycans, collagens, and other non-collagenous proteins residing in a highly aqueous 
environment. Chondrocytes are surrounded by a pericellular matrix (PCM) forming chondrons. The 
PCM, exclusively rich in collagen VI, is more easily destroyed during their extraction and 
subsequent in vitro culture than ECM. The retention of the PCM has a significant influence on the 
metabolic activity of the chondrocytes in addition to the mechanical signalling from and to the 
ECM via cell-matrix interactions. The ECM and the residing chondrocytes are organised into three 
distinct zones: superficial, middle and deep. The complex and organised structure of cartilage 
allows it to resist the tensile stress ‘superficial zone’, sheer stress ‘middle zone’, and compressive 
stress ‘middle and deep zones’ imposed by articulation.  
This study initially focused on the morphology and chondrogenic capacity of chondrocytes, 
chondrons (bovine) and mesenchymal stromal cells (MSCs, rat) alone in monolayer cultures to 
establish a baseline of PCM preservation and regeneration approaches. Co-culture monolayer 
models of cartilage cells with MSCs (20%, 50% and 80%) was established to assess the effect of 
MSC on PCM maintenance and ECM production by biochemical assays, immunofluorescence and 
histological staining. Co-culture of MSCs with chondrons enhanced ECM production, as compared 
to chondrocyte or chondron monocultures. The co-culture of MSCs with chondrons appeared to 
decelerate the loss of the PCM as determined by collagen VI expression, whilst the expression of a 
high temperature requirement family of serine proteases, HtrA1, demonstrated an inverse 
relationship to that of the collagen VI. The 50:50 ratio of MSCs: chondrons in co-culture presented 
the highest potential for better cartilage regeneration. For the first time, it is confirmed that MSCs 
directly or indirectly inhibited HtrA1 activity in the co-culture, which played a role in enhancement 
of ECM synthesis and the preservation of the PCM. However, PCM could not be fully preserved or 
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regenerated in 2D culture up to 7 day culture even starting from chondron, and co-culture with 
MSCs. 
Next 3D model systems using hydrogels to improve PCM formation and maintenance were 
developed. Four culture conditions were compared; hyaluronic acid (HA) versus agarose hydrogel; 
basal medium versus chondrogenic medium; chondron or chondrocytes versus co-culture with 50% 
MSC. Up to 21 day culture, chondron samples in both mono- and co-culture maintained PCM at all 
culture conditions. The quantity and quality of regenerated PCM in chondrocyte samples were 
culture condition dependent. HA in combination with chondrogenic media and co-culture with 
MSC was the best support for PCM generation and ECM deposition. Basal and chondrogenic 
culture mediums influenced the expression of cartilage-specific ECM markers but did not affect 
collagen VI synthesis. Synchrotron microFTIR measurements assisting with PCA analysis of 
spectra in fingerprint and lipid regions on the 3D cultured samples have cross-validated that 
culturing chondrocytes in HA hydrogel up to 21 days might generate chondron-like cell 
morphology and composition because day 14 and day 21 samples clustered to chondron spectra, 
whilst day 7 samples to chondrocyte spectra. 
Zonal-specific 3D hybrid scaffolds have been fabricated using a combination of polylactic acid and 
HA to induce the generation of near-native cartilage. For the superficial and middle zones, 
specifically orientated or randomly arranged polylactic acid nanofibre meshes were embedded in 
HA. For the deep zone, vertical channels in HA were created. The aligned nanofiber mesh used in 
the superficial zone induced an elongated cell morphology, lower GAG and collagen II production, 
than the middle zone scaffold. Within the middle zone scaffold, which comprised of a randomly 
orientated nanofiber mesh, the cells were clustered and expressed more collagen II. The deep zone 
scaffold induced the highest GAG production, the lowest cell proliferation and the lowest collagen 
I expression of the three zones. Overall a convenient and reproducible model system which mimics 
the zonal organisation of articular cartilage has been developed.  
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Chapter 1 : Introduction and literature review 
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1.1 Introduction 
Cartilage tissue is a soft connective tissue that is found in different parts of the human body such as 
the pinna of the ear, intervertebral discs, nose, and the knee. It has elastic, flexible and semi-
transparent properties, and can be classified into; elastic cartilage, fibrocartilage and hyaline 
cartilage based on its location, structure, and relative contribution as well as distribution of 
extracellular matrix (ECM) composition (Stockwell, 1979; Huber et al., 2000). 
The most common type of cartilage is hyaline cartilage which is found in the articular surfaces of 
joints. Proteoglycans (mainly aggrecan), collagen II and water are the key ECM components in 
hyaline cartilage. Fibrocartilage is often found at the ends of tendons and ligaments in bone 
attachment. The main ECM components of fibrocartilage include collagen I with smaller amounts 
of collagen II and aggrecan. The ear and nose are the places where elastic cartilage is found. This 
cartilage type is characterized by the presence of elastin (elastic fibres) in the ECM (Stockwell, 
1979; Nigg et al., 1999). 
Articular cartilage is a thin hydrated tissue that has a thickness approximately 1.5–3 mm in the 
adult knee (Zhang et al., 2009). It has a complex framework that provides the mechanical 
properties required to perform its functions (Huber et al., 2000). The major functions of articular 
cartilage include providing a smooth and stable movement of the joints, reducing the friction 
between the bones as well as providing resistance to shear and compressional force (Nigg et al., 
1999). 
Nevertheless, the ability of articular cartilage to repair itself is very low, since is lacks both blood 
vessels and nerves. Hence, both the cartilage and the joint are unable to function when the cartilage 
is damaged. Damage and subsequent degeneration can progress to a medical condition known as 
osteoarthritis (OA) (Hoemann, 2004). 
` 
   3   
 
OA is characterized by a gradual loss of cartilage which is accompanied by abnormal changes in 
the subchondral bone and synovium. Pain in the joints and restriction in joint movement resulting 
in disability can lead to a poor quality of life among patients (Loeser et al., 2012). According to 
Arthritis Research UK, 33% of people who are 45 years old and above have sought treatment for 
OA of the hip and knee (Arthritis Research UK, 2013). 
1.2 Composition and structure of articular cartilage  
Articular cartilage is a unique type of connective tissue that covers the ends of the long bones in 
synovial joints such as the knee. It is solely composed of a particular type of cell known as 
chondrocyte which greatly varies in density and phenotype with increasing depth from the articular 
surface (Huber et al., 2000). Chondrocytes are encapsulated within dense ECM (Stockwell, 1979) 
which is depicted in Figure 1.1. 
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Figure  1.1: Composition and structure of articular cartilage (Taken from Zhang et al., 2009). 
1.2.1 Chondrocytes  
About 1-5% of the total volume of cartilage tissue is occupied by chondrocytes and this is low 
compared to other tissue types such as skin or liver. In general, chondrocytes have a diameter 
approximately 13 μm (Hunziker, 2002). Chondrocytes vary in size and morphology across different 
regions of articular cartilage as they change from being spherical to being flat though they 
generally have an ovoid shape (Hunziker et al., 2002).  
In ECM, chondrocytes are responsible for the anabolic and catabolic activities to maintain the 
function and integrity of tissue (Archer and Francis-West, 2003). The correct size and mechanical 
properties of cartilage are maintained by chondrocytes actively replacing degraded matrix 
molecules to maintain homeostasis. Furthermore, the net synthesis and degradation of matrix 
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components (matrix turnover) must be maintained in order to guarantee consistent functioning of 
tissues. In fact, in the event that homeostasis becomes unbalanced then it will greatly affect the 
mechanical properties (Melero-Martin et al., 2007).  
1.2.2 Cartilage extracellular matrix (ECM) 
A hydrated ECM forms a major part of articular cartilage which contains a substantial amount of 
fluid (mainly water and also dissolved ions, gases and metabolites) corresponding to 60-80% of the 
total wet weight of the tissue (Mankin and Thrasher, 1975; Hoemann, 2004). The remaining 20-
40% of the total weight of the tissue consists of a variety of ECM molecules which are mainly 
collagens (50-70%, dry weight), proteoglycans (15- 30%, dry weight), and other non-collagenous 
proteins (15-20%, dry weight) (Buckwalter et al., 2005). The major components of articular 
cartilage are shown in Figure 1.2. 
 
Figure  1.2: A schematic drawing showing the major components of articular cartilage including 
chondrocytes, collagen II fibrils and aggregating proteoglycans (aggrecans) (Taken from 
https://veteriankey.com/oral-joint-supplements-in-the-management-of-osteoarthritis/). 
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1.2.2.1 Collagens of articular cartilage 
In most tissues, the major insoluble fibrous proteins of the ECM are collagens. Structurally, 
collagen comprises 3 polypeptide chains connected together by hydrogen bond to form a triple 
helical structure (Eyre, 2004). Each collagen chain has a sequence of amino acid with a unique 
pattern of repeating glycine in every third unit. Amino acids, proline and hydroxyproline make up 
about 20 % of the amino acids in collagen (Brodsky and Shah, 1995).  
The ECM contains at least 20 different types of collagen, and the predominant type varies based on 
the tissue. Although collagen II is the most abundant and characteristic collagen of articular 
cartilage, other types such as collagens I, V, VI, IX, X and XI are also found in smaller amounts 
(Mayne, 1989). Large fibrils are formed through the combination of types II, IX and XI, which then 
join together to give a mesh-like network. This mesh is responsible for the strength and tensile 
properties of articular cartilage (Cohen et al., 1998). Collagen VI is considered the main part of 
pericellular matrix (PCM) immediately surrounding the chondrocyte. Collagen VI supports the 
linking of chondrocytes to the ECM but its precise role is still under investigation (Poole, 1997). 
Collagen X contributes to the mineralization of cartilage and produces strength in the tissue. It only 
exists in cartilage-bone interface area (osteochondral region) (Schmid and Linsenmayer, 1985). 
The main collagens types found in articular cartilage are summarized in Table 1.1. 
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Table  1-1: Collagens found in cartilage and their roles within articular cartilage (Adapted from 
Mayne, 1989) 
Collagen type  Description 
Type II Makes up 80-95% of total collagen; forms the collagen fibrils 
Type IX Present on the surface of fibrils of collagen II; links fibrils to other 
components or to each other  
Type XI Present on the surface of fibrils collagen II; role in determining fibril 
diameter  
Type X Present in cartilage – bone interference area; contributes to cartilage 
mineralization and provide tissue integrity  
Type VI  Present in the PCM surrounding the chondrocytes; supports chondrocytes 
linking to the ECM 
1.2.2.2 Proteoglycans of Articular Cartilage 
Proteoglycans are large hydrophilic molecules composed of approximately 95% polysaccharide 
and 5% protein (Bayliss et al., 1983; Mankin et al., 2000). The proteoglycan distension mechanism 
enables the collagen fibres to contribute to cartilage compressive resistance (Huber et al., 2000).  
One of the main constituent of proteoglycan is the glycosaminoglycan (GAG). GAGs are long 
unbranched polysaccharides containing repeating disaccharides together with an amino sugar. 
GAGs are divided into 3 major groups based on their sugars, which include hyaluronan, 
chondroitin sulfate and keratan sulfate (Temenoff and Mikos, 2000). Table 1.2 demonstrates the 
major glycosaminoglycan found in cartilage. 
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Table  1-2: Major glycosaminoglycan found in cartilage and their roles within articular cartilage 
(Adapted from Muir, 1978) 
Glycosaminoglycan (GAG) type  Description 
Hyaluronan An anionic and non-sulfated disaccharide unit. It 
attachs to aggrecan to form huge supramolecular 
proteoglycan aggregates, which bind to collagen 
fibrillar network for load bearing 
Chondroitin sulfate  It is a disaccharide unit with highly sulfate modified. 
It represents up to 90% of the total GAG, providing a 
viscous phase to reduce friction and compressive load 
Keratan sulfate  A highly sulfated disaccharide unit. It helps to 
maintain the charge density of the aggrecan molecules 
to provide essential osmotic pressure  
The major type of proteoglycan found in articular cartilage is aggrecan (Hardingham et al., 1994). 
Its structure is made up of a polypeptide core protein to which are attached GAG side chains; 
chondroitin sulphate and keratan sulphate polysaccharides. Link protein connects the long 
polysaccharide chain of hyaluronan to aggrecan molecules. About 100 aggrecan molecules can 
align and interact with a single hyaluronan fibre giving rise to huge supramolecular proteoglycan 
aggregates which are trapped within a dense collagen II fibre network (Hardingham and Muir, 
1972; Huber et al., 2000; Milner et al., 2012). 
The main functions of articular cartilage include minimizing joint friction, distributing loads and 
resisting shear and compressive forces (Nigg et al., 1999; Ateshian et al., 2003).  
Cartilage has viscoelastic properties because contains solid and liquid phases and the interactions 
between these two phases characterise the viscoelastic properties of this tissue (Zhang et al., 2009). 
Articular cartilage encounters numerous mechanical stimuli such as compressive stress, shear stress 
and tensile stress under normal physiological conditions (Nigg et al., 1999). The biochemical 
composition of articular cartilage is affected by these mechanical stimuli. For instance, the ECM 
content of a cartilage in high-loading areas is more than that of a cartilage in low-loading areas 
(Treppo et al., 2000). Collagen fibrils are the main contributors to the tensile properties of articular 
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cartilage. Since different zones have different collagen organization, the tensile properties vary 
significantly among zones (Klein et al., 2009). 
The negative charge density increases as a result of the presence of proteoglycans with highly 
negatively charged GAGs in the ECM, and this helps to attract free cations in the fluid into the 
tissue (Bayliss et al., 1983; Zhang et al., 2009). An osmotic pressure known as the ‘Donnan 
osmotic pressure’ is formed due to the resultant high density of ions within the tissue. The water is 
expelled over the cartilage pores when the tissue is compressed. However, some residual water 
remains inside the tissue due to the Donnan osmotic pressure. This residual water experiences the 
compressive force in the cartilage and endows the cartilage with its viscoelastic properties 
(Ateshian et al., 2003; Zhang et al., 2009). This allows for a better load distribution and helps in 
lubrication of joint throughout loading (Stockwell, 1979; Nigg et al., 1999). 
The proteoglycan aggregate (aggrecan) found in the ECM of articular cartilage is shown in Figure 
1.3. 
 
Figure  1.3 : A proteoglycan aggregate present in articular cartilage ECM (Taken from King, 2014. 
Integrative Medical Biochemistry and Board Review. www.accesspharmacy.com) 
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Aside from large proteoglycan (aggrecan), smaller proteoglycans like decorin, biglycan and 
fibromodulin also found articular cartilage and they constitute approximately 3% of total 
proteoglycan mass (Huber et al., 2000). They have shorter protein cores and fewer GAG chains 
than their aggrecan. Unlike aggrecan, these molecules do not affect physical properties of the 
tissue, but are thought to play a role in cell function and organization of the collagen matrix 
(Temenoff and Mikos, 2000). Decorin and fibromodulin are binding to collagen II and help to 
organise and stabilise the collagen II mesh. Biglycan is concentrated in PCM region and bind to 
collagen VI and contribute in organise and stabilise the collagen VI meshwork (Chu et al., 2017). 
1.2.2.3 Non-collagenous proteins and glycoproteins 
The roles played by the non-collagenous proteins in ECM assembly include interactions with major 
macromolecules and chondrocytes, cell attachment and matrix maintenance as well as regulation of 
matrix metabolism (Roughley, 2001). These proteins have interrelated functions, which may 
increase the response of chondrocytes to environmental changes (Zhang et al., 2005). 
Polysaccharide and protein are the major components of glycoprotein just like proteoglycan, but 
the difference is that it contains more protein. The glycoproteins that are usually found in the ECM 
of cartilage as well as in the PCM of various tissues are fibronectin (Temenoff and Mikos, 2000). 
Fibronectin is rich in Arginyl-glycyl-aspartic acid (RGD) subunit and plays a vital role as a cell 
attachment molecule (Enomoto et al., 1993). In addition, it can attach to many substances such as 
collagen and fibrin. Lubricin is a large water-soluble glycoprotein that is found in the superficial 
zone and synovial fluid. Lubricating the joint surface as well as preventing the movement of large 
molecules into articular cartilage or synovial fluid is the main function of lubricin (Jones et al., 
2007).  
1.2.3 Cartilage tissue fluid 
 The avascular cartilage gets sufficient nutrients and oxygen from the fluid through an exchange 
process with the synovial fluid (Maroudas et al., 1968). The fluid also helps in tissue compression 
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resistance and restoring the original dimension after load evanescence (Temenoff and Mikos, 
2000). 
1.2.4 ECM organization 
ECM is secreted by chondrocytes around which it forms a framework. Depending on the distance 
from the cell, the secreted ECM can be divided into three different regions, namely; pericellular 
matrix (PCM), territorial matrix (TM) and interterritorial matrix (IM) (Zhang et al., 2009). The 
PCM is regarded as the closest matrix to the chondrocyte, and it contains a lot of collagen VI and 
smaller amounts of collagen II, IX, XI as well as proteoglycans and other non-collagenous proteins 
(Poole et al., 1984).  
The TM lies between the regions of the other two matrices and has the largest organized collagen 
fibre in comparison with the other two matrices. The IM has the greatest distance from the cells and 
contains collagen fibres which are the least organized when compared to the other two matrix 
regions (Buckwalter et al., 2005). Figure 1.4 illustrates the ECM regions in articular cartilage. 
 
Figure  1.4: Illustration of the ECM regions of articular cartilage, comprising pericellular matrix, 
territorial matrix and interterritorial matrix (Taken from Landínez et al., 2012) 
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1.2.5 Articular cartilage zonal structure  
Articular cartilage has an anisotropic, zone-specific structure that extends from the articular surface 
to the subchondral bone with different composition and functions. It is made up of the superficial 
zone, the transitional or middle zone, the radial or deep zone and the calcified zone (Figure  1.5). 
There is a unique composition and arrangement of chondrocytes and ECM within each zone 
(Hunziker et al., 2002). 
 
Figure  1.5: Schematic drawing showing articular cartilage zones; A. Cellular shape in each zone. B. 
Collagens fibers orientation in each zone (Taken Sophia et al., 2009) 
 The superficial zone 
It constitutes 10% of whole cartilage thickness (Weiss et al., 1968; Camarero-Espinosa et al., 
2016). This zone has the least thickness and comprises flattened chondrocytes interspersed between 
parallel collagen fibres (Camarero-Espinosa et al., 2016). It has the lowest proteoglycans 
concentration of than that in middle and deep zones (Crockett et al., 2007). The superficial zone 
structure and composition produces shear resistance and tensile strength (Guilak et al., 1994). 
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  The middle zone 
Within the middle zone which constitutes 60% thickness of articular cartilage, chondrocytes have a 
round shape with a random distribution (Camarero-Espinosa et al., 2016). An abundant amount of 
proteoglycan is found in the middle zone. In order to support resistance to the multidirectional 
compressive force and aid the retention of proteoglycan, the collagen fibres are oriented in random 
direction (Stockwell, 1979). 
 The deep zone 
In the deep zone chondrocytes are stacked like coins into vertical columns. This zone zones forms 
30% of the thickness of articular cartilage and it is rich in proteoglycans, (Klein et al., 2009). The 
deep zone also orientates thick collagen fibres in radial direction in order to help generate strength 
between cartilage and bone (Poole et al., 2001). 
 The calcified zone 
This zone is characterized by the presence of collagen X and absence of proteoglycan (Zhang et al., 
2009). It consists of collagen X fibres arching from cartilage into the bone to help attach cartilage 
to bone. This zone helps to transmit force and the limit diffusion from bone to deep zone (Cohen et 
al., 1998).  
1.2.6 The pericellular matrix and chondron 
Pericellular matrix is a specialized, thin layer of the ECM which immediately surrounds 
chondrocytes in cartilage (Poole et al., 1987). A chondron is a chondrocyte surrounded by its PCM. 
The PCM comprises different collagen II, VI, IX and XI, as well as proteoglycans and hyaluronan 
(Poole et al., 1997). Figure 1.6 illustrated the chondrons consist of chondrocytes surrounded by 
PCM. 
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Figure  1.6: Chondron morphology. A) an isolated chondron consists of a chondrocyte (C) 
surrounded by its pericellular matrix (PCM). B) Two isolated chondrocytes (C) without a PCM 
(Taken from Lee al., 1997).Scale bar =10 μm 
Although the PCM contains many of the same molecular constituents as the ECM, there are some 
distinct differences between the structure and composition of these regions. This region has been 
shown to contain a lot of proteoglycans (e.g., aggrecan, hyaluronan, and biglycan), and collagens 
(II and VI), but is primarily defined by the presence of VI collagen as compared to the ECM (Poole 
et al., 1997). Collagen VI is generally regarded as a basic component in PCM, and it is segmented 
into fibrils which form a fibrillar basket around the cell by intersecting at different angles. A 
mechanical protection against loading and deformation of cartilage is provided by this multi-angled 
configuration for chondrocytes (Chang and Poole, 1997). This significantly affects the stress-strain 
produced on the cartilage as well as the control of fluid flow of chondrocytes (Alexopoulos et al., 
2005). 
The interactions between the ECM and the chondrocyte play an important role in regulating the 
development and maintenance of cartilage. For example, the gene expression, proteoglycan 
metabolism and the response to growth factors are significantly affected by the interactions 
between the cell surface and ECM components (Adams and Watt, 1993). PCM likely influences the 
signals (both biochemical and biophysical) perceived by the chondrocyte since it is completely 
surrounded by the PCM (Poole et al., 1997). Thus, direct interactions are likely to occur between 
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cell surface receptors like integrins and the tissue matrix at the PCM level (Bidanset et al., 1992; 
Salter et al., 1992).  
The metabolic activity of chondrocytes has been shown to be altered by the retention of the native 
PCM (Larson et al., 2002, Vonk et al., 2010), which suggests that the PCM may affect the 
biochemical and biophysical factors of the cell, and as such, play a biological role in controlling 
cell biosynthesis.  
In addition to the fact that the PCM has a biological function, the chondron has also biomechanical 
function in nature. It performs a micro-mechanical function because it has the capacity to absorb 
the mechanical load by undergoing deformation and completely recovering when the load is 
removed (Szirmai, 1974). This potentially provides a protective role for the chondrocytes during 
loading through an “adaptive water loss from PCM proteoglycans” (Poole et al., 1988). According 
to a number of previous studies, the chondron serves as a filter or transducer of mechanical signals 
(Poole et al., 1992; Poole et al. 1997) particularly through the interaction of VI collagen with cell 
surface integrins or hyaluronan (McDevitt et al., 1991). 
The notion that the chondron represents a compression resistant, which absorbs mechanical load 
and provides hydrodynamic protection for the chondrocyte) was first considered by Benninghoff 
(1925) (Poole et al. 1997). This was later confirmed by Szirmai (1974) who concluded that 
physically robust chondrons could be considered as mechanical units of cartilage.  
A key marker of the PCM microenvironment is collagen VI (Poole et al., 1987), which is known to 
interact with various matrix macromolecules such as collagen II and decorin (Bidanset et al., 1992), 
proteoglycan and hyaluronan (Kielty et al., 1992). In addition, collagen VI has been shown in 
previous studies to interact with the integrin receptors of chondrocytes (Salter et al., 1992; Loeser, 
2014). This implies that collagen VI plays a dual role, one of which is creating macromolecular 
interactions to ensure the structural and functional integrity of the chondron, the other is to mediate 
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cell surface anchorage and signalling potential between the chondrocyte and its pericellular 
microenvironment (Cesconet al., 2015). 
Collagen VI in PCM, however, is a somewhat unique collagen in that it is not degraded by matrix 
metalloproteinases or by collagenase but is digested by some serine proteases (Lee et al., 1997). 
Previous studies suggest that a secretory enzyme and a member of the high temperature 
requirement family of serine proteases (HtrA1) is capable of degrading molecules in the 
pericellular matrix (Polur et al., 2010; Hou et al., 2013). HtrA1, a member of the mammalian HtrA 
serine protease family, has a highly conserved protease domain. In cartilage chondrocytes and 
synovial fibroblasts identified as major sources of secreted HtrA1which plays important regulatory 
roles. Substrates of HtrA1 have been identified, including aggrecan, decorin, biglycan, 
fibromodulin and fibronectin (Tsuchiya et al., 2005). It is also stated that collagen VI was not 
existent in chondrocytes synthesis HtrA1 in mouse OA joints, which is revealing of the disruption 
of the PCM of chondrocytes (Polur et al., 2010). HtrA1 has been implicated in rheumatoid arthritis 
(RA) and OA. Expression of HtrA1 is up-regulated in synovial fluids obtained from human RA and 
OA joints (Hu et al., 1998) and HtrA1 is the most abundant protease in human OA cartilages. 
1.3 Articular cartilage repair and current treatments 
Sport accident, trauma and irregular compression of cartilage can result in the damage of articular 
cartilage, are thought to lead to a loss of cartilage tissue, and without treatment, the injury can 
progress to OA (Hoemann, 2004). However, articular cartilage has poor repair capacity due to lack 
of blood supply and limited chondrocyte proliferation. The entrapment of chondrocyte in the dense 
ECM is thought to reduce chondrocyte proliferation (Huber et al., 2000). 
Cartilage injuries are grouped into three main types. The first type is the matrix disruption, caused 
by blunt force trauma to the tissue which results to damage to the ECM (Zhang et al., 2009). The 
presence of viable chondrocytes after the damage usually facilitates the recovery of this type of 
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injury. Their ECM turnover compensates for the change in durability of the cartilage which 
effectively increases their synthetic activity to recover the damaged ECM (Temenoff and Mikos, 
2000). The second type is the partial thickness defect which only affects the articular cartilage 
zones and does not permeate to subchondral bone. This defect frequently fails to repair as it does 
not allow the release of stem cells. Although chondrocytes are present in the cartilage tissue, they 
fail to move into the defect and proliferate to regenerate the injured region because they are 
embedded within the ECM (Fuller and Ghadially, 1972; Laurencin et al., 1999). The third type of 
cartilage injury is the full thickness defect which penetrates through all zones of articular cartilage 
down to the subchondral bone. This defect allows the release of stem cells such as mesenchymal 
stem cells (MSC) ‘undifferentiated cells able to differentiate into different cell types’ from the bone 
marrow into the damaged region and formation of fibrocartilage. Fibrocartilage has mechanical 
properties that are not the same as articular cartilage (Caplan et al., 1999; Hunziker et al., 1999). 
It has indeed become necessary to intervene in the repair process due to the low capacity of self-
healing or regeneration in damaged articular cartilage. Several surgical methods such as 
debridement, microfracture, autografts and cell therapy approaches like autologous chondrocyte 
implantation (ACI) have been employed to provide pain relief and improve joint function 
(Schurman et al., 2000). 
 Debridement 
Debridement involves removing the roughness of the cartilage surface by cleaning and smoothing 
the defect area in the knee joint. While this technique is easy to perform, the result is still 
questionable as only temporary improvements are usually experienced among patients with 
advanced stages of degeneration (Jackson et al., 2003). 
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 Microfracture 
Microfracture is a commonly employed method for repairing articular cartilage of patients having 
lesions less than 2 cm in diameter (Zhang et al., 2009). It is a less invasive process with short 
surgery and recovery time compared to other treatments (Clair et al., 2009). Microfracture involves 
boring a hole through articular cartilage and the subchondral bone to release bone marrow stem 
cells to the damaged site (Redman et al., 2005). Instead of the fibrin clot, the MSC which are 
gradually fill the lesion site and then totally fill the injured site after one week (Hunziker et al., 
1999). Over time, most of these MSCs can differentiate to chondrocytes, which then secrete 
articular cartilage proteins into ECM and repair the damaged articular cartilage site (Redman et al., 
2005). The main disadvantage of this method is the production of fibrocartilage with weaker 
mechanical properties that are not suitable for articular cartilage, which is linked with increased 
failure rate (Laurencin et al., 1999; Zhang et al., 2009).  
 Autograft transplantation 
In this technique, a full depth plug of tissue is collected from non-weight bearing area in the joint 
of the patient, followed by an implantation process into damage region of joint in order to obtain 
healthy tissue graft (Clair et al., 2009). In spite of the excellent medical outcomes using this 
autografting method, there are some shortcomings which include inadequate donor tissues both in 
terms of capacity and quality, donor area morbidity (Laurencin et al., 1999). Also, stability of the 
graft tissue at high weight-bearing region over time as a result of the graft tissue being extracted 
from a non-weight bearing area (Malloy et al., 2002). 
 Total and partial joint replacement 
When other methods fail to repair the cartilage damage or when the articular cartilage has severe 
damage and advanced joint disease, then either total or partial joint replacement are employed. This 
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method is done to restore typical function by removing the injured joint and implanting artificial 
shell (such as alloys and titanium), a polymer surface (such as polyethylene) as well as a metal 
stem. However, it comes with its own limitations including loosening of the artificial implant, 
wearing off and short life-span of implant (maximum of 15 years) and increasing pain of the patient 
(Zhang et al., 2009). 
 Autologous chondrocyte implantation  
Autologous Chondrocyte Implantation (ACI) is a process in which cells are harvested from the 
donor site within the injured joint, expanded in vitro and re-injected into the defect site under a 
natural or synthetic patch (Brittberg et al., 1994). ACI has evolved over the last 20 years and as 
result of its 80% clinical success rate (Mistry et al., 2017). This method is the first cartilage tissue 
engineering approach to be applied clinically, and cartilage tissue engineering is presently aimed at 
improving the method and outcomes using different cells, materials, and culture environments 
(Brittberg et al., 1994). 
Brittberg et al (1994) were the pioneers of the Autologous Chondrocyte Implantation (ACI) for 
cartilage. The ACI technique has been applied by different generations for several years (Marlovits 
et al., 2006). The first generation of ACI is the Brittberg’s technique which is based on two surgical 
processes. The first process involves the removal of a small piece of undamaged articular cartilage 
tissue, isolation of chondrocytes and their expansion in vitro to the required number of cells. In the 
second process, the cells are injected into the damaged region of articular cartilage and sutured by 
periosteal patch as a cover to ensure chondrocytes are within the defected area (Brittberg et al., 
1994). In the second generation of ACI, the cells are placed on a collagen matrix instead of the 
periosteal patch after being expanded in a monolayer. A collagen matrix is sutured over the 
cartilage lesion and the cell suspension is injected beneath (Haddo et al., 2004). In the third 
generation of ACI, the chondrocytes are spread homogeneously into the defect by placing their 
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suspension on a 3D biomaterial scaffold, and grafting is done using fibrin glue (Marlovits et al., 
2006). The whole surgical morbidity is minimized in the second and third generation of ACI as 
they facilitate the surgical process as well as reduce the surgical time and number of injury cases 
(Marlovits et al., 2006). In spite of the favourable outcomes recorded, this technique has a number 
of limitations such as the possibility of producing fibrocartilage, which has a different mechanical 
property from hyaline cartilage and requires multiple invasive surgeries. Also, it reduces the long 
term stability (Zhang et al., 2009). 
1.4 Cartilage tissue engineering 
Tissue engineering has witnessed a lot of growth over the last 30 years, and this has given rise to 
many innovative treatment sessions seeking to optimise the traditional treatment methods for 
damaged living tissue (Ikada, 2006). It is known to be an effective approach for repairing damaged 
living tissue through the application of some basic engineering, material science and biology 
concepts (Lanza et al., 2011). It has rapidly developed to include a variety of cell types (such as 
stem cell and chondrocytes), scaffolds (such as biodegradable and natural or synthetic materials), 
growth factors and mechanical stimuli (Melero-Martin et al., 2007). 
The ability of articular cartilage to repair itself is low, and the present treatments for cartilage 
damage are faced with some challenges. There is a continuous development in the field of tissue 
engineering, and a promising approach for articular cartilage regeneration is articular cartilage 
engineering. The production of tissue with similar structure, biochemical and biomechanical 
properties to native articular cartilage tissue is one of the objectives of cartilage tissue engineering 
(Solchaga et al., 2001). 
The cell source, biomaterial scaffolds, and stimulatory factors to mimic the natural articular 
cartilage environment are crucial factors that determine the successful repair and regeneration of 
cartilage (Ikada 2006). 
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Various cell sources such as chondrocytes and mesenchymal stem cells from various tissues have 
been investigated for potential use in cartilage tissue engineering (Muschler et al., 2011). The 
ability of numerous natural and synthetic materials to support cartilage engineering in vitro and/or 
in vivo have been evaluated (Hutmacher, 2000). Furthermore, important stimulatory factors like 
mechanical stress and biochemical stimuli have been introduced during culturing of cartilage 
constructs (Zhang et al., 2009). 
1.4.1 Cell sources for cartilage tissue engineering 
Finding the ideal and optimal cell source is the main challenge facing cartilage tissue engineering 
(Liu et al., 2017). An ideal cell source for cartilage tissue engineering should have little or no 
immunogenicity, be easy to access, as well as have the ability to expand and maintain /differentiate 
to form functional cartilage tissue (Zhang et al., 2009). The main cells that have been used in 
cartilage tissue engineering are chondrocytes and stem cells (Vinatier et al., 2009). 
1.4.1.1 The chondrocyte, chondron and PCM 
Autologous chondrocytes have been extensively used in articular cartilage repair and regeneration; 
however, there are some limitations using this cell source (Ikada, 2006; Liu et al., 2017). 
Some of these challenges include limited availability of autologous chondrocytes and the 
invasiveness of chondrocytes harvest process as well as the fact that it causes donor-site morbidity 
(Kock et al., 2012). The monolayer culture methods that are used to gather plentiful cell numbers 
cause chondrocytes to dedifferentiate towards fibroblastic with different properties for articular 
cartilage (Bonaventure et al., 1994; Goessler et al., 2004). 
De-differentiation decreases the expression of collagen II, aggrecan, and other proteins related with 
articular cartilage as well as an increased expression of collagen I, which is the main limitation of 
monolayer culture of chondrocytes (Bonaventure et al., 1994; Stewart et al., 2000; Goessler et al., 
2004). 
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 In articular cartilage, each chondrocyte is surrounded by a 2-4 µm thick collagen VI-rich PCM 
forming a chondron (Poole, 1997). Freshly extracted chondrons form a more cartilage-like ECM 
than chondrocytes (Larson et al., 2002; Vonk et al., 2014) and their surrounding PCM is thought to 
maintain chondrocyte phenotype. Chang and Poole (Chang and Poole, 1997) cultured chondrocytes 
for 24 h producing aggrecan, decorin, and fibronectin. A week later, the chondrocytes were 
surrounded by a ring of PCM containing collagen VI. Vonk et al., (2010) compared chondron with 
chondrocytes culture. They found that in the chondrons, the type VI collagen was traced around the 
cells along culture duration. Some type VI collagens were found around the chondrocytes after 25 
days of culture in alginate beads, but chondrocytes had a smaller amount of type VI collagen than 
that found around the chondrons and it has been demonstrated that maintaining the native 
chondrocyte’s PCM enhanced the cartilage markers (collagen type II and GAG) production. 
Shafaei et al., (2017) showed that float chondrons maintain their round morphology and PCM at 
day 7 and the gene expression showed that attached chondrons has low gene expression of collagen 
II and aggrecan with high collagen I versus floating cells. Also, they have been reported using 
unattached form of chondron in cartilage tissue engenering could be a promising method to solve 
dedifferentiation problem of chondrocyte. 
Through a combination of nanomanipulation, single cell RT-PCR and single cell 
immunolocalisation (Wang et al., 2008; Nguyen et al., 2010) determined that the presence of the 
PCM and its associated collagen VI makes the chondron stiffer than the chondrocyte and enhances 
ECM gene expression. Chondrons have a promising potential for the recovery of damaged articular 
cartilage. The use of chondrocytes together with chondrons has been predicted to have a better 
chance of self-healing compared to using only isolated chondrocytes. 
1.4.1.2 Stem cells  
Much effort is currently being put in place to explore better alternative cell sources as a result of 
the several aforementioned limitations associated with chondrocyte sources. Accessibility, 
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availability, and chondrogenic capacity are some of the desirable features for such sources (Saha et 
al., 2011). Stem cells are defined as undifferentiated cells with a capacity to self-renew and ability 
to differentiate into different types of specialized cells as chondrocytes, osteocytes and adipocytes. 
Therefore, stem cells such as adult MSCs have emerged as possible cell sources for articular 
cartilage tissue engineering (Mauck et al., 2003; Song et al., 2004; Boeuf and Richter, 2010; Liu et 
al., 2017). 
Friedenstein was the first person to provide details about MSCs in 1974, and since then there has a 
rapid increase in the interest of using them as potential source for cell therapy and regenerative 
medicine because of their capacity to proliferate and differentiate into different cell types of the 
mesodermal origin (Van Pham et al., 20016). 
MSCs can be extracted from bone, muscle, adipose tissue, synovial fluid (Johnstone et al., 2013). 
These stem cells have a relatively high capability to produce a sufficient amount of cells without 
altering their respective phenotypes, and also without causing any immune reactions. The 
minimally invasive isolation method can be used to separate MSCs from several mesenchymal 
tissues such as the skin and adipose. In comparison to other cell sources, this is most likely to 
reduce donor site morbidity as well as any form of harm to patients (Vinatier et al., 2009). 
Bone marrow-derived MSCs are considered to be vital source of adult cells and as optimal 
substitute for chondrocytes in cartilage tissue engineering experiments due to their availability and 
easy access, capacity for differentiation, and lack of minimal immunogenic effect (Wakitani et al., 
1994; Saha et al., 2011). 
1.4.1.3 Co-culture in cartilage tissue engineering 
In the UK, the standard treatments for small to medium sized cartilage defects in people of an age 
where they cannot have a joint replacement are either microfracture (Vijayan et al., 2010) or ACI 
(Richardson et al., 1999; Van Osch et al., 2009). Both procedures have their limitations and are not 
ideal to tackle large or full depth defects. 
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One favourable alternative could be using MSCs in cell therapy (Saha et al., 2011). Co-culture, a 
promising cell culture technology, enables delivery of the physical, chemical, and biological 
signals required by cells (Zhang et al., 2017). Co-culture systems have achieved tremendous 
success achieving a more realistic microenvironment of in vivo metabolism than monoculture 
system in the past several decades (Kook et al., 2017). There is some evidence that MSC co-culture 
with chondrocytes (Qing et al., 2011; Wu et al., 2011; Leijten et al., 2012) has the potential to 
enhance ECM production. While it is assumed that MSCs repair damaged tissues by differentiating 
them into specific cells to replace the lost cells (Bruder et al., 1994), but they produce cartilage 
tissues with inferior properties compared to chondrocytes because of the subsequent hypertrophy 
and mineralization of these cells after extended culture in chondrogenic conditions (Leijten et al., 
2012; Kock et al., 2012). 
The co-culture of articular chondrocytes and bone marrow mesenchymal stem cells has been 
reported to enhance matrix deposition (Tsuchiya et al., 2004). The differentiation of MSCs into 
chondrocytes has been suggested to be largely responsible for the beneficial effects of co-culturing 
chondrocytes with MSCs. Chondrogenesis has been shown to be supported by the release of 
soluble factors from chondrocytes in an indirect co-culture model of bone marrow MSCs and 
chondrocytes through the significant enhancement of proteoglycans and collagen II production 
(Qing et al., 2011; Wu et al., 2011; Levorson et al., 2014).  
For example, studies by Wu et al., (2012) and Qing et al., (2011) demonstrated that co-cultures of 
human MSCs and chondrocytes resulted in enhanced ECM (collagen II and aggrecan) production. 
The resultant phenotypic changes are considered to be the result of signalling via direct cell–cell 
contacts, in addition to other parameters generated by the cell types. Other studies have provided 
evidence in support of co-cultures (Levorson et al., 2014). Levorson et al., (2014) confirmed the 
cartilaginous ECM-like (collagen II and GAGs) production was prompted in a xenogeneic co-
culture model using rabbit MSCs and bovine chondrocytes within a nonwoven fibrous substrate. 
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Previous studies have stated that enhancement in ECM production by chondron and human MSCs 
in co-cultures for 4 weeks of pellet culture (Bekkers et al., 2013). Nikpou et al., (2016) used 
indirect human chondrons co-culture with human adipose-derived stem cells and used a nanofiber 
scaffold. In addition, Nikpou et al., (2016) used chondrons from osteoarthritis patients and reprted 
that chondrons obtained from osteoarthritic articular cartilage did not stimulate chondrogenic 
differentiation of adipose-derived stem cells in co-culture. 
1.4.2 Scaffolds for articular cartilage tissue engineering 
Biomaterial scaffolds are considered to be an essential aspect in tissue engineering because of their 
ability to provide structural and mechanical support as well as to promote cell attachment, 
proliferation and differentiation in three-dimensional (3D) environment (Hubbell, 1995; Frenkel 
and Di Cesare, 2004). Scaffolds should promote cell adherence and migration as well as be 
biocompatible, and biodegradable with suitable mechanical properties (Ahmed and Hincke, 2010; 
Mujeeb and Ge, 2014). 
Several investigations have been carried out on biomaterial scaffolds for tissue engineering, which 
covers a wide range of scaffold materials including natural materials obtained from living 
organisms as well as synthetic materials produced from various chemical processes (Hubbell, 
1995). 
1.4.2.1 Synthetic scaffolds 
Poly-α-hydroxy esters polymers such as poly (lactic acid) (PLA) and poly (lactic-co-glycolic acid) 
(PLGA) are the most popular synthetic polymers for cartilage tissue engineering scaffolds 
(Woodruff and Hutmacher, 2010). Through electrospinning, 3D printing, and gas foaming 
particulate leaching, these FDA approved biodegradable synthetic polymers can be fabricated into 
3D matrices (Zhang et al., 2009). The fabricated polymer scaffolds have a controllable porosity and 
a suitable surface structure for cell attachment, proliferation, and differentiation (Hutmacher, 
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2000). Furthermore, their structure, degradation features, and mechanical properties can be 
adjusted by modifying these materials (Nuernberger et al., 2011) 
However, there are some disadvantages associated with using synthetic polymers in cartilage 
engineering applications. For example, scaffolds used for cartilage tissue engineering lack 
signalling molecules for cell attachment, and their degradation products may give rise to a host 
response including inflammation which might lead to failure of the implant in vivo (Zhang et al., 
2009). 
1.4.2.2 Natural scaffolds 
The biocompatibility of several natural biomaterials for cell attachment and differentiation has led 
to their development for cartilage repair and regeneration (Hubbell, 1995). Hyaluronic acid 
(Burdick et al., 2011), agarose (Rahfoth et al., 1998) and alginate (Fragonas et al., 2000) and 
protein-based collagen (Nehrer et al., 1998) are some natural scaffolds used in articular cartilage 
tissue engineering. 
Collagens make up essential protein content in articular cartilage ECM, and they play a major role 
in cell adhesion, proliferation and differentiation. Thus, it is regarded as one of the promisng 
materials for constructing cartilage tissue engineering scaffolds. Yuan et al., (2016) have combined 
type I and type II collagens to construct a favorable injectable hydrogel whose compressive 
modulus can be regulated by changing the type I collagen content in the hydrogel. The 
chondrocytes embedded in the hydrogel maintain their natural morphology and secrete cartilage-
specific ECM. Funayamaet al., (2008) have developed an injectable type II collagen hydrogel 
scaffold and have embedded chondrocytes in the collagen-based hydrogel and injected it into the 
damaged rabbit cartilage without a periosteal graft. At 8 weeks after the injection, favorable hyaline 
cartilage regeneration with good chondrocyte morphology was observed, and significant 
differences between the transplanted and control groups were observed after 24 weeks. Hyaluronic 
acid cell carriers or scaffolds have bioactive properties as well as the ability to interact with 
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chondrocytes. Although the chondrocyte synthesis (such as collagen type II and GAG) in ECM in 
vitro and in vivo is enhanced by hyaluronan based matrices, but their mechanical properties cannot 
satisfy the cartilage tissue (Solchaga et al., 1999). Kontturi et al., (2014) have developed an 
injectable, in situ forming type II collagen/hyaluronic acid hydrogel for cartilage tissue 
engineering. After encapsulation of chondrocytes and chondrogenic growth factor transforming 
growth factor-β1 into the hydrogel, the cell viability and proliferation, morphology, 
glycosaminoglycan production, and gene expression have been investigated. This hydrogel is able 
to maintain chondrocyte viability and characteristics, and it maybe a potential injectable scaffold 
for cartilage tissue engineering. Yu et al., (2014) have fabricated an injectable hyaluronic acid/ 
polyethylene glycol hydrogel with excellent mechanical properties for cartilage tissue engineering. 
Han et al., (2018) have been provided a biocompatible cross-linkable hyaluronic acid hydrogel and 
have been demonstrated that the encapsulation of chondrocytes within the hydrogel matrix in vitro 
and in vivo supported cell survival, and the cells regenerated cartilaginous tissue. 
Cells encapsulated in the hydrogel in situ demonstrate high metabolic viability and proliferation. 
Typical example of polysaccharide biocompatible 3D scaffolds is agarose which is usually 
extracted from seaweed and are used to encapsulate cells for cartilage tissue engineering (Zarrintaj 
et al., 2018). 
 Dimicco et al., (2007) have been reported that the structure of collagen VI around chondrocytes 
embedded withn agarose is different than that in native structure that found in native articular 
cartilage. Garcia et al., (2017) have been facilated apromising method to encapsulate 
humanchondrocytes into thin biodegradable and natural fibrin-agarose hydrogels by using 
nanostructuration techniques with cartilaginous ECM production (collagen II and proteoglycan). 
 
` 
   28  
 
1.4.3 Hydrogels for cartilage tissue engineering  
Hydrogels are 3D hydrated networks made of hydrophilic polymers that are linked together either 
through covalent bonds or physical intramolecular and intermolecular attractions (Vega et al., 
2017). The use of hydrogel for scaffold construction in tissue engineering has generated a lot of 
interest for many years because of its flexibility and ability to be moulded into any shape, which is 
a required attribute for clinical applications (Grieshaber et al., 2011; Liu et al., 2017). In addition, 
insoluble hydrated polymers can take the shape of natural ECM both macroscopically and 
microscopically (Varghese and Elisseeff, 2006). Other benefits of hydrogels include the ability to 
act as a 3D structure to maintain cell shape and structure but unfortunately, this flexible nature 
decreases the mechanical strength of the hydrogel (Vega et al., 2017). 
Taking Hyaluronic acid (HA) hydrogel into view, HA, a naturally occurring polysaccharide 
composed of N-acetyl-d-glucosamine and d-glucuronic acid, is a major component of the ECM in 
connective tissues and is particularly abundant in vitreous and synovial fluids (Garg and Hales, 
2004). There are many advantages in using HA as a tissue scaffold. Some of these advantages 
include; 
(1) Biodegradability, biocompatibity and bioresorbability (Drury and Mooney, 2003), 
(2) it plays an important role in lubrication, cell differentiation and cell growth in ECM and these 
functions can be transferred to the scaffold (Balazs and Denlinger, 1989),  
(3) its functional groups (carboxylic acids and alcohols) enable crosslinking (Garg and Hales, 
2004), 
(4) its exogenous form can promote healing (Balazs and Denlinger, 1989),  
(5) it has the ability to maintain a hydrated environment, and 
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(6) it can be used to create a scaffold that is bioactive both in its intact structure and in the degraded 
form (Collins and Birkinshaw, 2013).  
While the application of HA as a tissue scaffold material is hindered by its short residence time and 
lack of mechanical integrity in an aqueous environment, these drawbacks can be addressed through 
chemical modification and crosslinking (Collins and Birkinshaw, 2013). 
Agarose is another hydrogel used in cartilage tissue engineering. It is a hydrophilic linear polymer 
extracted from “Gelidium gracilaria” and is composed of repeated units of disaccharide, 3, 6- 
anhydro-L-galactose and D galactose (Kuhtreiber et al., 1999). Agarose can vary in its mechanical 
stiffness since hydrogel contains flexible molecules. In addition, its low melting point makes it 
useful in facilitating the cell encapsulation before the gel setting (Zarrintaj et al., 2018). 
Furthermore, agarose hydrogel lack of cell adhesion or biomolecule interaction, and there is no 
integrin binding between cells and agarose. Thus, the use of agarose encapsulated chondrocytes 
helps to maintain the round shape of chondrocytes. In comparison to chondrocytes being seeded in 
monolayer, the preservation of the round cell shape and lack of cell attachments enhances 
chondrogenesis (Steward et al., 2011). As a result, agarose hydrogel has been used for a long time 
to encapsulate chondrocytes in cartilage tissue engineering because it provides a hydrated 
environment to native cartilage as well as preserves chondrogenic phenotype (Kuhtreiber et al., 
1999).  
Although there are many benefits of using agarose hydrogels as scaffolds in cartilage tissue 
engineering, there are some limitations which cannot be ignored such as their weak mechanical 
properties (Steward et al., 2011). Another major weakness is that the zonal organisation in native 
cartilage tissue can't be replicated by encapsulating chondrocytes with agarose hydrogel. 
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1.5 Nanofibers for cartilage tissue engineering 
In articular cartilage tissue, the ECM is composed of a collagen network, essentially nano-scale 
collagen II fibres organized in different directions, which acts as a natural scaffold to provide 
mechanical and structural support as well as promote cell attachment and proliferation (Camarero-
Espinosa et al., 2016). Nano-fabricated techniques make it possible to create nanofibers which 
closely mimic the nanofibrous collagen matrices that are found in articular cartilage ECM (Smith 
and Ma, 2004). 
In the field of tissue engineering, the term “nanofiber” is usually used to describe fibers whose 
diameters are between 1 and 1000 nanometres (Kumbar et al., 2008). These fabricated nanofibers 
possess the structural and mechanical properties of ECM, which promote the formation of 3D 
tissue structures (Jayakumar and Nair, 2012). Typically, nanofibres have large surface area per unit 
volume (Kumbar et al., 2008), which supports cell adhesion and proliferation (Dalby et al., 2002; 
Glass‐Brudzinski et al., 2008). Nanofibers have been observed to have higher rates of protein 
absorption than macro-scale surfaces, which are a key mediator in cell attachment to a biomaterial 
surface (Baharvand, 2014). Furthermore, the nanofibrous constructs have been found to selectively 
enhance the absorption of specific proteins such as fibronectin and vitronectin, (Woo et al., 2007) 
which is significant as fibronectin is a protein known to enhance cell adhesion and bind many 
growth factors. 
1.5.1 Production methods 
There are different methods to fabricate polymeric nanofibers, fore example; electrospinning, phase 
separation, drawing, and template synthesis (Barnes et al., 2007). Electrospinning is a highly 
efficient method of producing nanofiber, and as such, it is used in this project (Dahlin et al., 2006). 
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 Phase Separation 
Phase separation is a technique that has long been used to create porous polymer membranes and 
scaffolds (Van de Witte, 1996, Mikos, 2000). To produce a porous nanofiber structure, a polymer is 
dissolved in a proper solvent and rapidly cooled to induce phase separation. Then, the solvent is 
later exchanged with water, and the construct is freeze-dried (Van de Witte, 1996). Nanofibers can 
be obtained by selecting the appropriate gelling temperature. Higher gelling temperatures have 
been shown to produce microfiber formation while lower gelling temperatures reduce the diameter 
to nanofiber dimensions (Zhao et al., 2011). 
The advantages of this method include the fact that it does not require specialized equipment. In 
addition, constructs can be produced in a mould to achieve a specific geometry. However, this 
process can only be carried out with a limited number of polymers and would be difficult to scale-
up to a commercial setting (Barnes et al., 2007). 
 Drawing 
In this technique, the fibres are obtained when the polymer droplet on the flat surface comes in 
contact with a micropipette. The pipette is withdrawn from the surface of the droplet, and a fine 
fibre is pulled from the bulk (Ondarcuhu and Joachim, 1998). Unfortunately, the fibre formation 
appears inconsistent because the surface tension at the bulk material surface during drawing 
increases due to the evaporation of the solvent over time. However, this method is considered to be 
a time consuming and discontinuous technique though it is simple and requires minimum 
equipment (Ramakrishna et al., 2005). 
 Template Synthesis 
This technique is generally considered to be simple as it basically involves forcing the polymer 
solution through the specified dimensions and shape pores, and as a result, fibres having 
dimensions of the pores of the template are generated. The major drawback of this method is that it 
is limited to only a few number polymers .i.e conductive polymers like poly (p-phenylene 
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vinylene), polyphenylenes and poly (acetylene), and as such, it fabricates on a small scale 
(Ramakrishna et al., 2005). 
 Electrospinning 
Electrospinning is a time and cost-efficient technique for producing polymer fibres and is the most 
commonly used method for producing fibre meshes in tissue engineering. It has the capacity of 
producing long, continuous fibres ranging from 3 nm to 10 μm in diameter (Pham et al., 2006). 
Moreover, a 3D architecture for cell culture and tissue construction is provided by nanofibrous 
scaffolds which in turn promote 3D tissue formation (Barnes et al., 2007). 
1.5.2 Principles of electrospinning 
There are basically three essential components involved in the electrospinning technique; a syringe 
pump, a high voltage generator and a collector. As shown in Figure 1.7, an electrical field has been 
generated between the collector and needle on the syringe pump due to the potential difference 
between them. There are two basic forces that affect the solution drop in the fabrication of 
electrospun fibres, and these are the surface tension force and the applied electric field. The 
strength of the electric field causes the solution to drop from the needle in a conical shape manner 
known as Taylor Cone. If the surface tension of the polymer solution is overcome by the electrical 
force, the charged droplet forms a jet that arises from the tip of the Taylor Cone. As the jet extends, 
it is drawn into a thin fibre which undergoes a whipping motion as it travels towards the collector. 
The jet splits into smaller fibers due to the instability and repulsive forces created within it. During 
this process, the solvent gradually evaporates into the traveling space between the needle and the 
collector, which eventually leads to the formation of continuous and thin fibres on the collector 
(Teo and Ramakrishna, 2006). 
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Figure  1.7: The principles of electrospinning (Taken from Zhu et al., 2013). 
1.5.3 Electrospinning nanofibers for cartilage tissue engineering 
In the field of tissue engineering, electrospinning is considered as a favourable technique for 
fabricating 3D scaffolds. Electrospun scaffolds are very effective in facilitating cartilage repair in 
articular cartilage tissue engineering simply because electrospun fibres are very similar in size to 
collagen fibres in native articular cartilage tissue (Braghirolli et al., 2014). As a result, the influence 
of nanofibers in cartilage tissue engineering has been investigated by many researchers (Yang et 
al., 2011). 
It has been observed that electrospun scaffolds fabricated from PCL have the ability to proliferate 
and preserve the phenotypic characteristics of chondrocytes. Moreover, combining of nanofiber 
scaffolds with growth factors, human mesenchymal stem cells could be effectively differentiated 
into chondrocyte phenotype (Li et al., 2003). 
Sonomoto et al., (2016) demonstrated that PLGA electrospun scaffold induce MSCs derived from 
healthy donors and patients with OA to differentiate into chondrocytes with chondrogenic markers 
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(production of proteoglycan and collagen II). Other study reported that PCL /gelatin scaffolds 
fabricated using electrospinning processes were biocompatible with articular cartilage. In addition, 
the scaffold enhanced the chondrogenesis of MSCs and showed evidence of rabbit articular 
cartilage defect repair, resulting in an enhanced gross appearance cartilage-specific gene expression, 
suggesting a possible application in the treatment of articular cartilage defects (Liu et al., 2014). 
The behaviour of chondrocytes was investigated by Wimpenny et al., (2012) with the use of 
nanofiber composites (poly (L, Dlactide) (PLDLA) nanofibre coatings on PLDLA film). 
Electrospun nanofibers were found to enhance chondrocyte attachment as well as maintain the 
rounded phenotypic nature of chondrocytes. 
Steele et al., (2014) created a multi-zone cartilage construct by using electrospun polycaprolactone 
nanofibers. Analysis of the multi-zone scaffolds demonstrated region-specific variations in 
chondrocyte number, ECM composition, and chondrogenic gene expression. 
Mirzaei et al., (2017) have been provided a nanofibrous glucosamine - poly(L-lactide) acid / 
polyethylene glycol scaffolds which enhanced the biological properties such as cell adhesion, 
proliferation and protein absorption rate, and induction of chondrogenesis (collagen II and 
prtoglycan production). 
1.6 Aim and objectives of the project 
The overall aim of the thesis was to investigate new cellular and scaffold strategies for better 
engineering articular cartilage, particularly to assess the effect of MSCs’ role and other factors in 
2D and 3D culture environments on the maintenance and regeneration of PCM and ECM, and to 
assess whether the zonally-organised hybrid scaffolds can separately and synergistically replicate 
the three zonal structures of articular cartilage. 
The objectives of the thesis were:  
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1. To study 2D MSC co-culture with chondron and chondrocytes to determine whether there 
were any beneficial effects imparted by the direct cell-cell contact with MSCs on the 
process of chondrogenesis. The experimental approaches allowed the characterisation of 
maintenance and regeneration of PCM (collagen VI), the expression of HtrA1 and its 
relationship with the collagen VI expression (Chapter 3); 
2. To define the key factors in 3D culture environment that facilitated PCM maintenance and 
regeneration alongside ECM production by both chondrocytes and chondron monoculture 
and co-culture with MSCs (Chapter 4); 
3. To investigate whether FTIR microspectroscopy can reveal the impact of culture 
environments on chondrocyte’s phenotype change and ECM production (Chapter 4); 
4. To design hybrid zonal-specific 3D scaffolds in order to induce the formation of 
biomimetic zonal organisation and composition of ECM as in native articular cartilage 
tissue (Chapter 5). 
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Chapter 2 : Materials and methods 
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I: Materials: All used materials are listed in Table 2.1. 
Table:  2-1 List of materials, catalogue number and supplier 
Name 
Catalogue 
number 
Supplier 
α-minimal essential medium (α-MEM) BE12-169F  Lonza, UK 
β-Glycerophosphate G9422 Sigma-Aldrich, UK 
β-mercaptoethanol M6250 Sigma-Aldrich, UK 
3-Isobutyl-1-methylxanthin I7018 Sigma-Aldrich, UK 
1,4-Butanediol diglycidyl ether 220892 Sigma-Aldrich, UK 
1,9-dimethylmethylene blue (DMMB) 341088 Sigma-Aldrich, UK 
4′,6-Diamidino-2-phenylindole (DAPI) D9542 Sigma-Aldrich, UK 
4-20% Protein Gels, 10 wells x 50 μL NH21-420 
Novex Life Technologies, 
UK 
Acetic Acid 537020 Sigma-Aldrich, UK 
Acetone, for analysis A/0600/PC21 Fisher Chemical, UK 
Alcian blue A5268 Sigma-Aldrich, UK 
Agarose A9045 Sigma-Aldrich, UK 
Alizarin Red TMS-008-C Sigma-Aldrich, UK 
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Amersham Hybond P 0.45 PVDF 10600029 
GE Healthcare Life Science, 
UK 
Anti-aggrecan antibody (rabbit monoclonal IgG) ab36861 Abcam 
Anti-Collagen I antibody (rabbit monoclonal IgG)
   
ab138492 Abcam 
Anti-Collagen II antibody (mouse monoclonal IgG) ab185430 Abcam 
Anti- Collagen VI ( rabbit monoclonal IgG ) ab182744 Abcam 
Anti-GAPDH antibody ab8245 Abcam 
Anti-goat IgG, HRP-linked Antibody 7078P2 
Cell Signaling Technology, 
UK 
Anti-HtrA1 antibody ( rabbit polyclonal IgG) ab38611 Abcam 
Anti-mouse IgG, HRP-linked Antibody 7076P2 
Cell Signaling Technology, 
UK 
Anti-rabbit IgG, HRP-linked Antibody 7074P2 
Cell Signaling Technology, 
UK 
Ascorbic acid  A8960 Sigma-Aldrich, UK 
Bicinchoninic acid assay Kit 23225 
Thermo- Fisher Scientific, 
UK 
Bovine serum albumin (BSA) A2153-50G Sigma-Aldrich, UK 
Bovine tracheal chondroitin sulphate C9819 Sigma-Aldrich, UK 
BupH™ Tris-HEPES-SDS Running Buffer 28398 
Thermo- Fisher Scientific, 
UK 
Chloroform 288306 Sigma-Aldrich, UK 
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Chondroitinase ABC C3667 Sigma-Aldrich, UK 
Collagenase IA C9891 Sigma-Aldrich, UK 
Collagenase II C234155 Sigma-Aldrich, UK 
cysteine-HCL C7477 Sigma-Aldrich, UK 
Dexamethasone D4902 Sigma-Aldrich, UK 
Dimethyl sulfoxide (DMSO) D2650 Sigma-Aldrich, UK 
Dispase II D4693 Sigma-Aldrich, UK 
Dulbecco’s Modified Eagle’s Medium (DMEM) BE12-707F  Lonza, UK 
Donkey anti-rabbit polyclonal antibody SC-2089 Santa Cruz Biotechnology 
Ethylenediaminetetraacetic acid (EDTA) E6758 Sigma-Aldrich, UK 
Ethanol (absolute) E0650/17 
Thermo-Fisher Scientific, 
UK 
Falcon cell strainer 08-771-2 
Thermo-Fisher Scientific, 
UK 
FCS (fetal calf serum) DE14-801F Biosera labtech,UK 
Filter card  5991040 Shandon, UK 
Fluorescein isothiocyanate isomer I F7250-250MG Sigma-Aldrich, UK 
Formaldehyde solution F8775 Sigma-Aldrich, UK 
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Glycine G8898 Sigma-Aldrich, UK 
Goat anti-mouse monoclonal antibody SC-16516 
Santa Cruz Biotechnology, 
UK 
Goat anti-mouse IgG  sc-2010 
Santa Cruz Biotechnology, 
UK 
Goat anti-Mouse IgG (H+L) Poly-HRP Secondary 
Antibody, HRP 
32230 
Thermo- Fisher Scientific, 
UK 
Goat anti-Rabbit IgG (H+L) Secondary Antibody, 
Alexa Fluor® 594 conjugate 
A-11037 
Thermo-Fisher Scientific, 
UK 
Halt™ Protease Inhibitor Cocktail (100X) 78429 
Thermo- Fisher Scientific, 
UK 
Hank Buffer saline solution (HBSS) H9394-500ML Sigma-Aldrich, UK 
Hyaluronic acid (HA) sodium salt powder HA-T 
Shangdong Freda Biopharm, 
China 
Hyaluronidase H3506 Sigma-Aldrich, UK 
Hydrochloric acid (HCL) H1758 Sigma-Aldrich, UK 
L-Proline P0380 Sigma-Aldrich, UK 
L-glutamine 17-605E Lonza, UK 
Live/Dead Assay Kit L3224 
Thermo- Fisher Scientific, 
UK 
Indomethacin I7378 Sigma-Aldrich, UK 
Industrial Methylated Spirit (IMS) I99050 Genta medical, UK 
Insulin I9278 Sigma-Aldrich, UK 
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Insulin-Transferrin (ITS) T5240 6559 Sigma-Aldrich, UK 
Isopropyl alcohol I0398 Sigma-Aldrich, UK 
Methanol 322415 Sigma-Aldrich, UK 
Rabbit anti- mouse IgG-B ab8517 Abcam 
N,N-Dimethylformamide 227056 Sigma-Aldrich, UK 
NOVEX Sharp pre-stained protein ladder LC5800 
Thermo- Fisher Scientific, 
UK 
Novex® Tris-Glycine SDS Running Buffer (10X) LC2675 
Thermo- Fisher Scientific, 
UK 
NuPAGE 4 -20 % Bis-Tris gel NH21-420 Generon, UK 
NuPAGE® MES SDS Running Buffer (20X) NP0002 
Thermo- Fisher Scientific, 
UK 
Optimal Cutting Temperature (OCT) compound  AGR1180 Agar scientific , UK 
Oil Red O O0625 Sigma-Aldrich, UK 
Page Ruler™ Unstained Low Range Protein Ladder 4360954 Invitrogen , UK 
Papain P4762 Sigma-Aldrich, UK 
Paraformaldehyde 158127 Sigma-Aldrich, UK 
Penicillin, streptomycin,  17-602E Lonza, UK 
Phosphate buffered saline (PBS) BE17-516F Lonza, UK 
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Pierce BCA protein assay kit 23221 
Thermo Fisher Scientific, 
UK 
Pierce™ 20X TBS Tween™ 20 Buffer 28360 
Thermo Fisher Scientific, 
UK 
Pierce™ ECL Western Blotting Substrate 32109 
Thermo Fisher Scientific, 
UK 
Poly-l,d-lactic acid (PLA) 96% l/4% d Purac BV, the Netherlands 
Poly-L-lysine coated slides P0425 Sigma-Aldrich, UK 
Proteinase K P2308 Sigma-Aldrich, UK 
Quant-iTTM Picogreen® dsDNA assay kit P7589 Invitrogen, UK 
Radioimmunoprecipitation assay buffer (RIPA) 89900 
Thermo- Fisher Scientific, 
UK 
Silica gel grains 10087 Sigma-Aldrich, UK 
Sodium acetate S2889 Sigma-Aldrich, UK 
Sodium chloride (NaCL) 433209 Sigma-Aldrich, UK 
Sodium phosphate 342483 Sigma-Aldrich, UK 
Sodium pyruvate P2256 Sigma-Aldrich, UK 
Toluidine blue T3260 Sigma-Aldrich, UK 
Tris base 741883 Sigma-Aldrich, UK 
Tris Buffered Saline with Tween
® 
20 (TBST-10X) 
80-INSRT-E0l-
ALP 
Stratech Scientific Ltd 
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II: Methods 
2.1 Cell isolation and expansion 
2.1.1 Chondrocyte extraction and culture  
Bovine knee joints were collected from a local slaughter house and washed with 70% industrial 
methylated spirit (IMS). Cartilage tissue was extracted from the joints using a scalpel (Figure 2.1) 
and cut pieces were washed in sterile phosphate-buffered saline (PBS) supplemented with 2% 
(w/v) penicillin-streptomycin. The washed cartilage was finely chopped. The enzymatic 
chondrocytes isolation employed was based on published protocol (Wang et al., 2008) with minor 
modification. Cartilage pieces were digested with 0.1% (w/v) proteinase K at 37˚C for one hour. 
The proteinase solution was discarded and then the cartilage was further digested with 0.3% 
collagenase IA at 37˚C and 5% CO2 for 3 hours. The suspension was filtered using a 70 μm nylon 
mesh. The filtrate was centrifuged for 4 minutes at 750 g. The cell pellet was resuspended in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal calf serum (FCS) 
and 1% L-glutamine and 1% penicillin-streptomycin (basal media). Cell passaging or splitting is a 
technique that enables an individual to keep cells alive and growing under cultured conditions for 
extended periods of time. When cells reached confluence i.e. 80% cell coverage, they were released 
from tissue culture flasks by trypsinisation process through washing twice with PBS and incubating 
with 0.25% trypsin in 1 mM ethylenediamine tetraacetic acid (EDTA) for 5 minutes at 37 °C. The 
DMEM medium with 10% FCS was used in inhibit the trypsinisation. The cell suspension was 
Trizma hydrochloride T3253 Sigma-Aldrich, UK 
Transforming Growth Factor- beta 3 (β3) T5425 Sigma-Aldrich, UK 
Trypsin/EDTA10X 89900 Lonza, UK 
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collected and centrifuged for 3 minutes to get the cell pellet. The chondrocytes were cultured on 
T75 tissue culture plastic flasks at 3 x 10
3
 cells/cm
2
 cell density. The passage number of a cell 
culture is a record of the number of times the culture has been subcultured, i.e. harvested and 
reseeded into multiple ‘daughter’ cell culture flasks. In this study passage 0 (P0) refered to fresh 
isolated cells from tissues without culture and passage 1 (P1) cells refered to the first subcultured 
cells. Cells up to passage 1 were used for experiments.  
 
Figure  2.1: Cartilage tissues isolated from a bovine knee joint with scalpel. The arrows indicate the 
cartilage tissue. 
2.1.2 Chondron isolation and culture 
The enzymatic chondron isolation was based on established protocol (Wang et al., 2008) with 
minor modification. The chopped cartilage was digested with mixture of 0.3% (w/v) dispase II and 
0.2% (w/v) collagenase II dissolved in PBS for 5 h in an incubator at 37˚C and the suspension was 
filtered through 70 μm nylon mesh. The filtrate was centrifuged for 4 minutes at 750g. The cell 
pellet was resuspended in supplemented DMEM mentioned previously. For passage 1 experiments, 
chondron were seeded on T75 tissue culture plastic flasks at a density of 3 x 10
3
 cells/cm
2
 with 
expansion medium as described above.  
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2.1.3 Rat mesenchymal stromal cells isolation and culture 
MSCs were extracted according to Mao et al., 2005 and in strict accordance with the Animal 
(Scientific Procedures) Act 1986. The femurs and tibias from 28 days old Sprague–Dawley rats 
were dissected (Figure 2.2). After cutting both ends of the bones along the epiphysis, the bone 
marrow was driven out using 10 mL of α-minimal essential medium (α-MEM) supplemented with 
10% FCS and 1% L-glutamine and 1% penicillin-streptomycin. Bone marrow cells were cultured 
in a T25 flask and incubated at 37°C with 5% CO2. Non-attached cells were discarded, and culture 
medium was changed every 3 days. In this study P1 and P2 MSCs were used. Rat MSCs 
differentiation potential was assessed by the conventional tri-lineage differentiation assays 
according to the protocols (Carvalho et al., 2013).  
Histological staining studied the MSCs capacity to adhere to the tissue culture plastic and undergo 
differentiation into chondrocytes, osteocytes and adipocytes for Chondrogenic (Toluidine Blue), 
Osteogenic (Alizarin Red) and Adipogenic (Oil Red O) lineages. Cells were seeded at a density of 
2 x 10
4
 cells/cm
2
 (n=3) and cultured in the relevant differentiation media: 
 Chondrogenic differentiation medium  
 Chondrogenic differentiation media was comprised of supplementing DMEM with; 1% penicillin-
streptomycin, 1% L-glutamine, 1% FCS, insulin-transferrin-selenium (1% v/v), dexamethasone 
(0.1 μM), ascorbic acid (50 μM), l-proline (40 μg/ml), sodium pyruvate (1% v/v) and transforming 
growth factor (Mackay et al., 1998). 
 Osteogenic differentiation medium 
Osteogenic differentiation media consisted of: DMEM with; 1% penicillin-streptomycin,1% L-
glutamine, 1% FCS, dexamethasone (10 nM), ascorbic acid (50 μg/ml) and β-glycerophosphate (10 
mM) (Jaiswal et al., 1997). 
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 Adipogenic differentiation medium 
Adipogenic differentiation media was composed of DMEM with; 1% penicillin-streptomycin, 1% 
L-glutamine, 1% FCS, dexamethasone (0.5 μM), 3-isobutyl-1-methylxanthine (IBMX) (0.5 mM), 
insulin (10 μg/ml) and indomethacin (100 μM) (Pittenger et al., 1999). 
The cells that were cultured in proliferation media acted as the experimental controls, and all cells 
were cultured for 21 days with the media being changed every three days. Cells were fixed by 
formalin after 21 days culture for histological analysis. 
 
Figure  2.2: Dissected rat femur for extraction of rat MSCs 
2.2 Hydrogels scaffolds fabrication 
2.2.1 Agarose hydrogel preparation  
Agarose (2%) with a low gelation temperature ~ 26˚C was used. The agarose powder was mixed in 
distilled water (dH2O) and dissolved into viscous solution by using a microwave. Prior to use, 
agarose solution was sterilised three times under ultraviolet light for 90 seconds.  
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2.2.2 Cross-linked hyaluronic acid gel  
Hyaluronic acid (HA) sodium salt powder with an average molecular weight of 1.5 x 10
6
 Da was 
supplied by Shangdong Freda Biopharm Co., Ltd. China. The crosslinked HA hydrogel was formed 
following established protocol (Yang et al., 2016). The HA powder was dissolved in 1% sodium 
hydroxide (NaOH) at a concentration of 10% in a glass beaker. The solution was mixed by the 
mixer (MESE, United Kingdom) with the rate of 100 rpm for overnight at ambient temperature and 
the beaker was covered with Parafilm to avoid evaporation (Figure 2.3.A). 1,4-Butanediol 
diglycidyl ether (BDDE) was later added to the HA solution to a final concentration of 0.4 % (v/v) 
at a mixing speed of 200 rpm for 30 minutes. The reaction between HA and BDDE was performed 
in strong alkaline conditions to form a stable covalent ether bond. At a very high pH range, the 
epoxide groups of BDDE preferentially react with the hydroxyl groups of HA. In theory, six sites 
in every HA–disaccharide unit are available for the reaction with BDDE. The deprotonated 
hydroxyls are much stronger nucleophiles than both the anionic carboxylic group and the amide. 
Hence the hydroxyl groups are the most likely reaction sites, forming stable ether bonds with the 
BDDE. 
The solution was transferred to a petri dish and was allowed to crosslink at an operating condition 
of 40°C and 0.6 bar in a vacuumed oven for 5 hours, after that dried at room temperature for 3 days 
using a desiccator filled with silica gel grains (Figure 2.3.B). The dried hydrogel was swollen by 
adding 300 ml of dH2O until the pH value reaches almost 7 by using pH stripper measurement. 
PBS was then added to the crosslinked HA for rehydration (Figure 2.3.C). The swollen HA was 
dialyzed against deionized water and then PBS to remove any residual BDDE.  
The above HA gel was directly used to generate deep zone or the base for individual zone. Metal 
puncher was used to produce a 1 cm
2
 HA hydrogel pieces (Figure 2.3.D). The HA gel was further 
processed to allow the reconstruction into gels and was used for experiments. Briefly, the 
crosslinked HA gel was pulverised with a homogenizer (the mixer equipped with a metal drill bit) 
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(Figure 2.3.E) to obtain mini gel particles of 0-400 μm (Figure 2.3.F). The mixture of homogenised 
crosslinked HA gels and 2% (w/v) agarose in a ratio of 9:1 was used to enable the gel to be 
reconstructed with the required shape and thickness. 
 
Figure  2.3: HA hydrogel fabrication process. A) Hydrogel solution mixing process. B) Drying 
process. C) Swollen HA hydrogel. D) Punched HA hydrogel blocks. E) Homogenising process F) 
Reconstituted HA hydrogel after Homogenising process 
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2.3 Electrospinning of polylactic acid nanofibers 
2.3.1 General set-up of electrospinning system 
The electrospinning technique is used to fabricate different organised nanofibers to construct zonal-
specific scaffolds. The established protocol in the lab (Yang et al., 2011) was adopted to fabricate 
organised nanofibers. 2% poly-l,d-lactic acid (PLA) solution was prepared by dissolving PLA 
granules in a mixture of chloroform plus N,N-Dimethylformamide (solvents in a (7:3) ratio to 
produce nanofibers. The resulting 0.2 ml PLA solution was delivered at a 0.025 mL/ minute flow 
rate by a syringe pump through an 18G needle attached to the positive electrode. The distance 
between the positive and the collector (the negative electrode) was fixed to 15 cm. The needle and 
the collector were connected to a power supply charged at ±6 kV (Spellman HV, Pulborough, 
United Kingdom) as shown in Figure 2.4. The nanofibers formed were collected and glued to 
cellulose acetate frames of 16 cm
2
 in which the adhesive glue has been deposited to stabilize their 
orientation. Before use, these nanofibers were sterilised three times under ultraviolet light for 90 
seconds. 
 
Figure  2.4: The main parts of electrospinning set-up 
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2.3.2 New collector design for zonal specific nanofiber meshes 
A rectangular portable collector made up of a non-conductive material frame with conductive wires 
attached to the negative electrode (Figure 2.5) was used to produce highly aligned nanofibers 
meshes with low line density to replicate the matrix in superficial zone of articular cartilage (Yang 
et al., 2011). 
 
Figure  2.5: The rectangular collector for aligned nanofibers 
A metal ring collector (Figure 2.6) was used to collect random nanofibers to replicate the matrix in 
middle zone of articular cartilage.  
 
Figure  2.6: The ring collector for random nanofibers 
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2.4 Papain digestion for biochemical analysis 
The digestion solution was made at a pH of 6.5 by dissolving 125 μg/mL of papain in 0.1 M 
sodium phosphate, 5 mM EDTA, and 5 mM cysteine-HCl. At the end of the culture time point, the 
experimental samples were separately digested with 300 μL papain solution per sample for 8 hours 
at 60°C. The digested solutions were stored at -20°C for further analysis (DNA and GAG analysis). 
2.5 Cell viability and DNA assessment 
2.5.1 PicoGreen DNA assay 
PicoGreen DNA assay was used in quantifying the cell number. The Quant-iTTM Picogreen
®
 
dsDNA assay kit was used by the manufacturer’s instructions. Serial dilutions of DNA standard (0–
1 μg/mL) were used to construct a calibration curve. The PicoGreen solution was prepared as a 
1:200 dilutions in 1xTris-EDTA (TE) buffer. 100 μL of standard or cell/lysis sample was 
introduced into a 96 well-plates followed by 100 μL of 1xTE to each relevant well. This was put in 
the dark for 5 minutes before fluorescence readings were carried out. The fluorescence was 
determined at 485 nm excitation and 535 nm emission using Synergy II BioTek plate reader. The 
previous study stated value of 7.7 pg of DNA per chondrocyte was used to approximate cell 
number (Kim et al., 1988). 
2.5.2 Live/dead assay 
The cell viability was observed with the aid of a Confocal Laser Scanning Microscope (CLSM, 
Olympus Fluoview FV 1200 with Fluoview software (4.1 version)) after staining with the 
Live/Dead Assay Kit. The viability of the cells was evaluated by the manufacturer’s instructions. 
Calcein-AM ester dye was used fluorescently labelling viable cells in green, while the nucleus of 
dead cells was stained with Propidium Iodide dye (into red). 
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Cell culture media were taken out from samples, and the samples were washed with PBS and then 
immersed in the staining solution encompassing 10 μM Calcein-AM and 1 μM Propidium Iodide. 
They were later incubated for 20 minutes in the dark with 5% CO2 and at 37°C. The samples were 
washed twice with PBS and immediately imaged using confocal laser scanning Microscope. 
2.6 Total sulphated glycosaminoglycan contents assessment  
Total GAG production was evaluated using 1,9-dimethylmethylene blue (DMMB) dye following 
the established protocol (Farndale et al., 1986). DMMB regent was made by the dissolution of 4 
mg of DMMB in 250 mL of solution containing 0.58 g sodium chloride (NaCl), 0.75g glycine and 
2.08 mL of 0.1M hydrochloric acid (HCL) dissolved in 248 mL of dH2O. Standard (0-40 μg/mL) 
was made by dissolving bovine tracheal chondroitin sulphate in dH2O. 100 μL of cell lysis sample 
or culture media or standard was introduced into a 96 well-plates and then 200 μL/ well DMMB to 
all wells was added. The absorbance of the solution in the plate was read immediately at 530 nm 
with using Synergy II BioTek plate reader.  
2.7 Synchrotron FTIR spectroscopy 
Synchrotron FTIR data were acquired from Diamond Light Source (Oxford), B22. The station is 
equipped with a Hyperion 3000 microscope (Bruker) and a Bruker 80V FTIR spectrometer, 
combining with liquid nitrogen powered 100 x 100 μm2 MCT/A detector. A 36x Schwarzschild 
objective was used to obtain the spectra and images.  
2.7.1 Sample preparation and cytospining  
Prior to the cytospining process for cells encapsulated within hydrogel, the hydrogel was removed 
by heating up the samples in hot water bath (45
◦
C) for 45 seconds. The resultant was centrifuged at 
750 g for 2 minutes, and the cells pellets were resuspended in 0.9% NaCl. Cell suspensions were 
cytospun onto ZnS slides for 2 minutes at 1000 rpm using a cytofunnel and filter card. As soon as 
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the cells had been dumped on ZnS slides, samples were placed in a petri dish and fixed using 4% 
Paraformaldehyde (PFA). 
2.7.2 Spectral collection 
The system is accomplished by Opus software (Bruker). Typically, cytospun cellular samples were 
measured using a 10 X10 μm aperture, focusing the beam centrally onto nuclei region or 
peripheries of a cell. Spectral features were determined using former experiment measurements. 
Afterwards, a standard resolution of 4 cm
-1
 was used, 256 repetition scans per sample spectrum 
were taken as co-added scan from a single point and background measurement to maximise the 
signal to noise ratio and improve the resolution. Background measurements were taken every 30 
cells spectral collection from areas of the substrate that were free of any sample material. 
Transmission mode was use for all measurements, using a ZnS substrate, 0.5 mm thick. For each 
sample, 30 - 40 cells were measured. 
2.7.3 Data processing and analysis 
The Unscrambler software (Version X, Camo, Oslo, Norway) was used to process the FTIR spectra 
to correct the baseline (linear-offset), and the spectra were also normalised (Standard Normal 
Variate (SNV)) and smoothed (Savitzky-Golay). Initially, the spectra were cut off to the area of 
interest for each analysis. The spectra were cropped to the region of 2700-3100 cm
-1
 that covers the 
lipid region, and for the fingerprint region, the spectra were cut off to 1000-1800 cm
-1
. The SNV 
normalisation was performed after the baseline correction, which involves subtracting the mean 
spectrum and then dividing by the standard deviation for each spectrum. This helps to remove the 
effect of sample thickness as well as any baseline offset that may occur, and then the spectra were 
smoothed by applying Savitzky-Golay filter function. 
The Unscrambler software (version X, Camo, Oslo, Norway) was also used to perform Principle 
Component Analysis (PCA). Loading plots indicate how much a variable contributes to each PC. 
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The same software was also used to visualise the spectra after it has been interpreted by the support 
software used to acquire the data at Synchrotron facilities (Opus, Bruker). 
2.8 Cryostat sectioning 
Experimental samples or articular cartilage tissue directly from bovine as a ‘positive control’ were 
embedded in optimal cutting temperature (OCT) compound. Then samples were cut using a 
standard cryostat (Bright, United Kingdom) into 10 μm thick sections on poly-L-lysine coated 
slides and kept in -20C freezers. 
2.9 Histologic analysis 
2.9.1 Tri-lineage staining to confirm the MSCs phenotype 
 Alizarin red 
Alizarin red staining was used to confirm the osteogenic differentiation of MSCs. Before staining, 
1% of Alizarin red solution was prepared in dH2O and filtered using a 2 μm filter. The pH of the 
solution was set at pH 4. After 21 days culture; media was removed, and samples were washed in 
PBS and fixed by formalin. The samples were stained with Alizarin red solution for 5 minutes at 
room temperature. The stain was removed and washed three times in dH2O. Calcium depositions 
were stained red (positive). 
 Oil Red O  
Adipogenic differentiation was characterised using Oil Red O prepared in 60% isopropanol and 
filtered using 2 μm filters. Formalin was removed entirely after the sample fixation, and the 
samples were washed twice with dH2O. Oil Red O staining solution was added to the samples for 
15 minutes at room temperature. The samples were washed three times in dH2O and were rinsed 
with 60% isopropanol after removing the staining solution. Lipid formation appeared as small red 
droplets due to the differentiated MSCs in the adipocytes. 
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 Toluidine blue staining 
In the tri-lineage study, the GAG production was evaluated using toluidine blue to characterise 
chondrogenic differentiation. 4% toluidine blue staining solution was prepared by dissolved 4g of 
toluidine blue in 100 mL of 0.1 M sodium acetate buffer solution. After 21 days culture; culture 
media was aspirated, and samples were washed in PBS and fixed in formalin at room temperature 
for 30 minutes. The samples were then stained with 4% toluidine for 10 minutes at room 
temperature, and the stain was removed, after which the samples were washed three times with 
distilled water. The total GAG stained with toluidine Blue.  
2.9.2 Alcian blue staining 
Alcian blue was used to characterise the GAG production where 0.1% (w/v) alcian blue staining 
solution was prepared by dissolving 0.1 g of alcian blue powder in 3% acetic acid (3 mL Glacial 
Acetic Acid + 97 mL dH2O). The solution was appropriately dissolved and paper-filtered. At 
terminate culture points, the culture media was removed from the well, and each well was washed 
with PBS and fixed in formalin at room temperature overnight. The samples were then stained with 
0.1% alcian blue (pH 1) for 15 minutes at room temperature. The stain was removed, and the 
samples were washed three times with dH2O. 
In this study for 3D samples toluidine blue has been used because the alcian blue stained the 
background gel strongly more than the toluidine blue, which may cause artificial staining. 
2.10 Immunofluorescence assays 
Immunofluorescence technique allows certain proteins in cells or tissue sections to be assessed 
through the binding of specific antibody conjugated to the fluorescent substrate. In this study 
immunofluorescence staining was conducted using primary antibodies against the following 
components in the pericellular matrix (PCM) and extracellular matrix (ECM): collagen VI (goat 
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polyclonal IgG), collagen II (mouse monoclonal IgG), aggrecan (rabbit polyclonal IgG), collagen I 
(rabbit monoclonal IgG) and HtrA1 (mouse polyclonal IgG). 
 Three samples for each culture group were fixed with 4% PFA at room temperature for 30 
minutes. All samples were subjected to an unmasking treatment before the staining to develop the 
fluorescence detects the proteins following an established protocol (Wang et al., 2008). For 
detection of collagen VI, collagen II and collagen I samples were initially treated with 2 mg/mL 
testicular hyaluronidase (Hyase) by dissolving 2 mg of bovine Hyase in 1 mL of Tris-saline buffer 
at pH 5.0 (0.024 g trizma HCL with 0.08 g NaCl and 10 mL dH2O). As regard aggrecan, the 
samples were initially treated with 25 mU mL
–1
 chondroitinase ABC by dissolving 0.2 U 
chondroitinase ABC in 1 mL of 0.1 M Tris-acetate buffer at pH 8.0 (0.121 g Tis base and 10 mL 
dH2O) to generate ‘stubs’ of unsaturated disaccharides on the proteoglycan core proteins and to 
unmask epitopes. For HtrA1 detection, the samples were pre-treated with 25 mU/mL 
chondroitinase ABC and 2 mg/mL testicular hyaluronidase. The samples were washed three times 
with PBS containing 2% Bovine serum albumin (BSA) after treatment. These treated samples were 
then incubated with the primary antibodies and labelled with the fluorescein isothiocyanate (FITC)-
conjugated secondary antibody for collagen VI and aggrecan, while tetramethylrhodamin (TRITC)-
conjugated secondary antibody for collagen II, collagen I and HtrA1 and finally contrast stained 
with 4, 6-Diamidino-2-phenylindole (DAPI) to label the nuclei. DAPI (diluted 1:100 with PBS) 
was added for 20 minutes at room temperature. This was followed by three washes with PBS. 
Articular cartilage was used as a positive control. The samples in which primary antibodies were 
absent were assessed as negative controls.  
All samples were observed using a confocal laser scanning microscope. Articular cartilage was 
used as a positive control. Primary antibodies were omitted for negative controls. All cells were 
evaluated using the same exposure time, gain, and offset camera settings, so that the 
immunofluorescence intensity was directly comparable among the groups for each given antibody. 
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2.11 Semi-quantification of cell morphology and staining intensity 
Cell aspect ratio (length/width) of live cell images was used to assess the semi-quantification of 
cell morphology by using the image analysis using ImageJ software (1.51j 4). The longest chord of 
each cell was set as length, and the width was determined as perpendicular dimension to the length. 
At least 12 cells in each five randomly nominated areas for three biological samples were selected 
for the calculation. The mean values were collected and plotted for each group and at three culture 
time points. ImageJ software was also used to semi-quantify the intensity of staining. Five 
randomly selected areas from three images were chosen for each group. By using ImageJ software, 
the interest staining area and a region that has no stainig as a background were selected, and then 
the integrated intensity function was chosen. The total staining intensity was calculated according 
following formula: staining intensity = integrated density measurements – background 
measurements and the mean intensity were schemed for different groups and at different culture 
time points. Primary antibodies were omitted for negative controls. All cells were evaluated using 
the same exposure time, gain, and offset camera settings, so that the immunofluorescence intensity 
was directly comparable among the groups for each given antibody. 
2.12 Western blotting 
Protein in each sample was extracted after certain culture time point by digesting them in 
Radioimmunoprecipitation (RIPA) lysis buffer containing 1X protease and phosphatase inhibitor 
cocktail. The digestion buffer was kept on ice for 30 minutes, and then samples were centrifuged 
for 10 minutes at 11000 g at 4°C. The supernatant was then removed and stored at -20°C.  
The protein concentration was measured by the bicinchoninic acid (BCA) protein method. Bovine 
serum albumin (BSA) standards were prepared at concentrations between 0 and 2 mg/mL. BCA 
reagent was prepared by adding 4% copper (II) sulphate pentahydrate solution to BCA solution in 
the ratio of 1:50, and 100 μL of the reagent was added to either 10 μL of each BSA standard or 5 
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μL of each lysate diluted in 5 μL RIPA buffer. Lysates were incubated for 30 minutes at 37°C, and 
then the A570 was determined using Synergy II BioTek plate reader. A protein standard curve was 
evaluated according with BSA standard values. Then, the protein concentration in each lysate was 
calculated by using the calibration curve. 
A total volume of each lysate sample was calculated using the BCA assay containing 30 ug 
proteins and was added to 5 μL of a mixture of 150 μL of 1X NuPAGE sample and 7.5 μL of β- 
mercaptoethanol. To denature the protein content of the sample, the solution was heated for 15 
minutes at 80°C in thermal cycler (OmniGene, United Kingdom). 
A NuPAGE 4 -20 % Bis-Tris gel was loaded with 30 μg protein per well, and NOVEX® sharp pre-
stained protein ladder (10 μL) was also loaded onto the gel. Samples were run in 1X BupH™ Tris-
HEPES-SDS running buffer under a voltage of 70 V for 90 minutes. After that, the samples were 
transferred into an Amersham Hybond P 0.45 PVDF with 1X Novex
®
 Tris-Glycine SDS Buffer for 
90 minutes under a voltage of 30V. 
After transferring has been completed, the membrane was washed three times by 1x TBST and was 
later blocked with 5% skim milk for one hour at room temperature and incubated overnight at 4°C 
with primary antibodies against collagen II (1:400), collagen I (1:400) and aggrecan (1:400).The 
membranes were then washed twice 1x TBST and incubated with corresponding HRP-conjugated 
secondary antibodies (1:4000) for one hour at room temperature. After washing the membranes 
three times by 1x TBST for ten minutes, signals were visualised using the FluroChem system (Bio-
Techne). The membrane was washed three times by 1x TBST. The membrane was blocked in 5% 
skim milk, followed by the addition of the GAPDH (1:5000) primary antibody and washed three 
times by 1x TBST), and then incubated with (1:5000) HRP conjugated for 1 hour. Semi-
quantitative measurement for proteins expressions using western blot was determined using ImageJ 
software by measurement the intensity in each band area and then normalize it to the loading 
control. 
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2.13 Scanning electron microscopy  
A Hitachi S4500 SEM was used to view the images of the nanofiber scaffolds, where the 
specimens were coated with gold and imaged at an accelerating voltage of 15 kV. ImageJ software 
was used to determine the fibre diameters in analysing the SEM images (Wimpenny et al., 2012). 
The cross-sections of individual fibres were measured using a calibrated, line drawing tool. Two 
separate nanofibre subsamples were examined in at least three different areas, and about 50–200 
fibres were measured for each sample. 
2.14 Optical coherence tomography  
Optical coherence tomography (OCT) is an imaging technique that uses coherent light (they have a 
constant phase difference and the same frequency, and the same waveform) to capture micrometre-
resolution, two- and three-dimensional images from within optical scattering media (e.g., biological 
tissue). The light from a low-coherence source is split in two by the coupler with each part 
traveling along a separate arm of the interferometer, the reference and the sample arm. The light 
backscattered from the reference mirror and from the sample recombine at the coupler and 
generates an interference pattern, which is recorded by a single point detector. 
The micro-channel dimensions in the scaffolds and the morphology of the assembled acellular or 
cellular 3D hybrid zonal constructs were assessed using optical coherence tomography (OCT; 
Telesto II, Thorn lab, USA). It works with the wavelength centred at 1300 nm providing 
approximately 1 mm image penetration. 
2.15 Mechanical testing  
 An electro force model 3200 (BOSE, United Kingdom) (Figure 2.7) testing machine that was 
equipped with a 22-N load cell operated at a crosshead speed of 0.05 mm/sec was used to measure 
the mechanical properties of individual and assembled zonal scaffolds in uniaxial compression 
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testing. The dimension of the specimens dimension was measured as 1 cm X 1 cm for individual 
samples with a thickness of 0.5 mm for individual zonal scaffold and 0.6 mm for a 3D full zonal 
scaffold. The stress-strain curves were used to determine the compression modulus and the ultimate 
compression strength, which was taken as the maximum stress. Compression modulus was 
determined as the slope from the linear region of the stress–strain curve between 0.1 and 0.5 strain 
and the applied forces have been converted into stress with samples’ area (Stress = Force/Area). 
The height difference between samples has been considered in the strain values which were 
obtained from the displacement divided by initial height (Strain = Δ Length/Length0), where the 
ultimate compression strength was taken as the maximum stress (Engineering toolbox/ Stress, 
Strain and Young's Modulus, 2011).  
 
 
Figure  2.7: Compression mechanical test for different zonal scaffolds 
Mechanical strength through ball indentation test was performed for a hydrogel mixture 
optimisation. Several ratios of agarose and HA respectively were made (0:10; 0.5:9.5; 1:9; 2:8), 
after which the mixture solution was placed on 1 cm
2 
ring filter paper which was then inserted 
between two transparent plastic rings (20 mm) separately and held between two parallel flat metal 
plates with circular opening and tightened by a number of metal screws. These samples were 
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positioned on to a translation platform (Figure 2.8.A) and a plastic ball (1.23 mg) was placed on the 
centre of the sample to induce the deformation. The images of deformation were taken by long 
focal distance microscope which was connected with CCD camera linked to computer (Figure 
2.8.B). 
 
Figure  2.8: Ball indentation test for hydrogel mixture optimisation.  
2.16 Statistical analysis  
Four independent experiments have been run with three different chondrocyte preparations. The 
sample numbers in each independent experiment were triplicates. For statistical analysis, results are 
expressed as the mean ± standard deviation. Error bars on graphs indicate standard deviations (SD). 
The one-way analysis of variance (ANOVA) followed by Tukey post-tests was performed to 
determine statistical significance with significance defined as p < 0.05. All statistical analyses were 
performed using SPSS software. 
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Chapter 3 : Two-dimensional co-culture models of cartilage 
cells and mesenchymal stromal cells to study the enhancement 
of collagen VI and extracellular matrix production   
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3.1 Introduction  
The role and degradation of PCM in culture 
In the native articular cartilage tissue, a chondron is defined as a chondrocyte surrounded by a 
pericellular matrix. The PCM is rich in proteoglycans, collagen II and VI. Collagen VI is 
exclusively present in PCM. Hence, the “gold standard” for defining a chondron is the detection of 
collagen VI in associated cells (Poole et al., 1997). The PCM plays a significant role in the 
metabolic activity of the chondrocyte as well as the mechanical signalling from and to the 
extracellular matrix via cell-matrix interactions (Poole, 1987; Chang and Poole, 1997). 
Enzymatically extracted chondrons adhering to hard substrates in monolayer will change their 
morphology from a rounded shape to a fibroblastic shape. This morphological change accompanied 
the loss of PCM up to day 7 in culture (Lee and Loeser., 1998, Larson et al., 2002). Enzymatically 
extracted chondrocytes lose their PCM during isolation process (Bonaventure et al., 1994; Stewart 
et al., 2000) and undergo phenotypic changes faster than a chondron during 2D culture (Lee and 
Loeser., 1998). 
MSC and cartilage cell co-culture models 
In the literature, co-culture studies of articular chondrocytes or chondrons with mesenchymal stem 
cells have provided evidence of increased ECM production (Qing et al., 2011; Levorson et al., 
2014). According to Qing et al., (2011) chondrogenic properties (collagen II and aggrecan) were 
enhanced by the co-cultures of rabbit chondrocytes and rabbit MSCs in monolayer for 21 day 
culture. Levorson et al., (2014) confirmed the cartilaginous ECM-like (collagen II and GAGs) 
production was prompted in a xenogeneic co-culture model using rabbit MSCs and bovine 
chondrocytes within a nonwoven fibrous substrate. However, up till now, there have been no 
systematic studies to reveal whether MSC co-culture with cartilage cells makes reservation of PCM 
and what the associated mechanism (s) are.  
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Previous co-culture studies have tried to determine the effects of different ratios of chondrocytes or 
chondrons to MSCs in monolayer culture. As yet, there was no agreement but there were data to 
suggest that disparities between ratios could influence cell function, proliferation and even MSC 
differentiation (Qing et al., 2011; Walenda et al., 2010). The previous study also stated that 
collagen II and GAG production levels were higher in co-culture groups with a larger chondrocyte 
ratio to MSCs (chondrocyte: MSC; 4:1, 2:1 and 1:1). The optimal ratio of chondrocytes and MSCs 
in monolayer co-culture seemed to be 2:1 and 1:1 at day 7 culture (Qing et al., 2011). Previous 
work showed that a 1:1 ratio of chondrocytes to MSCs was capable of producing similar quantities 
of cartilage-like ECM as cultures of chondrocytes alone (Levorson et al., 2014). In another study, 
the 50% to 90% ratios of chondron/MSC cultures showed higher GAG production compared with 
chondron culture alone (Bekkers et al., 2013). 
The potential influence of HtrA1to PCM degradation 
To study the effect of co-cultures, particularly on the impact of the PCM as chondrogenic capacity, 
a biological marker which allows us to monitor the intactness of the PCM over time in culture is 
crucial. Collagen VI is the right marker. Interestingly, collagen VI cannot be digested by 
collagenase (during enzymatic extraction) and matrix metalloproteinases (during cartilage 
breakdown in OA), but it can be digested by serine proteases (Lee et al., 1997). Over the last 
decade, workers have considered whether upregulation of the serine proteinase, High Temperature 
Requirement A1, HtrA1, contributes to PCM disruption using human OA cartilage and mouse 
arthritic models (Polur et al., 2010; Hou et al., 2013). In one study (Polur et al., 2010) which used 
mouse knee cartilage, the relationship between HtrA1 and collagen VI was investigated. It was 
reported that collagen VI was degraded when chondrocytes secreted HtrA1, indicating that the 
PCM may be digested by HtrA1. Essentially, collagen VI disappeared from the PCM when HtrA1 
was expressed. This interesting finding suggests that to test the integrity of the PCM can be through 
the use of HtrA1 as a “degradation” marker. 
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3.2 Objectives 
The main aims of this chapter are to establish a xenogenic co-culture model of bovine chondrons, 
chondrocytes and rat MSCs, to determine whether MSCs play a role in the enhancement of 
chondrogenic capacity and PCM maintenance, and to define the optimal ratio of cell types. HtrA1 
was utilised as a marker to reveal the potential working mechanisms of MSC in the co-culture. This 
study has used monoculture of chondrons and chondrocytes and MSCs to generate baseline data. 
3.3  Materials and methods  
3.3.1 Cell isolation and expansions  
Bovine chondron and chondrocytes were used with passage 0 and passages 1 (P0, P1) exclusively. 
P1 and P2 rat MSCs was used. The cell isolation and culture details have been included in Chapter 
2, Section 1.  
Tri-lineage differentiation assays were conducted to confirm the multipotency of the used MSCs. 
The detailed MSC culturing for differentiation was explained in Chapter 2, Section 1.3. To confirm 
positive differentiation of each lineage, specific histochemical-staining was undertaken, as 
described in Chapter 2, Section 9. 1. 
3.3.2 Experiments design and set up 
Bovine articular chondrocytes (CY) and chondron (CN) at P0 and P1 were cultured in 2D 
monoculture or co-culture with rat MSCs. The ratios of chondrocytes or chondron to MSC were 
indicated in Table 3.1. All cultures were conducted in 48 well-plates at a seeding density of 1x10
4
 
cells/well in DMEM or α-MEM supplemented media. The cultured was for 7 days and culture 
media were changed every three days. Details are described in Chapter 2, Section 1. 
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Table  3-1: Description of experimental groups with cell types and seeding densities 
Experimental group Chondrocytes per well Chondrons per well MSCs per well 
CY 10,000 - - 
CY 80 8,000 - 2,000 
CY50 5,000 - 5,000 
CY20 2,000 - 8,000 
CN - 10,000 - 
CN80 - 8,000 2,000 
CN50   5,000 5,000 
CN20   2,000 8,000 
MSC - - 10,000 
3.3.3 Cell morphology monitoring  
The effect of all cell variables and culture time on cell morphology in monoculture and co-culture 
were monitored with an optical microscope (Olympus, Japan) attached to a CCD camera (1X 2-
SLP, Micropublisher S-ORTV, Japan). Image-Pro Insight software was used to acquire the images. 
The cell morphology was semi-quantified by calculation of cell aspect ratio (length/width) of live 
cell images through the image analysis using ImageJ software as described in Chapter 2, Section 
11. 
3.3.4 Biochemical assays 
At the end of the culture period, the experimental samples were digested by papain solution as 
described in Chapter 2, Section 4. The cells number was characterised by using PicoGreen DNA 
assay as explained in Chapter 2, Section 5.1. The GAG production was assessed by using DMMB 
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assay which was clarified in Chapter 2, Section 6. Overall the normalised value of GAG content 
per cell was calculated as well based on GAG content and cell number. 
3.3.5 Histological analysis of GAG production 
The GAG production in monocultures and co-cultures on all variables and different time points 
were assessed by Alcian blue staining as described in Chapter 2, Section 9.2.  
3.3.6 Immunolocalisation of key PCM and ECM components 
Immunostaining was used to identify the presence and distribution of PCM and ECM components 
(collagen II, collagen VI) and HtrA1, following the protocol described in Chapter 2, Section 10. 
Whole samples were stained using the same protocol. Semi-quantification of the cell morphology 
and the GAG and PCM component concentration was conducted based on the staining intensity 
across the groups and culture time by ImageJ analysis software as described in Chapter 2, Section 
11. 
3.4  Results 
3.4.1  Tri-lineage differentiation of MSCs 
The MSCs grown in chondrogenic media showed the positive staining for sGAG with toluidine 
blue dye; and cells in osteogenic media showed positive staining by Alizarin red dye for calcium 
deposition as the bright red nodules; and cells in adipogenic media were stained positively by the 
Oil Red O displaying lipid droplet formation (Figure 3.1). 
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Figure  3.1: Illustration of Tri-lineage staining images after 21 days culture of the MSCs.  
(A) Adipose differentiated cells (Red oil staining); (B) Osteoblast differentiated cells (Alizarin 
red); (C) Chondrogenic differentiated cells (Toluidine Blue). Scale bars represent 150 μm. 
 
3.4.2 Cell morphology  
3.4.2.1 Cell morphology in two-dimensional monocultures 
In 2D monocultures the cell morphology was observed up to passage 1 (Figure 3.2). At P0 (Figure 
3.2.A, day 1) chondrocytes and chondrons revealed a mostly rounded morphology while the MSCs 
had a spread spindle morphology. At the last culture time point, MSCs and chondrocytes had 
appeared as fibroblast-like spindle morphology while chondrons still maintained some of round 
shape. At P1 (Figure 3.2.B, day 1) all of the cell types had similar fibroblastic-like morphologies. 
In order to quantify the differences in cell morphology between chondrons and chondrocytes 
throughout culture time and passage number, live cell images were taken, and these images were 
analysed to estimate cell aspect ratio (length/width, Figure 3.2.C). At day 1, chondrons and 
chondrocytes showed a round shape, corresponding to an aspect ratio value of 1. For both 
chondrons and chondrocytes, their aspect ratio increased at days 5 and further at day 7. MSC 
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showed much higher aspect ratio for all culture time points. Cells at passage number 1 showed high 
aspect ratio for both chondrocytes and chondron with fibroblast-like spindles morphology along the 
culture time. MSC kept spread morphology. 
3.4.2.2 Cell morphology in two-dimensional co-cultures 
Cell morphology of co-cultures was then estimated. For all MSC ratios, chondrons seemed to 
maintain a more rounded morphology whilst chondrocytes a more elongated morphology (Figures 
3.3.A and B). At ratio 50:50, the morphology maintained the round shape for both chondrocytes 
and chondron during the first three days culture. After 7 days culture, the morphology slightly 
changes to elongated shape with some of round cell shape. The morphology of chondrons and 
chondrocytes at the ratio 20:80 or 80:20 co-cultures developed similarity to that of 50:50 ratio 
samples but with les round shape cells along cultures days.  
Figures 3.3.C and 3.3.D showed the co-culture ratios 50:50 and 80:20 with MSc and chondrocytes 
or chondrons at P1. In general, chondrons and chondrocytes in all co-culture ratios presented 
similarity on their morphology along the three-time points i.e. elongated cell morphology. At day 7 
both chondrons and chondrocytes became narrowed and extremely elongated cell morphology. 
Compared to monocultures, co-culture samples seemed to improve chondrogenesis for all ratios of 
MSC and chondrons. Initially, MSC and chondrons seemed to have a low aspect ratio which 
increased significantly at day 7. At passage number 1, cells showed high aspect ratio; MSC kept 
spread morphology, also chondrocytes and chondron had fibroblast-like spindles morphology along 
the culture times. 
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Figure  3.2: Cell morphology of chondrons (CN), chondrocytes (CY) and MSCs in monoculture at 
Days 1, 5 and 7 at (A) P0 and (B) P1. The scale bars represent 80 μm. (C) and (D) represented the 
cell aspect ratio analysis of P0 and P1 respectively chondron (CN) and chondrocyte (CY) in 
monoculture at days 1, 5, and 7. Data are expressed as mean ± SD (n = 3). *p < 0.05. 
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Figure  3.3: Cell morphology of co-culture of chondrons (CN, Panel A, P0) or chondrocytes (CY, 
Panel B P0), (CN, Panel C, P1) or chondrocytes (CY, Panel D P1) with MSCs.The scale bars 
represent 80 μm. 
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Figure  3.4: representive the cell aspect ratio analysis of P0 and P1 respectively chondron (CN) and 
chondrocyte (CY) in co-culture at days 1, 5, and 7. Data are expressed as mean ± SD (n = 3). *p < 
0.05. 
3.4.3 Total sulphated GAG production and cell number  
The total amount of sulphated GAG accumulated in cells in monoculture was assessed by DMMB 
at days 1, 3, 5 & 7 culture (Figures 3.4. A and B). At passage 0 and passage 1, the MSCs did not 
produce sulphated GAGs whilst the chondrons and chondrocytes accumulated a small amount of 
sulphated GAGs. 
Cell number at different culture conditions were assessed by DNA contents (Figures 3.5.A and B). 
At passage 0 and passage 1, it became clear that cell number increased along the culture time, 
whilst chondron at P0 in different time points had lower cell number than chondrocyte samples 
(p<0.05). MSC exhibited highest cell number along culture. However, at P1 the cell number of 
chondrocytes and chondrons showed similar increase pattern (p>0.05). Both chondron and 
chondrocytes had much higher cell number at P1 than at P0. 
Normalised data confirmed that sulphated GAG production per cell decreased with time and 
passage which was to be expected in monoculture conditions (Figures 3.6.A and B). GAG 
production was determined to be 16.8±0.61 pg/cell and 15.4±0.13 pg/cell for chondrons and 
` 
   73  
 
chondrocytes on day 1, and 10.0±0.45 pg/cell and 10.0±0.51 pg/cell on day 7, respectively. Figure 
3.7 shows MSC and chondron co-cultures increased GAG production. The highest increase was in 
the samples with 50% MSC ratio (p<0.05), but the GAG production per cell decreased with time 
and passage. 
 
Figure  3.5: sGAG of chondron (CN), chondrocyte (CY), or MSC in monoculture at days 1, 3, 5, 
and 7 at P0 (panels A) and P1 (panels B). Data are expressed as mean ± SD (n = 3). *p < 0.05 
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Figure  3.6: Cell number of chondron (CN), chondrocyte (CY), or MSC in monoculture at days 1, 3, 
5, and 7 at P0 (panels A) and P1 (panels B). Data are expressed as mean ± SD (n = 3). *p < 0.05.
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Figure  3.7: Total sGAG production normalised to cell number of chondron (CN), chondrocyte 
(CY), or MSC in monoculture at days 1, 3, 5, and 7 at P0 (panels A) and P1 (panels B). Data are 
expressed as mean ± SD (n = 3). * p < 0.05. 
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Figure  3.8: sGAG of chondron (CN), chondrocyte (CY), or MSC in co-culture at days 1, 3, 5, and 7 
at P0 (panels A) and P1 (panels B). Data are expressed as mean ± SD (n = 3). * p < 0.05. 
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For the co-culture samples, the chondrocytes co-culture represented a slight higher cell number 
than chondron at P0 during different culture times (p<0.05). However, at passage 1 the cell number 
of chondrocytes and chondrons showed similar value along different time points (p>0.05) and the 
higher MSC ratio sample (20:80) showed the highest cell numbers during the culture than other 
two ratio samples (Figures 3.8.B and C). In agreement with the measurements from monoculture, 
the normalised GAG production in co-cultures reduced with time and passage (Figure 3.9). For the 
chondrocytes-MSC co-cultures, the GAG production was similar to monocultures, whilst for 
chondrons-MSC co-cultures the production of GAG was higher compared to monocultures. 
Chondrons-MSC co-culture ratio 50:50 showed the highest increase compared to the monocultures. 
The normalised values showed an increase from 16.8 ± 0.61 to 18.5 ± 0.54 pg/cell on day 1, and 
10.0 ± 0.45 to 11 ± 0.38 pg/cell on day 7.  
The sGAG products appearing in the media showed slightly different pattern. The chondrocytes 
demonstrated higher total amount of GAGs accumulated and released into the surrounding media 
than in cells; whilst chondrons exhibited more GAGs in cells than in released GAGs into media 
(Figure 3.10). Herein, chondron has retained the GAGs along culture time and reduced to leach out 
into the surrounding media comparing with chondrocytes culture in both mono and co-cutlers.  
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Figure  3.9: Cell number of chondron (CN), chondrocyte (CY), or MSC in co-culture at days 1, 3, 5, 
and 7 at P0 (panels A) and P1 (panels B). Data are expressed as mean ± SD (n = 3). * p < 0.05. 
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Figure  3.10: Total sGAG production normalised to cell number of chondron (CN), chondrocyte 
(CY), or MSC in co-culture at days 1, 3, 5, and 7 at P0 (panels A) and P1 (panels B). Data are 
expressed as mean ± SD (n = 3). * p < 0.05. 
 
` 
   80  
 
The data in Figures 3.4-3.9 are re-plotted into Figures 3.11 and 3.12 to visualise GAG value and 
cell number changes versus culture time between the mono and co-culture. 
In general, the total GAG production in CN samples both mono- and co-culture samples (P0) were 
higher than corresponding CY samples in each culture time points. The production (or accumulated) 
rate of the total GAG in CN samples was higher than corresponding CY samples manifesting as the 
higher slope shown in Figures 3.11A and B, and Figures 3.12A and B.  
When addition of MSC with 50% and 20% ratio, the total GAG production increased in 
comparison to mono-culture samples (all corresponding values in co-culture samples were above 
those of mono-culture samples). The increased rate in CN sample was much higher than in CY 
samples manifesting as the higher slope shown in Figures 3.11A and B, and Figures 3.12A and B. 
Clearly, 50% MSC addition was better than 20% addition in both CN and CY samples. However, 
the enhancement extent of 50% and 20% addition was larger in CN samples than in CY samples. 
20% MSC addition in CY samples exhibited very close total GAG values to mono-type culture 
samples.
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Figure  3.11: sGAG production in media and in cells for monoculture (chondron (CN) and 
chondrocyte (CY)) and co-culture with 20, 50, and 80% of MSC ratio at day 1, 3, 5, 7 cultures with 
P0 cells.* p < 0.05. 
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Figure  3.12: sGAG production versus culture time. A) and B) the total sGAG mass; C) and D) the cell number; E) and F) total sGAG production 
normalised to cell number. A), C) and E) are for chondron mono- and co-cultures; B), D) and F) are for chondrocyte mono and co-cultures at days 1, 3, 5, 7 
cultures using P0 cells. Data are expressed as mean ± SD (n = 3). 
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Figure  3.13: sGAG production versus culture time. A) and B) the total sGAG mass; C) and D) the cell number; E) and F) total sGAG production 
normalised to cell number. A), C) and E) are for chondron mono- and co-cultures; B), D) and F) are for chondrocyte mono and co-cultures at days 1, 3, 5, 7 
cultures using P1 cells. Data are expressed as mean ± SD (n = 3). 
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3.4.4 Histological analysis of proteoglycans 
3.4.4.1 Histological analysis of proteoglycans in two-dimensional monocultures 
Alcian blue was used to detect proteoglycans and GAGs (Fig 3.13). The staining showed no 
detectable levels for MSCs. P0 chondrons showed a more intense staining compared to 
chondrocytes (Figure 3.13A), with the intensity increasing along culturing time. The staining 
appeared similar for both P1 chondrons and chondrocytes and overall lower when compared to P0 
samples (Figure 3.13B). ImageJ was used to quantify the intensity of staining for P0 and P1 
samples (Figure 3.13D). 
By using ImageJ Analysis software, the GAG staining intensity between the groups and culture 
time for P0 and P1 cells samples was semi-quantified as showed in Figures 3.13C and D. At all 
culture time points, chondrons had a higher GAG production than P0 chondrocytes samples. The 
GAG intensity increased constantly along the culture, with day 7 having a significantly higher 
amount of GAGs than day 5 and day 1. At passage 1, the amounts of GAGs produced by both 
chondrons and chondrocytes were similar, and there was only a slight increase over prolonged 
culture. 
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Figure  3.14: Representative images of alcian blue stained monocultures of chondrons (CN), 
chondrocytes (CY), or MSC at days 1, 5, and 7 cultures; A) at P0 and B) at P1. The scale bars 
represent 150 μm. 
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Figure  3.15: Representative quantification of alcian blue staining intensity of chondron (CN), 
chondrocyte (CY), and MSC in monoculture at days 1, 5, and 7 culture: A) at P0 and B) at P1. Data 
are expressed as mean ± SD (n = 3). *p < 0.05. 
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3.4.4.2 Histological analysis of proteoglycans in two-dimensional co-cultures 
Figure 3.14A and B show the co-culture staining for P0 and P1 cells by alcian blue. Chondrocyte 
co-cultures had less staining for GAG and proteoglycans than chondron co-cultures, and the highest 
staining intensity was found in a 50:50 co-culture. At all culture time points as well as all cell ratio 
samples, the GAG staining intensity (Figures 3.14C and D), which was quantitatively measured 
with the ImageJ software, showed that the amount of GAGs produced in MSC–chondron co-culture 
was significantly higher than that in MSC–chondrocyte co-culture. The staining intensity 
continuously increased along the culture time, such that the GAGs at day 5 and day 1 were 
significantly less than that of day 7. The highest GAG production was found in the co-culture 
samples containing 50% MSC and 50% chondrons or chondrocytes, while high MSC ratio samples 
(consisting of 20% chondrons or chondrocytes) had the lowest GAG production. While the staining 
intensity of chondrons and chondrocytes was similar for all culture points and cell ratio samples of 
P1 cells, the staining was less intense for P0 samples. 
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Figure  3.16: Representative images of alcian blue stained chondrons (CN) or chondrocytes (CY) 
with MSC in co-culture at days 1, 5, and 7 culture; A) at P0 and B) at P1. The scale bars represent 
150 μm. 
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Figure  3.17: Representative quantification of alcian blue staining intensity of chondron (CN), 
chondrocyte (CY), and MSC in co-noculture at days 1, 5, and 7 culture: C) at P0 and D) at P1. Data 
are expressed as mean ± SD (n = 3). *p < 0.05. 
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3.4.5 Expression of key PCM and ECM components  
3.4.5.1 Expression of key PCM components in two-dimensional monocultures 
Figure 3.15 displayed the PCM and ECM components markers in the monocultures through 
immunofluorescence staining. MSCs had no any expression of all PCM markers. Collagen II 
staining intensity was detectable around P0 chondrons and P0 chondrocytes with chondrons 
expression more at all the culture time points. Collagen II showed accumulated deposition along 
culture i.e. the latest culture day expressed more than the first culture day. A dramatic difference 
was found in the production of high collagen II content at passage 0 cells compared to the other 
passages cells. At passage 1, collagen II expression was presented albeit less intense. Collagen VI, 
exclusively located in the PCM, was only detected in the chondron cultures. By day 7 (P0), 
collagen VI staining was lost under the present culture condition. There was no expression at all at 
P1 chondrons and chondrocytes. Immunofluorescence staining for HtrA1 was absent for chondrons 
and chondrocytes of both P0 and P1 cells at day 1 but present at day 5 and 7 with accumulated 
deposition along extended time in culture. At P1, chondrocytes showed stronger HtrA1 staining 
than the chondrons at the same culture time points. The staining pattern of HtrA1 was inverse to 
collagen VI staining in P0 chondron. These data were confirmed by comparison with both negative 
and positive controls using both isolated cells and full-depth bovine articular cartilage. The semi-
quantification of staining intensity among the groups was presented in Figure 3.16, which 
correlated well with the immunofluorescent stained images (Figure 3.15). 
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Figure  3.18: Representative immunofluorescent stained images of chondrons (CN), chondrocytes 
(CY), or MSCs in monoculture at days 1, 5, and 7 at P0 (panels A) and P1 (panels B). The cells 
were collagen II (red; The cells were counter-stained by DAPI (blue). The white arrows indicate 
positive staining. The scale bars represent 20 μm. Immunofluorescent stained intensity analysis of 
chondron (CN), chondrocyte (CY), and MSC in monoculture at days 1, 5, and 7 at collagen II; C 
for P0 cells and D for P1 cells. Data are expressed as mean ± SD (n = 3). * p < 0.05. 
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Figure  3.19: Representative immunofluorescent stained images of chondrons (CN), chondrocytes 
(CY), or MSCs in monoculture at days 1, 5, and 7 at P0 (panels A) and P1 (panels B). The cells 
were collagen VI (green the cells were counter-stained by DAPI (blue). The white arrows indicate 
positive staining. The scale bars represent 20 μm. Immunofluorescent stained intensity analysis of 
chondron (CN), chondrocyte (CY), and MSC in monoculture at days 1, 5, and 7 at collagen VI; C 
for P0 cells and D for P1 cells. Data are expressed as mean ± SD (n = 3). *p < 0.05 
 
` 
   93  
 
 
 
Figure  3.20: Representative immunofluorescent stained images of chondrons (CN), chondrocytes 
(CY), or MSCs in monoculture at days 1, 5, and 7 at P0 (panels A) and P1 (panels B). The cells 
were HtrA1 (red; the cells were counter-stained by DAPI (blue). The white arrows indicate positive 
staining. The scale bars represent 20 μm. Immunofluorescent stained intensity analysis of chondron 
(CN), chondrocyte (CY), and MSC in monoculture at days 1, 5, and 7 at HtrA1; C for P0 cells and 
D for P1 cells. Data are expressed as mean ± SD (n = 3). * p < 0.05. 
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3.4.5.2 Expression of key PCM and ECM components in two-dimensional co-
cultures 
At any culture time points or cell ratio, collagen VI staining was absent for the chondrocyte: MSC 
co-culture groups. In contrast, collagen VI was identified for all time points and ratios (Figure 3.17) 
for all chondron: MSC co-cultures when using P0 chondrons. The 50% chondron: MSC co-cultures 
had a highest collagen VI staining which matched with the alcian blue staining (Figure 3.9). P1 
chondrons and chondrocytes had no any expression of collagen VI at all. 
Along culture time, P0 chondrocyte and chondron co-cultures revealed increasing in collagen II 
staining intensity. The 50% ratio co-culture had the most intense staining. There was no influence 
on collagen II expressions for the co-culture with P1 cells. HtrA1 staining intensity was lower in all 
chondrons and chondrocytes co-culture ratios than monoculture. At 50% chondron: MSC co-
cultures along all culture time points there were no detectable staining of HtrA1. The distinct 
staining intensity was in the chondrocyte: MSC co-cultures samples at day 7. At passage 1, the co-
culture presented significant low expression of HtrA1 in compared to the mono-culture. There was 
weak expression of HtrA1 at day 7. The semi-quantification of staining intensity is presented in 
Figure 3.18, which correlated well with the immunofluorescent stained images (Figure 3.16). 
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Figure  3.21: Representative immunofluorescent stained images of chondrons (CN), chondrocytes 
(CY), or MSCs in co-culture at days 1, 5, and 7 at P0 (panels A) and P1 (panels B). The cells were 
collagen II (red; the cells were counter-stained by DAPI (blue). The white arrows indicate positive 
staining. The scale bars represent 20 μm.  
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Figure  3.22: Representative Immunofluorescent stained intensity analysis of chondron (CN), 
chondrocyte (CY), and MSC in co-culture at days 1, 5, and 7 at collagen II; A for P0 cells and B 
for P1 cells. Data are expressed as mean ± SD (n = 3). *p < 0.05 
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Figure  3.23: Representative immunofluorescent stained images of chondrons (CN), chondrocytes 
(CY), or MSCs in co-culture at days 1, 5, and 7 at P0 (panels A) and P1 (panels B). The cells were 
collagen VI (green; the cells were counter-stained by DAPI (blue). The white arrows indicate 
positive staining. The scale bars represent 20 μm.  
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Figure  3.24: Representative Immunofluorescent stained intensity analysis of chondron (CN), 
chondrocyte (CY), and MSC in co-culture at days 1, 5, and 7 at collagen VI; A for P0 cells and B 
for P1 cells. Data are expressed as mean ± SD (n = 3). *p < 0.05 
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Figure  3.25: Representative immunofluorescent stained images of chondrons (CN), chondrocytes 
(CY), or MSCs in co-culture at days 1, 5, and 7 at P0 (panels A) and P1 (panels B). The cells were 
HtrA1 (red; the cells were counter-stained by DAPI (blue). The white arrows indicate positive 
staining. The scale bars represent 20 μm. 
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Figure  3.26: Representative Immunofluorescent stained intensity analysis of chondron (CN), 
chondrocyte (CY), and MSC in co-culture at days 1, 5, and 7 HtrA1 ; A for P0 cells and B for P1 
cells. Data are expressed as mean ± SD (n = 3). *p < 0.05 
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3.5 Discussion 
The chondrogenic capacity was assessed by cell morphology, the production rate of ECM (GAG 
and collagen II) and the presence of PCM (collagen VI) as the markers. Current study showed that 
the monolayer culture using hard substrate were unable to maintain the cartilaginous phenotype, 
and chondrocytes and chondron lose their phenotype from rounded to fibroblast-like spindle shapes 
with less collagen II and GAGs synthesis along 7 day culture duration. Co-culture of MSCs with 
chondrons enhanced ECM matrix production, as compared to chondrocyte or chondron 
monocultures. The co-culture of MSCs with chondrons appeared to decelerate the loss of the PCM 
as determined by collagen VI expression as compared to chondrons monoculture, whilst the 
expression of HtrA1 demonstrated an inverse relationship to that of the collagen VI. 
Chondron has a higher chondrogenic potential than chondrocytes  
This study has demonstrated that chondrons have higher chondrogenic potency than chondrocytes 
along culture duration regarding round shape morphology maintenance and ECM production; in 
terms of more accumulated GAG and collagen II production (8% and 11 % more in GAG and 
collagen II respectively). The higher ECM production in chondron culture in comparison to 
chondrocytes, which have no PCM, further confirms that PCM is an important source of 
chondrogenic signals for cartilage regeneration. Also, it has been shown in previous reports that 
chondrons have higher chondrogenic potency than chondrocytes (Larson et al., 2002; Bekkers et 
al., 2013). 
PCM degradation process in 2D culture 
 It is demonstrated that PCM was very fragile and sensitive to culture condition. The dramatically 
changed surrounding of cartilage cells during culture influenced PCM’s regeneration or 
preservation. Chondrocytes in both mono and co-cultures demonstrated that there was no PCM 
formation at any time points. While chondron in monoculture lost the native PCM gradually within 
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the culture duration; PCM was lost by day 7, whereas the co-culture chondron with MSC delayed 
the PCM degradation. The current study demonstrated that monolayer culture environment had no 
ability to preserve or rebuild PCM even with the co-culture of MSC if the culture plate was a hard 
substrate. It was confirmed that monolayer culture drove chondrocytes and chondron differentiation 
to fibroblast-like cell phonotype. It is speculated that without 3D microenvironment which mimic 
the native ECM and stabilise/accumulate newly formed PCM was the main cause for PCM lost by 
7 day culture. Collagen VI staining had shown a clear picture for the degradation process. These 
observations have been supported by previous studies (Lee and Loeser., 1998, Larson et al., 2002). 
The effect of co-culture and MSC ratios  
In the co-culture, it is likely that bi-directional interactions occurred between cartilage cells and 
MSCs. It has been reported that chondrocyte secrete factors such as transforming growth factor-
beta (TGF-β1), and bone morphogenetic proteins (BMP-2) (Bian et al., 2012; Wu et al., 2012) and 
these could induce chondrogenesis of MSCs and ECM production in vitro (Zhang et al., 2009; 
Lettry et al., 2010; Wu et al., 2012). In other studies it has been suggested that MSCs secrete 
chondrogenesis growth factors stimulating chondrocytes and therefore increasing cartilage matrix 
formation and proliferation matrix (Tsuchiya et al., 2004; Lettry et al., 2010; Levorson et al., 2014). 
Hence the ratio of MSC and cartilage cells in co-culture will influence the overall chondrogenic 
outcome. 
Three different ratios of MSC and cartilage cells were used in this study, which was believed to 
induce distinct influence on chondrogenic capacity in chondron and chondrocytes. In 80:20 MSC 
and chondrocytes or chondrons ratio, MSCs were dominated cell population with lower 
chondrogenic impact due to the low number of cartilage cells. While the 20:80 MSC and 
chondrocytes or chondrons ratio had prevailed cartilage cells number, then the MSCs exerted less 
effect. Optimally, 50:50 MSC and chondrocytes or chondrons ratio had a balance between the two 
types of cell populations which allowed exchanging the signalling to maintain the chondrogenic 
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phenotype longer for cartilage cells and induce more MSCs to differentiate into chondrogenic 
lineage cells. Our results confirmed that 50:50 ratio had the maximum enhancement on 
chondrogenesis. 
Reduction of HtrA1 production in co-culture 
There is a gap in the understanding of PCM degradation in co-culture. As a secreted member of the 
trypsin family of serine proteases, HtrA1 has the capability to degrade the PCM (Polur et al., 2010). 
It has been reported that chondrocytes, expressing HtrA1 in mouse OA joints, do not produce 
collagen VI, which implies the disruption of the PCM (Hou et al., 2013). Whereas, in a mouse OA 
joint collagen VI was detected in the PCM while HtrA1 expression was absent (Polur et al., 2010). 
The current study demonstrated the same inverse relationship between the expression of HtrA1 and 
collagen VI. Interestedly, at the same condition as monoculture (culture time points), chondron co-
culture with MSC samples had lower level HtrA1 expression. 50% chondron: MSC co-cultures did 
not show staining of HtrA1 at all culture time points, but the samples of chondrocyte: MSC co-
cultures at day 7 had the highest staining intensity. At passage 1, the co-culture showed significant 
low expression of HtrA1 in compared to the monoculture. There was indistinct expression of 
HtrA1 at day 7. Hence, it is hypothesized that the presence of HtrA1 could be crucial to the 
degradation of collagen VI. The integrity of PCM could be preserved through protecting collagen 
VI by inhibition or inactivation of HtrA1 production. Thus, we speculate that the presence of MSCs 
in co-culture directly or indirectly inhibits the production of HtrA1, which results in the 
preservation and promotion of PCM.  
The advantage of the current xenogeneic co-culture model 
A major setback associated with studies on co-culture is that a large number of cells is required, 
which cannot be gathered from the patient samples obtained at surgery. A large number of 
consistent chondrons is difficult to isolate from limited supplies of cartilage tissue. To avoid the 
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issue of cell numbers, well characterised bovine chondrocytes and chondrons were used alongside 
rat MSC in this study because it is very difficult to get bovine MSCs.  
Xenogeneic co-culture models using the bovine chondrocytes and either rat or rabbit MSCs have 
been successfully used by some other groups without any immune response or different inverse 
outcome (Levorson et al., 2014; Meretoja et al., 2014). Therefore, the xenogeneic co-culture model 
using rat MSCs and bovine cartilage cells will generate sufficient cells to clarify the effect on 
collagen VI. We have developed a xenogeneic co-culture model using rat MSCs to avoid the issue 
of the low yield of chondrons from small “off cuts” of patient tissue. It offers a valuable insight 
into chondrocyte and chondron co-cultures as well as the tool for classification of mechanism of 
MSC.  
3.6 Conclusion 
In conclusion, the monolayer culture system demonstrated an inability to maintain the 
chondrogenic phenotype, and chondrocytes and chondron changed their morphology from rounded 
to fibroblast-like spindle shapes. Also, it was confirmed that chondrons had higher chondrogenic 
potential than chondrocytes regarding GAG production and collagen II expression.  
Co-culture of MSCs with chondrons enhanced ECM matrix production, as compared to 
chondrocyte or chondron monocultures. The co-culture of MSCs with chondrons appeared to 
decelerate the loss of the PCM as determined by collagen VI expression, whilst the expression of 
HtrA1 demonstrated an inverse relationship to that of the collagen VI. The ratio of 50:50 of MSCs 
in co-culture with chondrons presented the highest potential for better cartilage regeneration. 
Together this implies that MSCs directly or indirectly inhibited HtrA1 activity. However, PCM 
could not be preserved or regenerated in 2D culture even starting from chondron, and co-culture 
with MSCs if the culture plate was a hard 2D substrate which stimulated chondrocytes and 
chondron differentiation to fibroblast-like cells.  
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Chapter 4 : Three-dimensional cartilage tissue models to study 
PCM maintenance and regeneration   
` 
106 
 
4.1 Introduction  
 The role of 3D environment in chondrogenic potential and in PCM regeneration and 
preservation 
The maintenance or rebuilding of the PCM has a significant influence on cell-matrix interaction 
and function of cartilage engineered tissue (Vonk et al., 2010; Zhang et al., 2014). However, the 
PCM can be destroyed during dissection and in vitro culture (Larson et al., 2002). The results in 
chapter 3 showed that both chondrocytes and chondrons lose the chondrogenic phenotype and 
reduced their production of collagen II and GAGs within 1 week monolayer culture. In addition, 
the monolayer culture study suggested that cartilage cells have a reduced ability to preserve or 
rebuild their PCM, even when co-cultured with MSCs.  
Hydrogels due to their high tissue-like water content, tuneable physical properties, homogenous 
cell distribution, high permeability for nutrients and waste products, have been developed for 
several tissue engineering applications (Tan et al., 2010; Eslahi et al., 2016). There is much 
evidence to show that preserving the chondrogenic phenotype can be achieved by culturing the 
chondrocytes and chondrons in a hydrogel environment (Chang and Poole, 1997; Dimicco et al., 
2007; Vonk et al., 2010). This is due to the fact that hydrogels have a 3D network which is similar 
in structure to that of the native ECM (Eslahi et al., 2016). Through the use of hydrogels, 
chondrocytes can be stimulated to produce cartilage-specific matrix, where the hydrogel preserves 
the newly-produced matrix to allow accumulation of ECM-related content (Aleksander-Konert et 
al., 2016; Eslahi et al., 2016).  
Using the well characterised agarose system, Chang and Poole (Chang and Poole, 1997) cultured 
chondrocytes for 24 h producing aggrecan, decorin, and fibronectin. A week later, the chondrocytes 
were surrounded by a ring of PCM containing collagen VI. Vonk et al. (2010) reported that 
chondrons retained their PCM whilst cultured in a well-defined alginate system for up to 25 days. 
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By comparison, chondrocytes needed a block of time to first rebuild their PCM, and then mature it. 
If these cells were going to be re-implanted into a cartilage defect, then there would be at least a 25 
day delay whilst they caught up with the chondrons. 
In the literature, co-culture studies of articular chondrocytes or chondrons with mesenchymal stem 
cells have provided evidence of increased ECM production (Qing et al., 2011; Levorson et al., 
2014). According to Levorson et al., (2014) confirmed the cartilaginous ECM-like (collagen II and 
GAGs) production was prompted in a xenogeneic co-culture model using rabbit MSCs and bovine 
chondrocytes within a nonwoven fibrous substrate. Previous studies have stated that enhancement 
in ECM production by chondron and human MSCs in co-cultures for 4 weeks of pellet culture 
(Bekkers et al., 2013). However, up till now, there have been no systematic studies to reveal 
whether MSC co-culture with cartilage cells makes reservation of PCM and what the associated 
mechanism (s) are.  
The gap of knowledge to be filled  
To date, most research has focused on PCM maintenance or regeneration within 3D 
microenvironment hydrogels. The field needs some systematic studies designed to investigate and 
compare multi-factor effects in 3D culture environment which could influence the efficiency of 
PCM maintenance or regeneration. For example, we need to explore co-cultures with MSCs since 
we have preliminary evidence to suggest that this approach can promote better PCM maintenance.  
Synchrotron microFTIR as a new tool to analyse PCM maintenance and regeneration  
ECM and PCM formation and maturation were usually monitored as well through a range of 
difference approaches such as metachromasia, biochemistry and immunolocalisation techniques. 
For example, metachromatic stains such as toluidine blue and alcian blue have been widely used to 
detect the presence of GAGs and their associated proteoglycans (mainly aggrecan). The 
dimethylmethylene blue assay is widely used for the quantitation of total sulphated GAGs but it 
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can be inaccurate due to interference from polyanions. Metachromasia only provides a crude 
assessment and it provides a limited amount of information. Biochemical assays such as total 
collagen analysis or Western blotting using immunolocalisation have been utilised to assess protein 
accumulation (mainly collagen type II but also collagen VI). These techniques are useful but to 
characterise both articular cartilage and chondrons at the microscale level it will be necessary to 
develop additional techniques which can resolve micron-scale structural changes and difference 
during chondrocyte culturing. 
Components of biological structures like human tissue and cells can be studied using Fourier 
Transform Infrared (FTIR) microspectroscopy (microFTIR). The advantage of using FTIR 
technique is that a single spectrum can reveal various important biomolecules simultaneously such 
as lipids, proteins, carbohydrates and nucleic acids. Each biomolecule produces its spectral 
signature depending on the nature of the bonds and concentrations of the molecules (Barth, 2009). 
Using a synchrotron source for FTIR provides a more powerful tool for cells and tissue study 
because of the high brightness which enables using smaller aperture to identify the spatial 
heterogeneity of biomolecules in single cells with as small as 5 micrometres apertures (Miller et al., 
2005). Synchrotron microFTIR offers spatial distribution mapping and chemical structure detection 
at the micron scale, when integrating chemical analysis specificity with microbeam precision 
(Deegan, et al., 2015). FTIR offers non-destructive identification tool with less sample preparation 
and provides integral information for the spatial distribution of proteins presence, proteoglycan 
contents and concentration and lipids. 
Several studies have recently been conducted on infrared spectroscopy on articular cartilage tissue 
and engineered constructs. Camacho et al., (2001) presented univariate parameters to quantify 
collagen and proteoglycan contents in articular cartilage. The amide I (1584 - 1720 cm
−1
) was 
shown to correlate with the collagen content, and the carbohydrate region (984-1140 cm
−1
) 
correlate with the proteoglycan content in pure compound mixtures of collagen and aggrecan 
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(Camacho et al., 2001). Potter et al., (2001) used FTIR spectral imaging, coupled with multivariate 
data processing to study the spatial distribution of ECM components in native cartilage tissue and 
3D cartilage tissue, generated by chick sternal chondrocytes in a hollow fibre bioreactor (Potter et 
al., 2001). The FTIR data analysis showed that tissue-engineered cartilage had more collagen and 
less proteoglycans than the native cartilage. 
A study reported that proteoglycans quantification could be enhanced by normalising the spectra of 
carbohydrate region by that of amide I in tissue-engineered cartilage, which reduced the thickness 
variation in the cartilage tissue sections (Kim et al., 2005). A statistically significant correlation 
was obtained between the FTIR spectral data and alcian blue staining. However, there was no study 
to assess the evolution process of PCM formation in tissue engineered cartilage constructs by FTIR. 
There was no synchrotron microFTIR study to map spatial distribution of chemical compositions of 
newly generated PCM in a tissue engineering cartilage model. 
4.2 Objectives 
This study aims to define the 3D culture environments that facilitate the preservation, regeneration 
and stabilisation of PCM by investigating and comparison of multi-factors such as; hydrogel types, 
presence of MSCs, culture medium types and culture duration in parallel. The non-destructive 
technique, the synchrotron microFTIR technique, would be explored to observe the PCM formation 
and cellular evolution of cultured cartilage cells in the 3D tissue-engineered cartilage models.  
4.3 Materials and methods 
4.3.1 Cell isolation and expansions 
Bovine chondron and chondrocytes were used with passage 0 (P0) exclusively. P1 rat MSCs was 
used. The cell isolation and culture details have been included in Chapter 2, Section 1.  
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4.3.2 Experiments design and set up 
Four cell groups containing monoculture, chondrocytes (CY), chondron (CN), and co-culture with 
mesenchymal stromal cells (MSC) in the ratio of 50:50 were prepared based on the 2D culture 
outcomes (chapter 3) for this study. All groups used basal (Bas) or chondrogenic (Ch) medium, 
respectively, and the cartilage cells were encapsulated with HA and agarose (ag) hydrogels in 
separate experimental groups. All samples were cultured in 96 well-plates. For hydrogel 
embedding, 75 μl of hydrogel mixture was cast first. After gelation, cells were seeded at a seeding 
density of 5x10
3
 cells/well (Table 4.1), and allowed to attach at 37˚C for 2 hours. Following 75 μl 
of hydrogel solution was filled in the well. The formed construct was incubated with basal or 
chondrogenic media (Table 2.1) and cultured up to 21 days at 37˚C and 5% CO2. The cell 
morphology, cell number, total sulphated glycosaminoglycan (sGAG) content and the 
immunolocalisation of key PCM/ECM components were assessed on day 1, 7, 14 and 21. 
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Table  4-1: Description of experimental groups with cell types and seeding densities 
Experimental group Chondrocytes  
per well 
Chondrons per well MSCs per well Mediums 
CY (HA) 5,000 - - 
Chondrogenic 
Basal 
CY50 (HA) 2,500 - 2,500 
Chondrogenic 
Basal 
CN (HA) - 5,000 - 
Chondrogenic 
Basal 
CN50 (HA)  - 2,500 2,500 
Chondrogenic 
Basal 
CY (ag) - 5,000 - 
Chondrogenic 
Basal 
CY50 (ag) 2,500 - 2,500 
Chondrogenic 
Basal 
CN (ag) - 5,000 - 
Chondrogenic 
Basal 
CN50 (ag) - 2,500 2,500 
Chondrogenic 
Basal 
4.3.3 Cell viability 
A standard live/dead cell staining kit was used to assess cell survival in hydrogel capsules. The 
protocols with set up details were detailed in Chapter 2, Section 5.2. 
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4.3.4 Cell morphology monitoring  
The cells and clusters morphology in monocultures and co-cultures on all variables and different 
time points were imaged with an optical microscope attached to a CCD camera.  
4.3.5 Biochemical assays 
Papain solution was used to digest the experimental samples at the end of the culture periods for 
PicoGreen DNA assay and DMMB assay as described in Chapter 2, Section 4, Section 5.1 and, 
Section 6 respectively. The normalised value of total GAG content per cell was calculated as well 
based on GAG content and cell number. 
4.3.6 Histology 
Hydrogel was removed by incubation for 45 seconds in a 40˚C water bath. The molten solution was 
centrifuged at 750 g; cells that were to be encapsulated on hydrogel were re-suspended in 0.9% 
NaCl. Cell suspensions were cytospun onto slides for 1 minute at 700 rpm. Once the cells had been 
deposited on slides, samples were fixed with 4% (v/v) formalin at room temperature for 30 
minutes, and then stained for deposited sGAG using toluidine blue staining. The staining protocol 
details were included in Chapter 2, Section 9.1. 
4.3.7 Immunolocalisation of key chondrogenic markers 
Immunostaining was used to identify the presence and distribution of PCM and ECM components 
(collagen type II, collagen type VI) and HtrA1. Immunostaining staining was conducted using the 
protocols described in Chapter 2, Section 10. Intact samples were stained and staining intensity was 
observed by a confocal microscopy.  
4.3.8 Semi-quantification of GAG and immunofluorescence staining intensity 
The intensity of toluidine blue and immunofluorescence staining were semi-quantified using 
ImageJ software following the protocols detailed in Chapter 2, Section 11. 
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4.3.9 Synchrotron FTIR spectroscopy 
For FTIR measurement, cytospun samples were prepared according to a described protocol in 
Chapter 2, Section 7. Five different groups were prepared; isolated chondron, isolated chondrocytes, 
and chondrocytes cultured in HA hydrogel with basal medium at days 7, 14 and 21. 
Synchrotron FTIR data were acquired from Diamond Light Source (Oxford). Principle Component 
Analysis (PCA) was performed with loading plots to show the variation in FTIR spectra according 
to variation in culture conditions. The protocol details can be found in Chapter 2, Section 7.3. 
4.4 Results 
4.4.1 Cell cluster morphology  
The shape of the cell clusters was assessed at different culture time points; 1, 7, 14 and 21 days 
(Figure 4.1). In monoculture, after 24 hours culturing both chondrocytes and chondrons displayed a 
rounded morphology in different hydrogel materials and media types. By day 7, both chondrocytes 
and chondrons showed a remarkable distinction within HA and agarose hydrogels. Chondrocytes 
and chondrons showed small spread round clusters within HA hydrogel, but they showed big 
clusters close to each other with less spreading in agarose hydrogel with both chondrogenic and 
basal media. At day 14, the appearance of the clusters changed dramatically; cell clusters presented 
a round shape with the slight spread. At 21 days, all of the cells in different groups tended to 
aggregate together as dense clusters. The Co-culture results showed variations in cell clustering. At 
the end of the first day, chondrons demonstrated a spread and rounded morphology in different 
hydrogel materials and media types. By contrast, chondrocytes formed small irregular clusters in 
close proximity to each other. Through the time course, both chondrocytes and chondrons clustered 
in a similar manner within both HA and agarose hydrogels at monoculture but with dense and 
smaller clusters with chondrogenic media. The co-culture samples at day 14 displayed a dense 
cluster with less spread comparison to monoculture. 
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Figure  4.1: Cell morphology in mono and co-cultures within hyaluronic acid (HA) and agarose (ag) hydrogels under chondrogenic (Ch) and basal (Bas) 
mediums at Days 1, 7, 14 and 21 with/without 50% MSC with (A) chondron (CN) and (B) chondrocytes (CY). The scale bars represent 150 μm. 
Day 1 
Day 7 
Day 21 
B 
Day14 
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4.4.2 Cell viability and cell number  
Figure 4.2 shows the live/dead cell images on the constructs taken by confocal microscopy at 
different time points; 1 and 21 days. The viable cells fluoresced green and the non-viable cells 
fluoresced red. Based on the image observation, by the first day all the cells in both chondron and 
chondrocytes in mono and co-cultures were viable and there were no dead cells. By the day 21 
most cells were viable, and there were only a few dead cells detected within the agarose hydrogel 
than HA hydrogel, and monoculture has less dead cells in comparison to co-culture. Also, 
chondron cultures contained less dead cells comparing to chondrocytes. 
Figure 4.3 shows that co-culture had a higher cell number in comparison with monoculture of both 
chondron and chondrocytes constructs. Also, the chondrocytes had higher cell number than the 
chondrons within the time in both mono and co-cultures. The HA hydrogel demonstrated a 
significantly higher cell number than the agarose hydrogel (p < 0.05) at different time points in 
both chondrogenic and basal mediums. Over time, the HA hydrogel had a higher proliferation rate 
in comparison with agarose which had almost the same cell number across the time course. 
Regarding media types, cell number was higher in a basal media culture in HA hydrogel in both 
chondron and chondrocytes mono and co-cultures (p < 0.05). Chondrogenic media culture showed 
that cell number and the proliferation rate decreased after day 7 in both mono and co-cultures.
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Figure  4.2: The live and dead staining of cartilage cells in mono and co-cultures within hyaluronic acid (HA) and agarose (ag) hydrogels, under chondrogenic 
(Ch) and basal (Bas) mediums at Days 1 and 21 with/without 50% MSC with (A) chondron (CN) and (B) chondrocytes (CY). Green represented live cells, 
red dead cells. The scale bars represent 100 μm. 
Day 1 
Day 21 
B 
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Figure  4.3: Cell number in monoculture with hyaluronic acid (HA) and agarose (ag) hydrogels 
under chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21 at (A) chondron (CN) and 
(B) chondrocytes (CY). Data are expressed as mean ± SD (n =3).  
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Figure  4.4: Cell number in co-culture with hyaluronic acid (HA) and agarose (ag) hydrogels under 
chondrogenic (Ch) and basal (Bas) mediums at Days 1, 7, 14 and 21 using 50% MSC with (A) 
chondron (CN) and (B) chondrocytes (CY). Data are expressed as mean ± SD (n =3). 
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4.4.3 Total sulphated GAG production 
Figures 4.5 and 4.6 demonstrate the accumulated sGAG in mono and co-cultures for both chondron 
and chondrocytes constructs using different hydrogel materials and media types at different culture 
time points; 1, 7, 14 and 21 days. Co-culture enhanced the GAG production in comparison with 
monoculture in both chondron and chondrocytes constructs. Also, the chondron produced higher 
accumulated GAG than chondrocytes within the same time point in both mono and co-cultures (p < 
0.05). HA hydrogel demonstrated higher GAG production than agarose hydrogel (p < 0.05) along 
different time points in both chondrogenic and basal media. The accumulated GAG increased with 
culture time. Chondrogenic medium culture showed enhancement and higher GAG production than 
basal medium culture in HA and agarose hydrogels in both chondron and chondrocytes in mono 
and co-cultures. 
Normalised data confirmed that sGAG production per cell increased with time. Furthermore, MSC 
and chondron co-cultures significantly increased GAG production per cell (p < 0.05). The highest 
normalised GAG production (Figures 4.7 and 4.8) was in the samples with the HA gel, 
chondrogenic media and 50% MSC in both chondron and chondrocytes.  
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Figure  4.5: Total sGAG production in monoculture within hyaluronic acid (HA) and agarose (ag) 
hydrogels and chondrogenic (Ch) and basal (Bas) mediums at Days 1, 7, 14 and 21 at (A) chondron 
(CN) and (B) chondrocytes (CY). Data are expressed as mean ± SD (n =3). *p < 0.05 
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Figure  4.6: Total sGAG production in co-culture within hyaluronic acid (HA) and agarose (ag) 
hydrogels under chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21 using 50% MSC 
with (A) chondron (CN) and (B) chondrocytes (CY). Data are expressed as mean ± SD (n =3). *p 
< 0.05
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Figure  4.7: Total sGAG production normalised to cell number in monoculture within hyaluronic 
acid (HA) and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 
14 and 21 at (A) chondron (CN) and (B) chondrocytes (CY). Data are expressed as mean ± SD (n 
=3). *p < 0.05 
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Figure  4.8: Total sGAG production normalised to cell number in co-culture within hyaluronic acid 
(HA) and agarose (ag) hydrogels under chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 
and 21 using 50% MSC with (A) chondron (CN) and (B) chondrocytes (CY). Data are expressed as 
mean ± SD (n =3). *p < 0.05 
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4.4.4 Histology 
Each cultured sample was stained with toluidine blue to detect the presence and distribution of 
GAGs. Throughout the time course, GAGs increased in chondron and chondrocyte mono and co-
cultures constructs (Figures 4.9 and 4.10). HA hydrogel showed more strongly stained than the 
agarose in mono and co-cultures. Furthermore, the samples cultured in chondrogenic media 
demonstrated more GAGs than basal media samples. Semi-quantification of the GAG staining 
intensity across the groups and culture time by ImageJ Analysis software was shown in Figure 
4.10. It is shown that at monoculture and co-culture, chondrons presented higher GAG production 
than chondrocytes at all culture time points significantly and the intensity continuously increases 
along the culture with significant high GAG at day 21 and 14 than day 7 and 1. The semi-
quantification of staining intensity correlated well with the total sulphated GAG (Figures 4.5 and 
4.6).  
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Figure  4.9: Representative toluidine blue stained in mono and co-cultures within hyaluronic acid 
(HA) and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 
and 21 with/without 50% MSC with (A) chondron (CN) and (B) chondrocytes (CY). The scale bars 
represent 100 μm. 
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Figure  4.10: Representative semi-quantification of toluidine blue staining intensity in (A) chondron 
(CN) monoculture, (B) chondron co-culture within hyaluronic acid (HA) and agarose (ag) 
hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. Data are 
expressed as mean ± SD (n =3). *p < 0.05 
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Figure  4.11: Representative semi-quantification of toluidine blue staining intensity in (A) 
chondrocytes (CY) monoculture, (B) chondrocytes (CY co-culture, within hyaluronic acid (HA) 
and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. 
Data are expressed as mean ± SD (n =3). *p < 0.05 
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4.4.5 Expression of key PCM and ECM components  
Immunofluorescence staining has been conducted to identify the essential PCM/ECM markers in 
the mono and co-cultures samples with different culture conditions at different time points using 
both chondron and chondrocytes. 
Expression of collagen type VI and HtrA1 
Figure 4.11 demonstrates collagen VI expression. It was clearly that collagen VI staining intensity 
and morphology were strongly dependent on the initial cartilage cells in the samples.  
In chondron monocultures, collagen VI was presented and located around the cells from day 1 
through whole culture period; but there was slight variation during the culture and reduction at the 
21 day culture in agarose hydrogel. While for chondron co-culture with MSCs at day 7, 14 and day 
21, there was no significant difference from the day 1 expression, also no difference with different 
culture conditions. The collagen VI staining was a dense, homogeneous and symmetric layer 
surrounding the cells in all chondron groups. 
When using chondrocytes monoculture, there was no collagen VI detection at day 1 at all 
conditions, but detected collagen VI expression at day 7 under HA condition. It became apparent 
that cell surfaces were stained positively for collagen VI at day 14 under agarose hydrogel. Co-
culture of MSC and chondrocytes increased overall collagen VI expression level; most importantly, 
the samples at all conditions expressed collagen VI from day 7 including under agarose gel 
condition. The expression of collagen VI increased in all conditions along culture time with HA 
condition showing the highest collagen VI. By the end of the culture period (3 weeks) the presence 
of a clear collagen VI stained region surrounding the chondrocytes with a little difference between 
mono and co-cultures and between HA and agarose hydrogels was obviously. However, the 
morphology of collagen VI staining layer in chondrocytes was quite different from that in chondron. 
Fragment and spotting appearance made distinction of the newly formed collagen VI from native 
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one. The semi-quantification of staining intensity correlated well with staining imaging of the 
collagen VI expression. 
Figure 4.13 showed immunofluorescence staining of HtrA1. Generally, HtrA1 staining had a lower 
expression in co-culture than monoculture across chondrons and chondrocytes at different culture 
conditions. The HtrA1 staining was absent in co-culture of chondron and chondrocytes in different 
culture conditions at day 1 and day 7, but in monoculture there was visible HtrA1 staining at day 7. 
At day 14 co-culture, cells showed low and indistinct expression of HtrA1, but with considerable 
visible staining at monoculture. The immunofluorescence staining for HtrA1 at day 1 but present at 
day 7 and 21 with accumulated deposition with extended time in culture. Figure 4.14 presented the 
semi-quantification of HtrA1 staining, which corresponded with immunofluorescent staining for 
HtrA1.
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Figure  4.12: Representative collagen VI immunofluorescent stained in mono and co-cultures within 
hyaluronic acid (HA) and agarose (ag) hydrogels under chondrogenic (Ch) and basal (Bas) media 
at Days 1, 7, 14 and 21 with and without 50% MSC with (A) chondron (CN) and (B) chondrocytes 
(CY). The scale bars represent 20 μm. 
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Figure  4.13: Representative semi-quantification of collagen VI immunofluorescent staining 
intensity in (A) chondron (CN) monoculture, (B) chondron co-culture within hyaluronic acid (HA) 
and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. 
Data are expressed as mean ± SD (n =3). *p < 0.05 
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Figure  4.14:Representative semi-quantification of collagen VI immunofluorescent staining 
intensity in (A) chondrocytes (CY) monoculture, (B) chondrocytes co-culture within hyaluronic 
acid (HA) and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 
14 and 21. Data are expressed as mean ± SD (n =3). *p < 0.05 
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Expression of collagen type II  
Both chondron and chondrocyte in mono and co-cultures showed fluorescent staining for collagen 
II (Figure 4.15) under all different culture conditions and the expression increased along the culture 
time points. There was different staining intensity of collagen II under HA hydrogel and agarose in 
mono and co-cultures but the difference was not significant. HA hydrogel generated higher 
collagen II than agarose samples. Furthermore, chondrogenic media demonstrated expression 
enhancement for collagen II with higher fluorescent staining than basal media. It was expected that 
the staining for collagen type II in 50% chondron: MSC co-cultures was more intense than in 
monocultures for both chondron and chondrocytes, with chondron co-culture expressing higher 
value. Semi-quantification of the collagen II staining intensity across the groups and culture time 
by ImageJ Analysis software was shown in Figure 4.16 with consistent conclusion as the staining 
images.
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Figure  4.15: Representative HtrA1 immunofluorescent stained in mono and co-cultures within 
hyaluronic acid (HA) and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) mediums 
at Days 1, 7, 14 and 21 at (A) chondron (CN) and (B) chondrocytes (CY). The scale bars represent 
20 μm. 
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Figure  4.16: Representative semi-quantification of HtrA1 immunofluorescent staining intensity in 
(A) chondron (CN) monoculture, (B) chondron co- within hyaluronic acid (HA) and agarose (ag) 
hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. Data are 
expressed as mean ± SD (n =3). *p < 0.05 
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Figure  4.17: Representative semi-quantification of HtrA1 immunofluorescent staining intensity in 
(A) chondrocytes (CY) monoculture, (B) chondrocytes co-culture within hyaluronic acid (HA) and 
agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. Data 
are expressed as mean ± SD (n =3). *p < 0.05 
 
` 
139 
 
 
 
Figure  4.18: Representative collagen type II immunofluorescent stained in mono and co-cultures 
within hyaluronic acid (HA) and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) 
media at Days 1, 7, 14 and 21 with 50% MSCs with (A) chondron (CN) and (B) chondrocytes 
(CY). The scale bars represent 20 μm. 
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Figure  4.19 Representative semi-quantification of collagen VI immunofluorescent staining 
intensity in (A) chondron (CN) monoculture, (B) chondron co-culture within hyaluronic acid (HA) 
and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. 
Data are expressed as mean ± SD (n =3). *p < 0.05 
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Figure  4.20: Representative semi-quantification of collagen II immunofluorescent staining intensity 
in (A) chondrocytes (CY) monoculture, (B) chondrocytes co-culture within hyaluronic acid (HA) 
and agarose (ag) hydrogels and chondrogenic (Ch) and basal (Bas) media at Days 1, 7, 14 and 21. 
Data are expressed as mean ± SD (n =3). *p < 0.05 
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4.4.6 FTIR Analysis of chondrocytes grown in HA hydrogel 
As earlier stated, each biomolecule will produce its own spectral signature based on the nature of 
the bonds and their concentration in an individual spectrum. A typical spectrum of a biological 
sample is presented in Figure 4.17. 
 
Figure  4.21: A typical FTIR spectrum of a cell showing the absorbance bands for phosphate, 
carbonate, and protein amide bonds. (Taken from De Ninno et al., 2010). 
A FTIR spectrum analysis can be divided into two regions; fingerprint region which correlates 
explicitly with protein and proteoglycan content. Another region is lipid region which relates to cell 
number in general. Figure 4.18 showed the mean spectra of different experimental groups for 
fingerprint region (1000–1800cm−1). Each the mean spectra were produced from at least 40 spectra, 
or 30 cells. 
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Figure  4.22: Mean spectra at fingerprint region for different experimental groups; controls: bovine 
chondron (CN), chondrocytes (CY); cultured chondrocytes in HA hydrogel at day 7, day 14, and 
day 21. 
Clearly, the means plot displayed spectral variation between the culture samples and controls 
(native chondron and chondrocytes), also the chondrocytes culture duration (day 7, 14 and 21). To 
extract the main difference between groups and controls, the Unscrambler Software (Version X, 
Camo, Oslo, Norway) was used to analyse the acquired spectra by using PCA analysis. PCA and 
loading plots were used to visualise the differences between the spectra and where those 
differences are. 
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Figure  4.23: PCA scores and the loading lines at fingerprint region for different experimental 
groups; A) chondron (CN) vs chondrocytes (CY); B) chondron (CN) vs chondrocytes (CY) and 
chondrocytes (CY) with culture time points; day7, day14 and 21. 
The PCA scores and loadings plot of spectra displayed a clear spectral clustering between CY and 
CN samples (Figure 4.19. A), also the chondrocyte constructs cultured at day 7, day 14 and day 21 
samples (Figure 4.19. B). 
Figure 4.19. B showed that CY and day 7 PCA scores had major separation from CN, day 14 and 
day 21 samples. In addition, there was no considerable separation between CN and day 21 samples. 
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Figure 4.20 shows the mean spectra for different experimental groups for lipid region (3100–
2700cm
−1
). 
 
Figure  4.24: Mean spectra at lipid region for different experimental groups, chondrocytes cultured 
at day 7, day 14, and day 21.and control groups (bovine chondron (CN), chondrocytes (CY)).  
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Figure  4.25: PCA scores and the loading lines at lipid region for different experimental groups; A) 
Chondrocytes (CY) vs chondron (CN); B) Chondron (CN) vs chondrocytes (CY) and chondrocytes 
(CY) with culture time points; day7, day14 and 21. 
The PCA scores and loadings plot of spectra demonstrated certain overlapping between 
chondrocytes and chondron (Figure 4.21.A). Figure 4. 21. B revealed a distinct difference in PCA 
scores between controls (chondrocytes and chondron) from experimental samples of day 7, 14 and 
21 cultures. 
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4.5 Discussion 
This study demonstrated that 3D culture environment (HA and agarose hydrogels) can preserve the 
native PCM during culturing of chondrons, as well as regenerate PCM in chondrocytes within 3 
weeks culture at different culture conditions; mono or co-culture with MSC, with different medium 
types, and hydrogel types. The newly formed PCM marked by collagen VI expression in 
chondrocytes which were cultured within the 3D environment have been detected in both co- and 
monocultures, under agarose and HA hydrogel with varied concentrations, and the variation was 
culture condition dependent. Basal and chondrogenic culture media influenced the expression of 
cartilage-specific ECM markers but did not affect collagen VI synthesis. In addition, it has been 
confirmed that the synchrotron microFTIR technique by analysis of spectra in both lipid and 
fingerprint regions can reveal indirectly the PCM formation and cellular evolution of cultured 
chondrocytes in 3D hydrogel environment non-destructively.  
Chondron has a higher chondrogenic potential than chondrocytes  
The retention of the native PCM has been reported to affect the metabolic activity of the 
chondrocytes (Vonk et al., 2010). A key marker of the PCM microenvironment is collagen VI 
(Poole et al., 1987), which is known to interact with various matrix macromolecules such as 
collagen II and decorin (Bidanset et al., 1992), proteoglycan and hyaluronan (Kielty et al., 1992). 
In addition, collagen VI has been shown in previous studies to interact with the integrin receptors 
of chondrocytes (Salter et al., 1992; Loeser, 2014). This implies that collagen VI plays a dual role, 
one of which is creating macromolecular interactions to ensure the structural and functional 
integrity of the chondron, the other is to mediate cell surface anchorage and signalling potential 
between the chondrocyte and its pericellular microenvironment. In this light, it would be logical to 
use collagen type VI as a key detection indicator for the structural and functional integrity and 
maturation of matrix in tissue engineered cartilage. 
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This study has been shown that the culturing chondrons formed a more cartilage-like ECM 
(collagen II and GAG) and led to better hyaline cartilage production on a 3D hydrogel 
microenvironment than the chondrocytes along all culture conditions. This strongly suggests that 
the PCM is an effective source of chondrogenesis. The preserved PCM indicating by strong 
collagen VI staining in all chondron included groups explained the higher ECM productions in the 
groups. Although we use different species, the trend in results concur with Vonk et al. (2010) study 
in which goat’s chondrons and chondrocytes were cultured for 25 days in alginate beads, and it has 
been demonstrated that maintaining the native chondrocyte’s PCM enhanced the cartilage markers 
(collagen type II and GAG) production.  
HA has a better chondrogenic potential than agarose  
Cell-matrix interaction plays an important role in the proliferation, differentiation and survival of 
chondrocytes (Svoboda, 1998). In this study, a round cell shape and cluster of cartilage cells was 
found in HA and agarose hydrogels culture with the increase of cluster size with culture time. 
Overall in this study, both hydrogels culture (HA and agarose) supported the deposition of 
cartilage-specific matrix markers including GAGs, collagen II and the unique marker of PCM 
collagen VI, which promoted rebuilding cartilaginous–like ECM, but HA hydrogel culture had 
higher chondrogenic potency than agarose hydrogel culture in all culture conditions in terms of 
more accumulated GAG and collagen II production (13% and 10 % more in GAG and collagen II 
respectively for chondrocytes samples at day 21(Figure 4.6 and Figure 20)). 
The chemical and physical environments of ECM in native cartilage can be better mimicked by 
using highly hydrated hydrogels. Thus, hydrated hydrogels serve as an ideal cellular 
microenvironment for maintaining chondrogenic phenotype and cell proliferation (Aleksander-
Konert et al., 2016; Eslahi et al., 2016). A specific subset of known integrins is produced by each 
cell type, which controls the interactions between the cells and their microenvironment (Hynes, 
1992). Agarose hydrogel has no cell adhesion motifs to support direct cell anchorage as it prevents 
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the absorption of adhesive proteins from the environment (Steward et al., 2011). Thus, agarose can 
maintain the round shape of chondrocytes if it is used to encapsulate chondrocytes (Kuhtreiber et 
al., 1999). HA found natively in cartilage tissue, has been studied for decades (Yoo et al., 2005). 
Chondrocytes in native articular cartilage tissue demonstrated round shape morphology and 
clustered in small groups (Hunziker et al., 2002). HA is known to interact with chondrocytes via 
various surface receptors including CD44. This surface receptor bound to HA and triggers 
chondrocytes to retain their original morphology and phenotype, an area that is still not fully 
understood (Yoo et al., 2005). 
MSCs promoted chondrogenesis  
Herein, co-culture MSCs with both chondron and chondrocytes had a higher GAG and collagen II 
production in comparison with their monoculture in 3D hydrogel conditions. There were 
potentially two impact pathways through which the presence of MSCs in co-culture enhanced the 
formation of the PCM and ECM.  
This chondrogenic enhancment is considered to be the result of signaling via direct cell–cell 
contacts, as well as secreted factors generated by MSCs and chondrocytes. Chondrocyte-secreted 
factors such as TGF-β1 and BMP-2 may promote chondrogenesis of MSCs in vitro (Bian et al., 
2012; Wu et al., 2013). Another study demonstrated that articular chondrocytes secreted 
parathyroid hormone-related protein which can inhibit hypertrophy of chondrocytes or MSCs 
during chondrogenesis (Fischer et al., 2010). Other studies have hypothesised that MSCs secreted 
TGF-β1 and BMP-2 growth factors regularly from cultured MSC. The increased cartilage matrix 
formation and proliferation rate was explained due to stimulation of the chondrocytes by MSCs 
(Tsuchiya et al., 2004; Lettry et al., 2010; Levorson et al., 2014). There is a gap in the 
understanding of PCM degradation in co-culture. As a secreted member of the trypsin family of 
serine proteases, HtrA1 has the capability to degrade the PCM (Polur et al., 2010). It has been 
reported that chondrocytes, expressing HtrA1 in mouse OA joints, do not produce collagen VI, 
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which implies the disruption of the PCM (Hou et al., 2013). Whereas, in a mouse OA joint collagen 
VI was detected in the PCM while HtrA1 expression was absent (Polur et al., 2010). Uniquely, we 
speculate that MSCs directly or indirectly suppressed the production of HtrA1, or generated 
inhibitors for HtrA1 in co-culture, which led to the preservation and promotion of PCM integrity. 
In chapter 3, it was revealed clearly that the monolayer co-culture of chondrons and MSCs reduced 
the HtrA1 production. This pathway hypothesis was confirmed with the 3D culture by the 
immunostaining results. Figure 4.12 and 4.13 showed that there was an inverse relationship 
between HtrA1 and collagen VI expression in both chondron and chondrocyte mono and co-culture 
with MSCs. Overall, the presence of 50% MSCs enhanced cartilage cells’ chondrogenic capacity. 
Different effect of culture medium types on chondrogenesis  
In order to enhance the chondrogenic capacity, the catabolic and anabolic processes of 
chondrocytes are known to be influenced by a defined medium of several growth factors which 
stimulate ECM production and promote the chondrogenesis of MSCs (Mackay et al., 1998; Fortier 
et al., 2011). There is no report, till date, whether the PCM integrity and production are affected by 
different culture medium, especially about the synthesis of collagen VI. 
In this study, chondrogenic media showed enhancement in cartilage-specific matrix markers, i.e. 
GAGs and collagen II production using both hydrogels types and in both mono and co-cultures in 
comparison to basal media (11.5% and 14 % more in GAG and collagen II for chondrocytes 
samples at day 21 respectively (Figure 4.6 and Figure 20)), but both of mediums types had no 
influence in collagen VI syntheses. We speculated that chondrogenic media used in this study only 
supplemented with specific growth factors influencing on GAG and collagen II production but 
containing less specific stimulators on collagen VI synthesis.  
The effect of culture time on PCM formation and maintenance  
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In contrast to 2D culture in chapter 3, mono and co-culture of chondrons in all 3D conditions in this 
chapter maintained PCM manifesting as the clear collagen VI staining from day 1 up to 21 days 
culture duration. Co-culture with MSCs did not only stabilise PCM expression but also increased 
its production as the increase of culture time (Figure 4.11).  
Dramatic observation was the newly formed PCM in the culture of isolated bovine chondrocytes in 
mono and co-culture constructs. The new PCM exhibited a various deposition across the time 
course. The culture in HA hydrogel displayed the presence of collagen VI after 7 days in both 
mono and co-cultures with speckled stripe structures surrounding the chondrocytes, whilst agarose 
culture required 2 weeks to restore the PCM. With the co-culture of MSCs, thin layer of collagen 
VI appeared in agarose culture after 7 days. In all culture conditions, collagen VI expression 
increased with culture duration. By 14 day culture, all condition culture has detected collagen VI 
staining. However, chondron demonstrated dense and homogenous collagen VI staining, whilst 
chondrocytes staining showed a spotting and thin deposit of collagen VI staining along the culture 
duration. This study clearly showed that PCM regeneration was time-dependent and the newly 
formed PCM had different quality to native counterpart (Figure 4.12). Further investigation on the 
difference is required.  
The current study outcomes are consistent with previous study. It has been reported collagen VI 
regeneration is a slow process, requiring time to accumulate collagen VI (Dimicco et al., 2007). 
Chang and Poole (1997) observed a narrow ring of collagen VI around the cells after 7 days when 
chondrocytes were cultured in agarose hydrogel, and an 11 week period was needed to remodel 
into a mature and native-like PCM. To confirm VI collagen present in chondron, Vonk et al 
compared chondron with chondrocytes culture. They found that in the chondrons, the type VI 
collagen was traced around the cells along culture duration. Some type VI collagens were found 
around the chondrocytes after 25 days of culture in alginate beads, but chondrocytes had a smaller 
amount of type VI collagen than that found around the chondrons (Vonk et al., 2010). 
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Synchrotron microFTIR as a new tool for observation of PCM and cellular evolution  
Synchrotron microFTIR is a non-destructive analytic tool with less sample preparation request. It 
can provide spatial distribution of proteins, proteoglycan and lipids, and associated concentration 
within a single measurement. The PCA was performed as an unsupervised analysis that reduces 
large numbers of variables (microFTIR spectral vectors) into a few principle components (PC) (that 
are calculated from the covariance of the data set being analysed). Thus, it will be able to identify 
where there are differences in the data sets. Loading plots indicate how much a variable contributes 
to each PC. Hence PCA analysis can demonstrate where there are high levels of variance with a 
spectrum. 
Synchrotron microFTIR offers spatial distribution mapping and chemical structure detection at the 
micron scale, when integrating chemical analysis specificity with microbeam precision. FTIR 
offers non-destructive identification tool with less sample preparation and provides integral 
information for the spatial distribution of proteins presence, proteoglycan contents and 
concentration and lipids. 
However, there was no study to assess the evolution process of PCM formation in tissue engineered 
cartilage constructs by FTIR. There was no synchrotron microFTIR study to map spatial 
distribution of chemical compositions of newly generated PCM in a tissue engineering cartilage 
model. 
Originally, the spectra were collected in peripheral and nucleus regions and aimed to distinguish 
them by the presence of PCM. Unfortunately, the used aperture was too large and we could not get 
the separated spectra well. However, when we mixed all peripheral and nucleus region spectra for 
each groups and analysed their similarity to control chondrons and chondrocytes groups.Originally, 
the spectra were collected in peripheral and nucleus regions and aimed to distinguish them by the 
presence of PCM. Unfortunately, the used aperture was too large and we could not get the 
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separated spectra well. However, when we mixed all peripheral and nucleus region spectra for each 
groups and analysed their similarity to control chondrons and chondrocytes groups. 
There was the clear spectral difference between chondrocytes and chondron samples, also day 7, 
day 14 and day 21 samples. PCA scores for fingerprint region showed that chondrocytes and day 7 
had major separation from chondron, day 14 and day 21 samples. However, there was no 
significant separation between chondron and day 21 samples (Figure 4.23). PCA score in lipid 
region showed no considerable difference between chondrocytes and chondron samples, but with 
the significant difference from samples of day 7, day 14 and day 21 (Figure 4.25). 
As captured in the fingerprint region, the loadings showed similar spectra for PC1 and PC2, with 
the main differences occurring around 1550 cm
-1
 which implied that there were changes within 
amide II stretch, C-N stretch and N-H bend which correlated with collagen concentration 
(Camacho et al., 2001; Barth, 2009). The difference around ̴ 1240 – 1310 cm-1 implied that there 
were changes within amide III band components of proteins C-N stretch, N-H bend, C-C stretch 
and SO
−3
 asymmetric stretching vibration of sulphated GAGs (Bychkov and Kuzmina, 1992; 
Camacho et al., 2001; Barth, 2009). The lipid region loadings displayed a difference at 3000 cm
-1
 
which was indicative of CH2 and CH3 stretching and also at  ̴ 2950 and 2850 cm
-1
 which also 
indicated a change in the symmetrical C-H stretch of CH2 within lipid membranes (Barth, 2009). 
According to PCA scores, the cluster of day 14 and day 21 constructs with chondron indirectly 
demonstrated that chondrocytes cultured under the current conditions might generate chondron-like 
cell phenotype. The presence of PCM on day 14 and day 21, which contained collagen type VI and 
proteoglycan, could explain their similarity of spectra to chondron, not chondrocytes. These 
speculations were further supported by the PCA analysis in lipid region. The separation of 
chondron, chondrocytes, day 7, day 14 and day 21 were not strong as in fingerprint region because 
the change of the lipid region reflected cell number in general. These data shed light to reveal the 
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cellular evolution of cultured chondrocyte in tissue-engineered cartilage model by synchrotron 
microFTIR technique. 
4.6 Conclusion 
This work showed that 3D culture systems can maintain the chondrogenic phenotype and 
manifesting as identification of collagen VI in the culture which is the unique marker for PCM. In 
the HA cultures, PCM was observed after 7 days in both mono and co-cultures with speckled stripe 
structures surrounding the chondrocytes surface. The cultures required 2 weeks to restore the PCM. 
For agarose cultures, small scattered stippled layer around the chondrocyte of PCM appeared after 
7 days in co- cultures and after 14 days in monocultures. PCM was restored after 3 weeks. In 
addition, the presence of MSC directly or indirectly suppresses the production of HtrA1, or 
generates inhibitors for HtrA1 in co-culture, which led to the preservation and promotion of PCM 
integrity. 
It is revealed that the chondrogenic culture media enhanced the expression of cartilage-specific 
ECM markers in comparing with basal media but both of them had no preferred effect on PCM 
marker ‘collagen VI’ synthesis.  
Synchrotron microFTIR technique can be used as a non-destructively technique to observe the 
PCM formation and cellular evolution of cultured chondrocytes in tissue-engineered cartilage 
model by analysis of spectral changes in both lipid and fingerprint regions. 
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Chapter 5 : Constructing and testing of hybrid zonal-specific 
scaffolds for better cartilage regeneration 
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5.1 Introduction 
The nature zonal organisation in articular cartilage  
Articular cartilage is anisotropic in nature and organised into distinct zones; there are at least three 
architectural zones (superficial, middle and deep) with striking variations between their structure, 
chondrocyte phenotype, ECM composition and mechanical properties (Aydelotte et al., 1988; 
Hunziker et al., 2002). In the superficial zone, chondrocytes are elongated as a result of the tightly 
packed collagen fibres which have a parallel orientation to the surface to dissipate high tensile 
strength; also the concentration of proteoglycans is low than that in middle and deep zones 
(Camarero-Espinosa et al., 2016). The middle zone contains rounded chondrocytes with a random 
collagen fibres orientation, and this zone has a large amount of proteoglycans. In this zone, the 
collagen fibres are randomly oriented to provide resistance to the multidirectional compressive 
force (Stockwell, 1979; Hunziker et al., 2002). The deep zone contains chondrocytes stacked in 
columns with radial collagen architecture and high proteoglycan concentration. This radial 
orientation provides cartilage with a high compressive stress resistance (Camarero-Espinosa et al., 
2016). 
Current techniques to mimic zonal organisation in cartilage tissue engineering  
It is essential to produce articular cartilage with full functional capacity for patients with large 
cartilage defects. Replication of the zonal organisation of tissue-engineered cartilage is one of the 
multiple strategies to generate functional cartilage. Up till now, there are a small number of studies 
which sought out for zonal cartilage tissue engineering (Klein et al., 2003; Waldman et al., 2003; 
Ng et al., 2005; Malda et al., 2010; Steele et al., 2014). Approaches to mimic the zonal structure 
and function include cell-based, scaffold-based, a combination of cells and scaffold (Klein et al., 
2009). Cell-based methods have typically replicated the native distribution of chondrocyte 
populations by the isolation of zonal chondrocytes and cultured in micro mass pellet or in a cell 
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culture insert (Klein et al., 2003; Waldman et al., 2003). In these studies, the chondrocytes have 
been employed in specific regions of a construct, and they have been shown to retain their zone-
specific phenotype and secrete specific zonal ECM components such as aggrecan, collagen II and 
collagen X (Waldman et al., 2003; Malda et al., 2010). Other study has used multi-layered 
hydrogels to support cartilage production within different zonal sub-populations. Ng et al., (2005) 
took zonal populations of chondrocytes and seeded them into layers of 2% and 3% agarose. Steele 
et al., (2014) created a multi-zone cartilage construct by using electrospun polycaprolactone 
nanofibers. Analysis of the multi-zone scaffolds demonstrated region-specific variations in 
chondrocyte number, ECM composition, and chondrogenic gene expression. 
Potential biomaterials to create new 3D zonal scaffolds  
Electrospun nanofibres have been extensively studied and shown to have a great potential in tissue 
engineering (Kumbar et al., 2008). The fabrication of polymeric nanofibers by electrospinning has 
been used to mimic nanofibrous collagen matrices, which are found in articular cartilage ECM 
(Wise et al., 2014). Electrospun polylactic acid (PLA) nanofibres have been used widely for 
medical devices and in the field of musculoskeletal tissue engineering (Woodruff and Hutmacher, 
2010) since PLA is an FDA-approved polymer. Hyaluronic acid (HA) is a major component of 
synovial fluid and cartilage, and has a high capacity to maintain chondrocyte phenotype (Collins 
and Birkinshaw, 2013), and it has promising biocompatibility, biodegradability, and non-
immunogenicity (Yoo et al., 2005). Combination of electrospun nanofiber and HA as zonal 
scaffolds has not been tried previously. 
5.2 Objectives 
The aim of the study in this chapter is to design hybrid zonal-specific 3D scaffolds which can 
induce the formation of biomimetic zonal organisation and composition of ECM as in native 
articular cartilage tissue. Initially, the influence of individual scaffolds on both chondrocyte 
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morphology and ECM production in different zones is investigated. Aligned and randomly 
arranged nanofibers in combination with HA hydrogel are used to create the superficial and middle 
zones scaffolds, respectively. The HA hydrogel including defined micro-channels is used to mimic 
the characteristics of the native deep zone. All three zone constructs are combined into a single 
construct to assess the cell distribution and integrity of a full 3D zonal construct with a biomimetic 
zonal organisation. 
5.3 Methods and materials 
5.3.1 Cell isolation and expansions  
Bovine chondrocytes were used with passages 1 (P1) to simulate the clinical application. The cell 
isolation and culture details have been included in Chapter 2, Section 1.1.  
5.3.2 Fabrication of PLA nanofibers 
PLA nanofibers were generated by electrospinning technique using 2% PLA solution. The 
fabrication protocols with set up details are described in Chapter 2, Section 3. 
5.3.3 Fabrication of hydrogel scaffolds  
Crosslinked HA hydrogel was used to generate deep zone or the base for individual zone. The 
reconstructed HA gel was used to stabilize nanofiber meshes in individual zones or assembled 
samples following the protocols described in Chapter 2, Section 2.2. 
5.3.4 Fabrication and assembling of zonal constructs 
5.3.4.1 Fabrication and assembling of individual zone constructs 
Each individual zonal construct was produced using different combination of materials, where each 
was equipped with a different microstructure. In the fabrication of the superficial and middle zone 
constructs, an aligned and a randomly aligned PLA nanofiber meshes were placed respectively on a 
1 cm
2
 slice of crosslinked HA gel. The chondrocytes (1x10
5
 per sample) were seeded onto the 
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hybrid scaffolds. 100 l of the reconstituted HA gel and 2% (w/v) agarose hydrogel mixture in a 
ratio of 9:1 was applied to the scaffold surface to stabilize the cell and nanofiber position after 2 
hours cell seeding. The deep zone construct was formed by crosslinking HA hydrogel (1 cm
2
 X 0.6 
mm) with micro-channels. Ten microscale channels/sample were made using micro needle ( 400 
μm) pass through HA hydrogel. Chondrocytes (104 cell/channel) were seeded into the channels of 
the scaffolds. The chondrocytes (1x10
5
 per sample) seeding in the reconstituted HA gel without 
nanofiber and channels were fabricated as the negative control following above procedure. The 
samples were cultured in DMEM supplemented with 10% FCS and 1% L-glutamine and 1% 
penicillin-streptomycin at 37˚C in 5% CO2 for 14 days. 
5.3.4.2 Fabrication and assembling of the multiple zone construct 
The layer-by-layer assembly method was used to form zonal construct (Yang et al., 2011). The 
hydrogel with micro-channels was placed on PTFE plate and was seeded with cells at cell density 
of 1 x 10
4
/ channel. The samples were incubated for 2 hours at 37˚C, 5% CO2 to allow the cells 
attachment. PLA random nanofiber meshes were placed on top of the hydrogel and 1 x 10
5
/cm
2 
chondrocytes were seeded on nanofiber meshes. The cells were allowed to attach at 37
o
C for 2 
hours. 100 μl of the reconstructed HA hydrogel and 2% (w/v) agarose hydrogel mixture in a ratio 
of 9:1 were then loaded on top of the construct. The aligned nanofiber meshes were placed on top 
of the hydrogel. After that, the chondrocytes were seeded on nanofiber meshes at a cell density of 1 
x 10
5
/cm
2
. The cells were left for 2 hours in the incubator to allow for attachment. The formed 3D 
constructed samples were sealed by the reconstructed HA hydrogel, and thereafter incubated with 
supplemented DMEM mentioned previously and cultured for 14 days at 37˚C and 5% CO2. 
5.3.5 Characteraization of scaffolds  
Nanofiber scaffolds were imaged using SEM. Fibre diameters were determined using ImageJ 
through the SEM images by the protocol described in Chapter 2, Section 13. 
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OCT was used to measure the micro-channel morphology and the dimension of assembled 3D 
hybrid zonal scaffold. The OCT utilizes the wavelength centred at 1300 nm, providing 
approximately 1 mm image penetration. 3D zonal hybrid scaffold was placed inside a covered 
round small Petri dish. 2-D images were taken to record the morphological properties of 3D zonal 
hybrid scaffold. 
The mechanical properties of individual and assembled zonal scaffolds and the bovine cartilage 
tissue (positive control) and the HA gel alone construct (negative control) were measured in 
uniaxial compression testing using BOSE machine. The protocols with set up details can be found 
in Chapter 2, Section 15. Mechanical strength through ball indentation test was performed for the 
optimization of ratio of hydrogel mixture. The mixture gel in several ratios of agarose and HA were 
made (0:10; 0.5:9.5; 1:9; 2:8). The protocols with set up details are described in Chapter 2, Section 
15. 
5.3.6 Cell morphology monitoring  
The morphology of chondrocytes on each 3D zonal scaffold at different time points was imaged 
with an optical microscope attached to a CCD camera. Image-Pro Insight software was used to 
acquire the images. 
5.3.7 Cell viability 
In order to assess cell survival in hydrogel capsules, a standard live/dead cell staining kit was used 
following the protocol described in Chapter 2, Section 5.2. 
5.3.8 Biochemical assays 
Papain solution was used to digest the experimental samples at the end of the culture periods as 
described in Chapter 2, Section 2.4 for PicoGreen DNA assay and DMMB assay in Chapter 2, 
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Section 2.5.1 Section 6 respectively. The normalised value of total GAG content per cell was 
calculated based on GAG content and cell number in each sample. 
5.3.9  Immunolocalisation of key chondrogenic components 
Immunostaining was used to identify the specific ECM markers, collagen II and aggrecan, within 
each zone constructs and collagen I was also carried out to further confirm the phenotype of cells. 
3D visualisation of samples was achieved by scanning sections from bottom to top through a 
confocal microscopy. The z-stack of confocal microscope images with 20-μm intervals between 
each plane of the specimens throughout the thickness of 3D zonal scaffolds was reconstructed 
using Imaris 8.1 analysis software; which provided a tool to visualise the zonal structure in 3D 
constructs. Immunostaining was conducted using the protocol described in Chapter 2, Section 10. 
Intact samples were stained using this same protocol. 
5.3.10 Western blotting 
Western blotting was used to identify the production of specific ECM markers, collagen II, 
collagen I and aggrecan in the construct samples. The protein bands were shown with PVD 
membrane. Semi-quantitative measurement for proteins expressions using western blot was 
determined using ImageJ software. Western blotting was carried out according the protocol 
described in Chapter 2, Section 12.  
5.4  Results 
5.4.1 Optimization of mixture gel ratio 
The pulverised crosslinked HA gel had poor mechanical property. It could not form stable and 
portable hydrogel as scaffolds. Hence small percentage of agarose was mixed with HA gel to 
reconstruct mechanical strong and stable hydrogel. To identify the lowest agarose percentage in the 
hydrogel mixture, hydrogels with different ratios of HA and agarose were prepared, and the 
mechanical strength was assessed by ball indentation test. 
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Figure 5.1 showed the ball indentation setting up to test different composition of the reconstructed 
gel, higher agarose percentage, and higher mechanical strength. The mixture gel with 95% HA plus 
5% agarose could not withstand the metal ball and the ball penetrated the hydrogel layer 
immediately. 90% HA and 10% agrose mixture hydrogel was the mixture with the lowest agarose 
concentration withstands the metal ball loading for 30 minutes (Figure 5.1.A). Hence 90% HA plus 
10% agarose reconstructed gel has been used for the rest of experiments in this chapter. 
 
Figure  5.1: Microscopic side view images showing mechanical strength of HA and agarose mixture 
gel by ball indentation test in order to optimize the ratio of HA and agarose in the reconstructed gel. 
A) a mixture gel of 90% HA and 10% agrose. B) a mixture gel of 80% HA and 20% agrose. (*) 
and dash circle denote the metal ball, lines indicate the HA and agarose mixture hydrogel layer and 
arrows indicate filter paper as hydrogel support. The background is the free space. 
5.4.2  Scaffold morphology and mechanical property  
The SEM images (Figure 5.2.A, I, II) show the highly aligned and randomly arranged nanofiber 
meshes produced. The fibre diameter between the two types of fibres did not differ significantly 
(518±60 nm versus 486±80 nm, Table 5.1). Figure 5.2.A III clearly demonstrates the top view of 
` 
  165   
 
micorchannels in the deep zone, with an average channel diameter of 489 µm ±100, Table 1. Figure 
5.2.B illustrates the cross section of individual scaffolds fabricated through the combination of 
electrospun fibre with HA hydrogel or HA hydrogel with the channels passed through the gel.  
The cross-section of the assembled 3D zonal scaffold with zonal organisation; superficial, middle 
and deep zone was illustrated by using OCT imaging technique (Figure 5.3). This bottom-up, layer-
by-layer assembly technique has created distinct zonal organization in a 3D scaffold, both aligned 
nanofiber (superficial zone) and random nanofibers (middle zone) were placed on top of the 
hydrogel with defined micro-channels. 
The compression modulus was determined by the slope from the linear region of the stress–strain 
curve between 0.1 and 0.5 strain and the applied forces have been converted into stress with 
samples’ area. The height difference between samples has been considered in the strain values 
which were obtained from the displacement divided by initial height, whilst the ultimate 
compression strength was taken as the maximum stress. It was demonstrated there was little 
variation of the compression modulus between superficial, middle and deep zones, and gel alone 
scaffold, but the full 3D zonal scaffold had about 22 % higher compression modulus than each of 
the individual scaffolds. However, all scaffolds had lower compression modulus than native 
cartilage tissue (Table 5.1). The representative load deformation curves were displayed in Figure 
5.4. 
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Figure  5.2: Morphology of individual scaffolds and hybrid scaffolds. (A) Top view images of 
individual 3D zonal scaffolds; (B) Side-view of individual 3D zonal scaffolds. I) aligned nanofibre 
and superficial zone; II) random nanofibre and middle zone (The insert is the high magnification 
for aligned and random nanofibres); and III the emtey channels in HA hydrogel and deep zone (The 
insert is the reconstructed z-staged image showing the vertical channels). SEM images for I, II; 
light microscope and OCT images for III. (*) denotes the HA hydrogel layer. Scale bar is 100 μm. 
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Figure  5.3: Morphology of assembled scaffolds and constructs (A) Schematic illustration of the 
assembled zonal scaffolds with corresponding thickness. (B) An OCT image of the assembled 3D 
zonal constructs showing the aligned nanofibre as superficial zone, random nanofibre as middle 
zone, and the vertical emtey channels as deep zone. Scale bar is 250 μm. 
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Figure  5.4: Representative Stress-strain curves. A) The three individual, assembled 3D zonal 
scaffolds, and HA gel alone construct (negative control). B) Bovine cartilage tissue (positive 
control). 
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Table  5-1: Physical parameters of the hybrid zonal scaffolds, HA gel alone scaffold and bovine 
cartilage tissue 
Scaffold 
cartilage 
mimicking 
Scaffold 
orientation 
Fiber and 
channel 
size (μm) 
Ultimate compression 
stress (KPa) 
Compression 
modulus 
(KPa) 
Superficial Aligned 
(horizontal) 
0.518± 0.06 143± 32.35 15.47± 3. 5 
Middle Random 0.486± 0.08 149± 28.11 16.16± 2.9 
Deep Vertical 
channels 
489± 100 153± 12.41 15.85± 4.2 
Full scaffolds 
construction 
- - 209± 40.35 25.12± 4.4 
HA gel alone 
scaffold 
- - 145± 31.83 17.67± 3.8 
Bovine cartilage 
tissue 
- - 3410 ± 983  570 ± 164 
5.4.3 Chondrocyte morphology in individual constructs 
Figure 5.5 illustrates the morphology of live chondrocytes on each 3D zonal construct. Within the 
superficial zone, it can be seen that the individual chondrocytes appeared to stretch along the 
aligned nanofibers from day 1 and developed a highly aligned morphology at 2 weeks. By contrast, 
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chondrocytes maintained their round shape in the random oriented nanofibers within the middle 
zone. The cells appeared to cluster together. Within the HA channels of the deep zone, the 
chondrocytes appeared to form vertical round shape cells stacking up within the channels. 
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Figure  5.5: (A) Microscopic images of the live chondrocytes in the three separately cultured zonal 
scaffolds and HA gel alone constructs showing their morphology and orientation along culture at 
different time points (n = 3). Scale bar is 150 μm. (B) The schematic illustration the live 
chondrocytes morphology and orientation in the assembled three zonal scaffolds. Scale bar is 150 
μm. 
5.4.4 Cell viability 
Figure 5.6 shows the live/dead cell images of constructs taken by confocal microscopy. Based on 
the image observation, all zonal constructs had high viable cells (most green stained cells) and low 
dead cells (few red cells). In addition, in the superficial zone constructs chondrocytes aligned 
longitudinally along the nanofibers. High cell viability was demonstrated in the control construct. 
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Figure  5.6: The live and dead staining images of chondrocytes in three separately cultured scaffolds 
and HA gel alone construct taken at day 14 culture. The insert is the reconstructed z-staged image 
showing the cells within the vertical channel, indicating channel direction by an arrow. Green 
indicates live cells, and red dead cells. Scale bar is 100 μm, (n=3). 
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5.4.5 Cell number 
DNA quantitative assay was used to indicate the cell numbers. Figure 5.7 illustrates cell number in 
zonal constructs. It was demonstrated that at all culture time points, the HA gel alone, deep zone 
and middle zone scaffolds had almost the same cell number. However, the cell numbers were lower 
than that in the superficial zone scaffolds (p < 0.05). 
 
Figure  5.7: Cell number in three separately cultured scaffolds and HA gel only construct at Days 5, 
10 and 14 culture. Data are expressed as mean ± SD (n = 3). *p < 0.05 
Total sulphated GAG content production 
The total amount of sulphated GAG accumulated in the different 3D zonal scaffolds was quantified 
as shown in Figure 5.8. It is clear that the cells in HA gel alone, deep and middle zone scaffolds 
produced significantly higher GAG amounts than that in the superficial zone scaffold (p<0.05). The 
normalised GAG content (μg) per cell in different 3D nanofabricated zonal constructs is shown in 
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Figure 5.9. Seemingly, the GAG content with respect to DNA present was highest in the deep zone 
scaffold compared to the other zones, especially at later time points (p<0.05).
 
Figure  5.8: Total sGAG production in three separately cultured scaffolds and HA gel only construct 
at Days 5, 10 and 14. Data are expressed as mean ± SD (n = 3). *p < 0.05 
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Figure  5.9: Total sGAG production normalised to cell number in three separately cultured scaffolds 
and HA gel only construct at Days 5, 10 and 14. Data are expressed as mean ± SD (n = 3). *p < 
0.05 
Expression of ECM components  
Figure 5.10 shows the immunofluorescence staining for markers of ECM in individual 3D zonal 
constructs. Immunostaining for collagen I was also carried out to further confirm the phenotype of 
cells. It can be seen that the cells in superficial zone sample had the highest collagen I production 
whilst the lowest collagen II and aggrecan production. Middle and deep zone samples demonstrated 
higher collagen II and aggrecan expression than superficial zone. On the other hand, with regards 
to collagen I, the staining intensity decreased with the depth-dependent constructs, whereas to 
aggrecan, its expression increased with the depth-dependent constructs. For collagen II, the highest 
staining was seen in the middle zone samples and the lowest was observed in the superficial zone 
samples. However, production and secretion of collagen II were present in all scaffold types, which 
was not the case for collagen I staining. The staining images of native bovine cartilage samples 
showed the depth variation of collage I, II and aggrecan expression with collagen I expression in 
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superficial zone only; collagen II across all zones and strong aggrecan in middle and deep zones 
(Figure 5.11). 
Western blot results in Figure 5.12.A showed the superficial zone samples produced higher 
collagen I and lower collagen II and aggrecan expression. Whilst the collagen II demonstrated 
higher level in middle zone scaffold with low collagen I expression. Aggrecan, one of the main 
markers of articular cartilage, showed high expression with depth; deep zone had the highest 
aggrecan and lowest collagen I concentration. The intensity of proteins expression (Figure 5.12.B) 
seemed to correspond to the Western blot results (Figure 5.12.A). The results were consistent to 
immunohistological staining.  
To demonstrate that the chondrocytes could be incorporated and maintained in individual zonal 
scaffolds when assembling the individual zonal constructs into a construct, DAPI was used to label 
the cells first and the three-different zone constructs with labelled cells were assembled and further 
cultured for 14 days. The cross-sectional image and reconstructed 3D image of the assembled 
construct were shown in Figure 5.13. Both live/dead staining images and DAPI tracking image 
showed that the zonal structure was well maintained, and the cells were spread across the zones. 
Few red cells in live/dead staining assay demonstrated the high cell viability in the assembled 
constructs (Figures 5.13.A and B). 
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Figure  5.10: Immunostaining images of chondrocytes cultured in the three separate zonal scaffolds and HA gel only constructs: column A; superficial zone, 
column B; middle zone, column C; deep zone, column D; chondrocytes are grown in HA hydrogel. Blue: nuclei; green: aggrecan; red: collagen II or 
collagen I. Scale bar is 100 μm. (n=3, three independent experiments). 
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Figure  5.11: Illustration of Immunostaining images of freshly dissected bovine cartilage. (A) collagen I, (B) collagen II, (C) aggrecan, (D) Toluidine blue. 
Blue: nuclei; green: aggrecan; red: collagen II or collagen I; purple: GAG. Scale bar is 100μm. 
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Figure  5.12: (A) Western blotting of collagens I and II and aggrecan expression of chondrocytes in 
the three zonal constructs after culturing for 14 days. (B) Representative semi-quantification of 
western blotting results and expression levels relative to the loading control (GAPDH). Data are 
expressed as mean ± SD (n = 3). *p < 0.05 
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Figure  5.13: Reconstructed 3D images of DAPI labelled chondrocytes in the assembled 3D zonal scaffolds alongside live/dead kit staining covering the 
superficial, middle, and deep zones (presenting one vertical channel only). A) live cells (green); B) dead cells (red); C) DAPI (blue). Scale bar is 250 μm.
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5.5  Discussion 
The zonal organisation of scaffolds that mimics the organisation and the structure of cartilage tissue 
and potentially induce the synthesis of appropriate ECM within the separate zones could lead to 
long-term functionality in cartilage regeneration. There is no doubt that this is a complex challenge 
to tackle. In this study, hybrid cartilage scaffolds have been successfully fabricated, comprising 
PLA nanofiber and a HA hydrogel which appeared to provide appropriate zone-specific parameters 
mimicking microstructural organisation and inducing ECM production. The multiple imaging, 
biochemical and biomechanical assessments demonstrated that the seeded bovine chondrocytes 
responded to the scaffolds spatial orientation and arrangement. The current hybrid zonal-specific 
3D scaffolds induced the formation of biomimetic zonal organisation and composition of ECM as 
found in native articular cartilage tissue. However, HA gel scaffolds only achieved randomly 
distributed round chondrocytes with homogeneous ECM distribution.  
The ‘contact guidance’ from electrospun nanofibers triggers distinct cell arrangement 
Articular cartilage has a heterogeneous arrangement of cells and ECM, which comprises rounded 
and orientated cells, demanding specific ECM fibres structure in defined regions. It has been 
confirmed that the electrospun nanofibres developed in this study could stimulate chondrogenic 
capacity selectively through providing a surface similar to the native zones of articular cartilage.  
It has been reported that cytoskeletal morphology and orientation of ECM is tightly interrelated 
(Dalby et al., 2002; Tijore et al., 2018). The control of the orientation and the morphology of cells 
can be used to control the architecture of secreted ECM because the orientation of newly produced 
ECM follows the cytoskeletal shape. Inversely, artificial ECM with specific patterns on the cell 
culture substrates can induce the aligned cellular patterns through ‘contact guidance’ (Vrana et al., 
2008; Wilson et al., 2012). Dalby et al. (2002) have documented that the ECM architectures and 
cytoskeletal orientation can be controlled by nanometre-scale structures. Work from our own group 
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(Wimpenny et al., 2012) further demonstrated that electrospun nanofibres facilitated the adhesion 
of chondrocytes and the regulation of their morphology. 
The crosslinked HA hydrogel is chondrogenic  
Hydrogels have a promising potential for tissue engineering applications due to their high-water 
content, tunable physical properties, able for homogeneous cell distribution, high permeability for 
nutrients and waste products of metabolism (Aleksander-Konert et al., 2016; Eslahi et al., 2016). 
Moreover, highly hydrated hydrogels can better mimic the chemical and physical environments of 
ECM and therefore are ideally cellular microenvironment for cell proliferation and differentiation 
(Tan et al., 2010).  
The hydrogel for cartilage regeneration needs to have the capacity to maintain their chondrogenic 
capacity. HA found natively in cartilage tissue, has been studied for decades (Yoo et al., 2005). 
Chondrocytes in native articular cartilage tissue demonstrated round shape morphology and 
clustered in small groups (Buckwalter et al., 2005). HA is known to interact with chondrocytes via 
various surface receptors including CD44. This surface receptor bound to HA and triggers 
chondrocytes to retain their original morphology and phenotype, an area that is still not fully 
understood (Yoo et al., 2005). High aggrecan and collagen II production in the deep zone scaffold, 
channelled HA from this study supported that HA is highly chondrogenic.  
Hybrid scaffolds mimic native zonal structure  
In this study, nanofibers acted as a contact guidance platform to control cell morphology and 
matrix production as well as provided further evidence to show that the aligned and randomly 
orientated fibre morphology resulted in elongated and small clusters of round cells morphology 
respectively in superficial and middle zones scaffolds. 
Chondrocyte phenotype is defined by a change in morphology and the alteration of crucial ECM 
components including collagen II and aggrecan (Bonaventure et al., 1994; Bobick et al., 2009). 
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This study showed the organisation of cell aggregates regulated the biochemical synthesis and 
ECM organisation. In the superficial zone, the aligned nanofibres produced elongated chondrocytes 
cells, which altered the cell phenotype to fibroblast-like phenotype with higher collagen I synthesis 
and the lowest collagen II, aggrecan and GAG. The middle zone scaffold maintained the round 
shape of chondrocytes with random clusters with higher collagen II, aggrecan and GAG production 
in comparison to superficial zone. Apparently, the orientation of electrospun fibres can be smartly 
used to regulate rather precisely chondrocytes’ phenotype through their morphology from fully 
elongated to round cell shapes and variation of ECM synthesis. In the current study, we used 
crosslinked and reconstructed HA gel as the stable hydrate environment for chondrocytes in a 
prolonged culture period. The micro-channels were made through the HA hydrogel to mimicking 
the deep zone. In the deep zone scaffold, the chondrocytes formed round, columnar cell clusters 
with higher aggrecan and GAG production in comparison to superficial zone. Current data 
illustrated that HA can be utilised to control both ECM production and maintain chondrocyte 
morphology. 
 This study adapted a smart hybrid and sandwich style fabrication for zonal distinct constructs, 
which separately and synergistically has the potential to regulate a chondrocytes’ phenotype, 
enabling chondrocyte elongation (superficial zone) or aggregation (random clusters in the middle 
zone and columnar clusters in the deep zone). The bottom hydrogel layer restricted cells attaching, 
which drove cells adhered and oriented along nanofiber meshes, whilst the top layer of hydrogel 
(reconstructed HA gel) provided the support necessary to stabilise the orientation of cells and 
nanofibers meshes. Altogether, combining of using a highly hydrated hydrogel, which has low 
protein affinity, with nanofibers, which have high cell attachment capacity, has the potential to lead 
to a clinically benefit product in the cell therapy of cartilage treatment. Hence, the adaptation of the 
two level control strategies in scaffold fabrication has the potential to create multiple zone cartilage 
regeneration. Different from other reports, this work has generated hydrated and full thick construct 
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with distinct ECM architecture and composition along depth (Klein et al., 2003; Malda et al., Ng et 
al., 2005; Steele et al., 2014). 
5.6 Conclusion 
This feasibility study confirmed that PLA nanofiber meshes with different alignment and 
micorchannels in an HA hydrogel could be used to create hybrid scaffold models. The current 
hybrid scaffolds induced chondrocyte alignment and generation of ECM as found in different zones 
of native cartilage, evidenced by the cell morphology and ECM component production level. The 
regulation of chondrocytes’ aggregation state and skeleton morphology by nanofiber and micro-
channels and maintaining of these morphologies in highly hydrate gel can become a facile 
technique to replicate zonal specific cartilage construct. The three zonal constructs can be 
assembled and kept intact during culture. Thus, this study presents new hybrid scaffolds and facile 
method for biomimetic cartilage regeneration. 
 
 
 
 
 
 
 
 
 
` 
  185   
 
Chapter 6 : General discussion, overall conclusion and future 
work  
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6.1 General discussion  
The healthcare challenge to regenerate human articular cartilage is at an exciting point but there are 
some key issues which remain difficult but important steps. This PhD study has attempted to 
address key issues to further our understanding and to move the field forward. Isolated 
chondrocytes are not the ideal form of cartilage cells to produce cartilage ECM but they are the 
cells used in the recently NHS approved cartilage cell therapy (National institute for health and 
clinical excellence UK, 2017). They are ideal for treating small focal cartilage defects. However, 
the field needs to continue to move forward to find a better solution for large, full depth defects 
which affect both cartilage and bone. Freshly extracted chondrons form a more cartilage-like ECM 
than chondrocytes and their surrounding PCM is thought to maintain chondrocyte phenotype (Vonk 
et al., 2014; Zhang et al., 20014). The PCM is crucial for many functions including good ECM 
formation (Poole, 1997; Larson et al., 2002). The presence of a PCM has been shown to enhance 
matrix production by chondrocytes, suggesting that an intact PCM improves cartilage regeneration 
(Vonk et al., 2010). Herein, the data obtained in chapter 3 and 4 have provided evidence to support 
work performed by Lee and Loeser, (1998). Using bovine chondrocytes in a monolayer model, we 
have demonstrated that chondrons appeared to have better chondrogenic potential when compared 
to chondrocytes with respect to GAG, collagen II and collagen VI synthesis. Crucially, the PCM is 
important for ECM synthesis but it is a fragile structure.  
Currently there is an equal weight of evidence suggesting that MSCs with or without other cell 
types are suitable for cartilage cell therapy. This was evidenced, for example, by the observational 
cohort study by Nejadnik et al, (2010) who reported that MSCs in cartilage repair were as effective 
as chondrocytes. Only recently, it has become clear that co-culture MSCs with articular cartilage 
cells offers an even great potential to cartilage growth.  
 A main impediment related to co-culture studies is that a large number of cells is required, which 
cannot be gathered from the patient samples obtained at surgery. A large number of consistent 
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chondrons is difficult to isolate from limited supplies of cartilage tissue. To avoid the issue of cell 
numbers, well characterised bovine chondrocytes and chondrons were used alongside rat MSC in 
this study because it is very difficult to get bovine MSCs. Xenogeneic co-culture models using the 
bovine chondrocytes and either rat or rabbit MSCs have been successfully used by some other 
groups without any immune response or different inverse outcome, but that immune reactions were 
not assessed (Levorson et al., 2014; Meretoja et al., 2014). 
 The phenotypic changes are considered to be the result of signalling via direct cell–cell contacts, 
as well as secreted factors generated by MSCs and articular cartilage cells (Bian et al., 2012, 
Levorson et al., 2014). The reciprocal effect has been used to explain the ratio effect when co-
culture MSCs with cartilage cells in 2D model. 50:50 of MSC and cartilage cells produced better 
enhancement effect in ECM production in comparison to 20:80 and 80:20 ratio samples. In 80:20 
MSC and chondrocytes or chondrons ratio samples, MSCs were dominated cell population with 
lower chondrogenic impact due to the low number of cartilage cells. While the samples with 20:80 
MSC and chondrocytes or chondrons ratio had prevailed cartilage cells number, then the MSCs 
exerted less effect. 50:50 MSC and chondrocytes or chondrons ratio had a balance between the two 
types of cell populations which allowed exchanging the signalling to maintain the chondrogenic 
phenotype longer for cartilage cells and induce more MSCs to differentiate into chondrogenic 
lineage cells. 
The PCM is believed to have chondrogenic potential evidenced by the enhanced ECM matrix 
production in co-culture of chondron and MSCs, as compared to chondrocyte or chondron 
monocultures. The co-culture of MSCs with chondrons appeared to decelerate the loss of the PCM 
as determined by higher collagen VI expression. However, the high chondrogenic potential will be 
lost if there are no appropriate cell growth and matrix protection environments even the presence of 
MSCs. 
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The HtrA1 secretory enzyme was suggested to degrade collagen VI in the PCM. The hypothesis 
was proved correct in this study deduced from the immunostaining results showing an inverse 
relationship between HtrA1 expressions and collagen VI concentration in the PCM. It is confirmed 
that the presence of MSC directly or indirectly suppresses the production of HtrA1 or generates 
inhibitors for HtrA1 in co-culture samples, which led to decelerate the loss of the PCM as 
determined by collagen VI expression.  
Figure 6.1 illustrates the modelling and remodelling processes of PCM at different culture 
conditions in our 2D model based on the collagen VI staining outcome. The overall observation 
from this study was that monolayer culture could not preserve mature PCM nor regenerate PCM 
even co-culturing chondron with MSCs. 
 
Figure  6.1: The schematic illustration of modelling and remodelling processes of PCM during 
different culture conditions in 2D culture models. 
This study demonstrated that 3D culture environments as appropriate scaffold are essential 
conditions required to mimic the native ECM microenvironment which preserved existing PCM 
molecules; bound/stored newly produced PCM and enhanced the chondrogenic capacity during 
cartilage regeneration. Multiple factors in 3D culture including hydrogel types (hyaluronic acid 
versus agarose hydrogels); cartilage cell types (chondron versus chondrocytes); mono or co-culture 
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with MSC and different medium types affected the chondrogenic capacity assessed by the cell 
morphology, production rate of ECM (GAG production and collagen II expression) and the 
presence of PCM (collagen VI expression) (Figure 6.2). 
This study confirms the newly formed PCM from isolated bovine chondrocyte culture has various 
deposition across mono and co-cultures, and HA and agarose hydrogels encapsulation along culture 
time. In the HA cultures, PCM was observed after 7 days in both mono and co-cultures 
chondrocytes with speckled stripe structures surrounding the chondrocytes surface (Figure 4.11). 
The cultures required two weeks to restore the PCM. For agarose cultures, small scattered stippled 
layer around the chondrocyte of PCM appeared after 7 days in co-cultures and after 14 days in 
monocultures. PCM was restored after three weeks. When using chondrons in 3D culture, PCM 
was maintained in all culture period and all the studied conditions. The co-culture with MSCs 
stabilized the PCM better than the monoculture. 
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Figure  6.2: The schematic illustration of modelling and remodelling processes of PCM in 3D 
culturing with (A) chondron; (B) chondrocytes at different culture time points with different culture 
conditions. 
Using a synchrotron source for FTIR provides a more powerful tool for cells and tissue study 
because of the high brightness which enables using lower aperture to identify the spatial 
heterogeneity of biomolecules in single cells with as small as 5 micrometre aperture. Also, 
synchrotron microFTIR offers spatial distribution mapping and chemical structure at the micron 
scale, when integrating chemical analysis specificity with microbeam precision. 
The current study confirmed the multiple advantages of microFTIR. It is a non-destructively 
technique with less sample preparation and provides integral information for the spatial distribution 
and concentration of proteins, proteoglycan and lipids, which correlated to the PCM formation and 
cellular evolution of cultured chondrocytes in tissue-engineered cartilage models. 
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PCA scores showed changes in amide II which was related to protein structure and concentration. 
The spectral difference in the amide III band could be due to changes in SO
-3
 groups. Indirectly, 
PCA spectra of data showed that day 14 and 21 samples clustered to chondrons, indicating that 
chondrocytes cultured under these conditions could generate chondron-like cell morphology and 
PCM. Thus day 14 and 21 samples which contained collagen VI and more proteoglycan may 
explain the spectral similarity to chondrons but not to chondrocytes. PCA analysis in the lipid 
region further supported this hypothesis where the chondron and chondrocyte separated, but the 
separation was not as strong as compared to the fingerprint region on all three time points (day 7, 
14, and 21). Synchrotron microFTIR spectroscopy and PCA can indeed help in better 
understanding the cellular evolution of cultured chondrocytes in tissue-engineered cartilage models 
involving subtle changes in protein types and proteoglycan concentration. 
Cartilage can withstand large forces due to its complex structure and tissue organisation. Articular 
cartilage has an anisotropic zonal structure extending from the articular surface to the subchondral 
bone. The zones are variations in mechanical properties, cellular and extracellular matrix 
(Buckwalter et al., 2005). The goal of cartilage engineering is to generate in vivo recapitulated 
tissues with integrity and function by combining cells and scaffolds with chondrogenic ability. 
Although there are some success stories using this approach, there is little information on well 
organised constructs. Given the importance of recapitulation of in vivo tissues, it is imperative to 
engineer cartilage tissues with zonal structure and biofunction. 
In this study, a hybrid and sandwich fabrication approach were employed for distinct zonal 
constructs allowing separate and synergistic regulation of chondrocyte phenotype (Figure 5.3). The 
model showed chondrocyte elongation in the superficial zone or chondrocyte aggregation in either 
the middle zone or deep zone (columnar clusters). The bottom layer of the hydrogel limited cell 
attachment and this drove cells to adhere and orient their somas alongside nanofiber meshes 
(Figure 5.5). In the top layer of the hydrogel (reconstructed HA gel), cell orientation was stabilised 
` 
  192   
 
on the nanofiber meshes. The aligned nanofiber mesh used in the superficial zone induced an 
elongated cell morphology, lower glycosaminoglycan (GAG) and collagen II production, higher 
cell proliferation and collagen I production than the cells in the middle zone scaffold. Within the 
middle zone scaffold, which comprised of a randomly orientated nanofiber mesh, the cells were 
clustered and expressed more collagen II. The deep zone scaffold induced the highest GAG 
production, the lowest cell proliferation and the lowest collagen I expression of the three zones. 
The combination of highly hydrated hydrogels with low protein affinity allowed chondrocyte 
chondrogenesis at the macroscopic level. By using nanofibers with their high cell attachment 
affinity, it is possible to control cell morphology at the zonal level. These characteristics will 
eventually speed up the cell therapy development where the maturation of therapeutic cartilage 
with the zonal organisation can be realised pre and post-implantation. 
6.2 Overall conclusion 
According to the results obtained it is concluded that both chondrons and MSCs enhanced ECM 
production and maintained PCM at the same time via MSCs’ ability to delay the PCM destruction. 
The hypothesis that MSCs secreted inhibition factors for HtrA1 were supported by the finding of 
inverse expression of collagen VI to this enzyme, and HtrA1 was responsible for degrading PCM 
components. This study clearly demonstrated that 2D culture environment could not maintain or 
regenerate PCM even with MSC presence because the hard substrate (culture plate), induced 
chondrocytes and chondron differentiation to fibroblast-like cell phenotype. Without ECM 
microenvironment, which stabilise and accumulate newly formed PCM; matured PCM in chondron 
would lose during the 2D culture in short duration.  
This work showed that 3D culture systems could maintain the chondrogenic phenotype of cartilage 
cells manifesting as the presence of collagen VI during the culture. The 3D culture preserved PCM 
in chondron from day 1 up to 21 day culture. In addition, the appearance of collagen VI in the 
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cultured chondrons was dense and homogenous; and co-culture with MSCs did not affect much the 
appearance and density of collagen VI. 
3D culture of chondrocytes had ability to regenerate PCM manifesting as the gradual production of 
collagen VI along the culture. The variation of collagen VI concentration was strongly culture 
condition dependent. In contrast to collagen VI appearance in chondron culture, the newly formed 
collagen VI was spotted, less dense.  
At the first day of culture, chondrocytes displayed no staining of collagen VI. By day 7, it was 
apparent that cell surfaces were staining positively within HA hydrogel in both mono and co-
cultures with significant high expression in HA co-culture, while the agarose culture just showed a 
small scattered stippled layer around the chondrocyte in co-culture with no expression in 
monoculture at day 7. At day 14, collagen VI staining was found at all culture conditions including 
agarose monoculture. After 21 days the presence of a boundary of collagen type VI stained region 
surrounding the chondrocytes with a little change between mono and co-cultures for both HA and 
agarose hydrogels. Also, it is revealed that the chondrogenic culture media enhanced the expression 
of cartilage-specific ECM markers (collagen II and GAG) comparing with basal media, but both of 
them had no any effect on PCM marker ‘collagen VI’ synthesis. The best culture condition to 
generate high ECM/PCM content from chondrocyes was in HA hydrogel, using chondrogenic 
media and with 50% MSCs. 
The study has developed a new non-destructively technique to observe the PCM formation and 
cellular evolution of cultured chondrocytes in tissue-engineered cartilage model by using the 
synchrotron microFTIR technique via analysis of spectral changes in both lipid and fingerprint 
regions. 
Fingerprint region analysis for FTIR spectrum demonstrated that cultured chondrocytes might 
generate chondron-like cell morphology specifically at day 14 and day 21. The presence of PCM 
on day 14 and day 21, which contained collagen type VI and proteoglycan, could explain their 
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similarity of spectra to chondron, not to chondrocytes by PCA analysis. The spectrum analysis in 
lipid region further supported these speculations. Lipid region revealed that the separation of 
chondron, chondrocytes, day 7, day 14 and day 21 were not strong as in fingerprint region because 
the change of the lipid region reflected cell number most. 
The current study confirmed that PLA nanofiber meshes with different alignments (aligned and 
random) and micro-channels in HA hydrogels could act as hybrid scaffolds which can induce 
distinguished chondrocyte alignment and ECM generation in three native cartilage zones. The three 
zonal constructs can be assembled and kept intact during culture. Both biological responses were 
evident at cell morphology and ECM production levels. Regulating chondrocyte aggregation, state, 
cytoskeletal morphology with nanofibers and micro-channels in highly hydrated hydrogels through 
the hybrid scaffolds become a simple technique to induce and generate zonal-specific structure of 
the cartilage. The aligned nanofiber mesh induced chondrocyte alignment and generation of ECM 
as found in the superficial zone, evidenced by the elongated cell morphology, low GAG production 
and collagen I production than the cells in the middle and deep zones scaffolds. The middle zone 
scaffold with randomly alignment nanofiber induced round chondrocyte clusters and expressed 
more collagen II. As a deep zone scaffold; the micro-channels in HA induced the highest aggrecan 
and GAG production and the lowest collagen I expression of the three zones. 
6.3 Future work 
The work described in this study has raised some approaches for future work, which could help in 
the cartilage tissue engineering. 
Regarding the cell source, human cells could then be conducted instead of cross-species like bovine 
or rat cells, which is likely to provide the opportunity to mimic human articular cartilage tissue 
before they become clinically useful products. 
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Further characterisation could then be conducted to determine the mechanism behind the co-culture 
and direct cell-cell contacts signalling and identify the secreted factors generated by MSCs and 
chondrocytes or chondron. 
With regard to the development of 3D nanofibre-hydrogel composite, further work is suggested to 
replicate full thickness native articular cartilage tissue, which could be achieved through bottom-
up, layer-by-layer assembly method. The biological and biomechanical properties of the new 
cartilage constructs will be characterised thoroughly. It would be hoped that these improvements by 
incorporation of growth factors would further enhance the ECM-like cartilage. 
Furthermore, it would be beneficial to determine the long-term stability and tissue formation over 
increased culture duration, HA concentration in the constructs and application of mechanical 
condition for the constructs which accelerate the ECM production are potential approaches to 
increase the mechanical property of the constructs. 
Further work is suggested to study formation of PCM through different zones by using 3D 
nanofibre-hydrogel composite which is likely to provide functional engineered cartilage tissue. 
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Appendix  
 
 
Figure  1: Typical standard curve performed for DMMB assay using serial dilutions of GAG 
ranging from 0 to 40 µg/ml 
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Figure  2: Typical standard curve performed for PicoGreen assay using serial dilutions of DNA 
ranging from 0 to 1000 ng/ml 
 
` 
  221   
 
 
Figure  3: Typical standard curve performed for BCA assay using serial dilutions of protein ranging 
from 0 to 2000 µg/ml 
 
 
 
 
 
Figure 4: Illustration of freshly dissected bovine cartilage stained by alcian blue. Scale bars 
represent 150 μm. 
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Figure 5: Illustration of freshly dissected bovine cartilage stained by toluidine blue. Scale bars 
represent 150 μm. 
